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Comparison of Human Skin or Epidermis Models with Human and Animal Skin in In
Vitro Percutaneous Absorption
A. Billich, F. Schmook, and J. Meingassner
Novartis Research Institute, Vienna, Austria
For the study of in vitro skin penetration of candidate drugs, excised animal skin is frequently used as
replacement for human skin. Reconstructed human skin or epidermis equivalents have been
proposed as alternatives. We compared the penetration properties of human, pig and rat skin with
the Graftskin(tm) LSE(tm) (living skin equivalent) and the Skinethic(tm) HRE (human
reconstructed epidermis) models using four topical dermatological drugs (salicylic acid,
hydrocortisone, clotrimazole and terbina®ne) with widely varying polarity. In agreement with
published data, pig skin appeared as the most suitable model for human skin: the ¯uxes through the
skin and concentrations in the skin were of the same order of magnitude for both tissues, with
differences of at most two- or four-fold, respectively. Graftskin(tm) LSE(tm) provided an adequate
barrier to salicylic acid (¯ux of 45 mg per cm2 per h as compared to 22 mg per cm2 per h for human
skin), but was very permeable for the more hydrophobic compounds (e.g. about 900-fold higher
¯ux and 50-fold higher skin concentrations of clotrimazole as compared to human skin), even
more than rat skin. In the case of the Skinethic(tm) HRE we found similar concentrations of
salicylic acid as in human skin (745 mg per g) and an about 7-fold higher ¯ux (153 mg per cm2 per
h). In contrast, the permeation of hydrophobic compounds through the epidermal layer was vastly
higher than through split-thickness human skin (up to a factor of about 800). To conclude,
currently available reconstituted skin models cannot be regarded as generally useful for in vitro
penetration studies, while pig skin is a suitable model for human skin for this purpose.
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Altered Sebaceous Gland Morphology and Function in Parathyroid Hormone-Related
Protein Transgenic Mice
G. Woodard, Y. Cho, and J. Foley*
Medical Sciences, Indiana University School of Medicine, Bloomington, Indiana; *Dermatology, Indiana
University School of Medicine, indianapolis, Indiana
Murine transgenic models that either overexpress or lack parathyroid hormone-related protein
(PTHrP) in the epidermis suggest that the peptide in¯uences both the development and
maintenance of adnexal structures in the adult. In this study we evaluated sebaceous gland
morphology and function in both the K14-PTHrP mice and the collagen II-PTHrP (rescued)-
PTHrP-knockout mice that overexpress or lack the peptide, respectively. In the adult mouse skin,
the most intense PTHrP mRNA and protein labeling was observed in the upper portion of the
external root sheath of the hair follicle close to where the sebaceous gland intersects the structure.
During the ®rst hair cycle (1±3-weeks), sebaceous gland morphology and function in the two
PTHrP transgenic models did not appear to differ greatly from that of wild-type littermates. By 8±
12-weeks, differences in coat texture became apparent in both the K14-PTHrP and the rescued
PTHrP-knock out mice as compared to sex matched wild-type littermates. The dorsal coat of the
12±16-week-old K14-PTHrP mice appears dry, neutral lipids in the hair were decreased by ~50%
and the average sebaceous gland area was increased 27 + 5% as compared to sex matched wild-type
littermates. The coat of the 12±16-week-old rescued PTHrP-knockout mice appears to be matted
and greasy, neutral lipids in the hair were increased ~2 fold and the average sebaceous gland area
was decreased by 53 + 6% as compared to sex matched wild-type littermates. Morphologic analysis
of the oldest skin samples available form both of the models (6 months for the rescued PTHrP-
knockout and 1.5 years for the K14-PTHrP) suggest that the respective trends in the size of the
sebaceous glands appear to become more pronounced with age. Taken together these ®ndings
suggest that PTHrP may function to regulate sebocyte precursor proliferation/differentiation in the
adult mouse.
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Activators of Peroxisome Proliferator-Activated Receptors (PPARs) Alter the Pro®le of
Lipid Synthesis in Rat Preputial Sebocytes
I. Safonova, C. Chomat, S. Michel, and J. Voegel
Galderma R + D, Sophia Antipolis, France
Excess of sebum production is one of the major factors contributing to the formation of primary
lesions in acne. Androgens play an important role in acne due to their effects on sebaceous gland
growth and differentiation. Recently, activators of another subfamily of nuclear receptors, PPARs,
have been shown to induce sebocyte differentiation in vitro as judged by counting the number of
lipid forming colonies stained with Oil Red O. In the present work, we describe the effects of
Methyltrienolone (R1881) a speci®c agonist of the androgen receptor (AR) and selective activators
of the three PPAR subtypes (PPARa, PPARd and PPARg) on the pro®le of lipid synthesis in rat
preputial sebocyte cultures. Lipid synthesis was analyzed by incorporation of 14C-acetate followed
by thin layer chromatography. Polar lipids represented approximately 80%, triglycerides 2±3%,
cholesterol 7±8%, fatty acids 2±4%, diglycerides 2%, cholesterol- and wax esters 0±2% of total lipids
synthesized by sebocytes. Treatment of sebocytes with the speci®c AR agonist R1881 at 10±8 M
did not alter the pro®le of lipid synthesis. BRL49653, a speci®c agonist of PPARg, induced a 2-
and 4-fold increase of triglyceride and cholesterol/wax ester synthesis, respectively, while synthesis
of diglycerides, cholesterol and fatty acids remained unchanged. A synergistic effect on the
triglyceride (5-fold increase) and cholesterol/wax ester synthesis (12-fold increase) was observed
when sebocytes were treated with BRL49653 and R1881. The effects of selective agonists of
PPARa (Wy14 643) and PPARd (L-165041) on the lipid synthesis pro®le of cultured rat preputial
sebocytes will also be presented. In conclusion, rat preputial sebocytes respond synergistically to
AR and PPAR agonists by an increase in the synthesis of lipids observed in sebaceous glands,
namely triglycerides and cholesterol/wax esters.
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The Skin as a Steroidogenic Tissue: Enzymes and Cofactors Involved in the Initial Steps
of Steroidogenesis are Expressed in Human Skin and Rat Preputial Sebocytes
D. Thiboutot, A. Sivarajah,* K. Gilliland, Z. Cong, and G. Clawson*
Dermatology, Penn State University, Hershey, Pennsylvania; *Pathology, Penn State University, Hershey,
Pennsylvania
Cytochrome P450 cholesterol side chain cleavage enzyme (P450scc) catalyzes the rate-limiting step
in steroid hormone synthesis. In concert with its cofactors, adrenodoxin and adrenodoxin
reductase, and transcription factor, steroidogenic factor-1, this enzyme converts cholesterol to
pregnenolone. Translocation of cholesterol from the outer to the inner mitochondrial membrane is
regulated by the steroidogenic acute regulatory protein. Although the human sebaceous gland can
synthesize cholesterol from two carbon fragments and can metabolize steroids such as
dehydroepiandrosterone into potent androgens, the de novo production of steroids has not been
demonstrated in human skin. The goal of this study is to delineate the steroidogenic pathway
upstream from dehydroepiandrosterone by documenting the presence of members of the P450scc
system. Immunoreactivity of an antibody to P450scc and cytochrome P450 17-hydroxylase was
noted in human facial skin, cultured human sebocytes and keratinocytes, and rat preputial
sebocytes. These enzymes were expressed in the epidermis, hair follicles, sebaceous ducts,
sebaceous glands, and eccrine glands of human facial skin. Immunoreactivity of antibodies to the
steroidogenic acute regulatory protein, adrenodoxin, adrenodoxin reductase and the steroidogenic
factor-1 colocalized to areas of cytochrome P450scc and cytochrome P450 17-hydroxylase
expression. Results of immunohistochemistry were con®rmed with Western blotting using protein
extracts of human sebaceous glands. Biochemical activity of cytochrome P450scc and cytochrome
P450 17-hydroxylase was documented in rat preputial sebocytes as detected by radioimmunoassay.
These data suggest that the skin can synthesize steroid hormones de novo. These steroids in turn
may mediate skin diseases such as acne, androgenetic alopecia and hirsutism.
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Human Speci®c Sebaceous Lipid Synthesis and Sebum Secretion in Human Skin-Scid
Mouse Chimera
W. Li, M. Anthonavage, K. Stenn, and M. Eisinger
Skin Research Center, Johnson & Johnson,CPWW, Skillman, New Jersey
Human facial skin from postmenopausal females contains relatively small sebaceous glands mostly
associated with sebaceous or vellous hair follicles. Split thickness grafts of such skin, transplanted
onto male SCID mice 5±6 weeks of age, revealed presence of small glandular structures within the
®rst two months post transplantation (0.5% of total skin area occupied by glands ± TOG). A
signi®cant increase in the gland size was noticed between 8 and 12 weeks post transplantation (4.3%
TOG). Following this period of time, the glands remained approximately the same size or
decreased slightly during the 4±8 weeks. Compared to the skin sample prior to grafting, the glands
post transplantation enlarged approximately 6.5 fold. Sebum secretion was ®rst detected by
SEBUTAPE four weeks post grafting. There was a gradual increase in sebum secretion that
paralleled the observed increase in gland size. Maximal secretion was at 12 weeks. The levels were
approximately the same at 20 weeks post grafting. In parallel experiments, when the same skin was
transplanted onto female mice, the gland enlargement and sebum production was not observed.
However, topical treatment of such grafts with androgens (DHT) resulted in increased gland size
and sebum production, similar to that seen in the male mice. Thus, the observed increase in gland
size and sebum production was presumably initiated by androgens produced by the male mice. Ex-
vivo labeling with 14C acetate, followed by high performance thin layer chromatography
(HPTLC), showed increased sebaceous lipid synthesis in 3-month-old transplants when compared
to the pretransplantation levels. Interestingly, the sebaceous lipids synthesized in the transplanted
skin were human speci®c, showing the presence of squalene and wax esters and other sebum
components, i.e. triglyceride. In addition to human speci®c lipid production other sebocyte
expressed markers, i.e. epithelial membrane antigen, b-endorphin and melanocortin-5 receptor
were all detected in the human sebaceous glands in SCID mice. The presented data provide
evidence for functional sebaceous glands displaying a human phenotype in the SCID mouse. This
204
Metabolic Fate and Selective Utilization of the Major Fatty Acids in Sebaceous Glands
A. Pappas, M. Anthonovage, and J. Gordon
Skin Biology Research, Johnson & Johnson CPWW, Skillman, New Jersey
Wax esters are one of the major products of the lipid secreting sebaceous gland of mammalian skin.
The synthetic pathways and enzymes involved have not yet been determined. Towards the
understanding of their synthesis, the metabolism of exogenously supplied saturated (16:0, 18:0),
monounsaturated, D9 (16:1, 18:1) and the linoleic D9, 12 (18:2) fatty acids (FAs) was followed in
cultured sebaceous glands. Explanted glands from human facial skin and hamster ear were
incubated with the above radiolabeled FAs or acetate for 24 h. Acetate and 16:0 were incorporated
into all of the cellular and sebaceous speci®c lipids in both hamster and human systems. The 16:0
was elongated to 18:0 by both species but the hamster glands desaturated them to 16:1 and 18:1,
respectively. In both species 16:1 was incorporated more extensively into polar lipids than
triglycerides, but not into sebaceous speci®c lipids and was elongated to 18:1 (D11). As proven by
HPTLC analysis 18:0 and 18:1 were both incorporated into the cellular lipids but at a lower rate
than the 16:0 into wax esters. In the hamster gland 18:0 was desaturated to 18:1 but was not further
metabolized to other fatty acids. Furthermore, addition of exogenous 18:1 was not further
metabolized. In human explants, linoleic acid was the only fatty acid that appeared to be b-
oxidized. That oxidation was speci®c since it did not induce a general oxidation of other FAs. The
ability of the explants to synthesize sebaceous lipids correlated with the putative b-oxidation of
linoleic acid. In addition the oxidation of linoleic acid was not detected in hamster explants. Thus
the oxidation of linoleic acid is speci®c for the human sebaceous cells and correlated with their
function and differentiation. Our results support the hypothesis that the sebaceous gland selectively
utilizes fatty acids.
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Extracellular Protein Binding Diminishes Cellular Uptake, Metabolism and Biological
Effect of 13-cis Retinoic Acid on Human Sebocytes
M. Tsukada, C. Orfanos, and C. Zouboulis
Department of Dermatology, University Medical Center Benjamin Franklin, The Free University of Berlin,
Berlin, Germany
13-cis Retinoic acid (13cRA) is rapidly absorbed into human sebocytes, is selectively isomerized to
high levels of all-trans retinoic acid and exerts an antiproliferative effect by binding the retinoic acid
receptors in normal culture conditions in vitro (J Invest Dermatol 115:321±327, 2000). In this study,
we provide evidence that the levels of extracellular binding protein plays an important role for
cellular uptake, metabolism and biological effect of 13cRA on human sebocytes. Serum albumin,
which selectively binds nonaromatic retinoids, has been used. The addition of highly concentrated
bovine serum albumin (20-fold) to the serum-free medium resulted in a decreased and controlled
uptake of 13cRA into SZ95 sebocytes, i.e. almost constant levels of 13cRA for 72 h after a single
treatment. In addition, delayed isomerization of 13cRA into all-trans retinoic acid was observed.
The intracellular concentration of all-trans retinoic acid after 13cRA treatment was nearly similar to
that of 13cRA at 24 h, however, it was 2- to 8-fold higher at 48±120 h after treatment. In a parallel
experiment, the antiproliferative effect of 13cRA (10±7 M) was diminished by adding high levels of
bovine serum albumin in the serum-free medium compared to the effect detected in experiments
with normal levels of bovine serum albumin. These results indicate a critical function of serum
albumin, as extracellular retinoid-binding protein, in reducing the intracellular concentration of
functional retinoids and in diminishing the biological effect of retinoic acids on human sebocytes.
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The Human Sebaceous Gland in Healthy, Non-Lesional and Lesional Acne Skin
Expresses Peroxisome Proliferator ± Activated Receptor (PPAR) a and b as well as g
T. Street, D. Holland,² N. Meyers,* W. Cunliffe,² and V. Randall
Department of Biomedical Sciences, University of Bradford, Bradford, UK; *SmithKline Beecham, Harlow,
UK; ²Department of Dermatology, Leeds General In®rmary, Leeds, UK
PPARs are known to be important in fatty acid metabolism and adipocyte differentiation and may
play a role in the human sebaceous gland; we have already demonstrated the presence of PPARg
only in the sebaceous and apocrine glands in normal and acne skin by monoclonal antibody. To
determine whether there could be a role for other members of the PPAR family, frozen facial skin
sections from normal and acne patients and sebocytes cultured from human facial skin were
immunostained with antibodies to PPARa and PPARb. Facial skin cryosections from 5 normal
women and 7 acne patients were stained with a goat polyclonal antibody to either PPARa or
PPARb. Positive nuclear staining occurred in basal and early differentiated sebaceous gland cells
(but not within fully mature sebocytes) and in the sebokeratinocytes of the pilosebaceous duct. It
was also seen in epidermal keratinocytes and the outer root sheath of hair follicles. In acne
nonlesional and lesional skin, both sebaceous glands and comedones exhibited positive staining.
Primary cell lines of facial sebocytes also exhibited peri-nuclear staining of PPARa and PPARb.
PPARa and PPARb were more widespread than PPARg, but were also present in sebaceous
glands in normal and acne skin as well as in cultured sebocytes. This suggests that PPARs have a
role in sebaceous lipid metabolism in the human sebaceous gland; understanding their role may be
important in developing new therapies for the treatment of both seborrhoea and acne vulgaris.
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The Red Deer (Cervus Elaphus) ± a New Sebaceous Animal Model which Expresses
Both the Androgen Receptor and Peroxisome Proliferator-Activated Receptor g
(PPARg)
V. Randall, T. Street, and N. Meyers*
Department of Biomedical Sciences, University of Bradford, Bradford, UK; *SmithKline Beecham, Harlow,
UK
Red deer skin, like Man, exhibits androgen dependent hair growth, has large sebaceous glands and
material is obtainable for research without ethical considerations as animals are routinely harvested
for food. Since there are major advantages over laboratory mammals, red deer skin has been
investigated to determine its potential as a novel animal model for pilosebaceous research. Winter
coat samples of deer neck skin, from 12 to 16 month deer and facial skin samples from women
between 20 and 68 years were frozen and sectioned (7 mm). Five sections from each sample were
stained with either Sacpic or oil red, to compare and contrast sebaceous gland structure and lipid
content or immunostained to identify regions of cell proliferation (Ki67), androgen receptor
expression and PPARg presence. Deer sebaceous glands demonstrated a similar structure and lipid
content to human glands, but were smaller in size. The distribution of cell proliferation, androgen
receptor expression and PPARg paralleled that in human glands suggesting that the red deer
sebaceous gland could be a useful animal model for sebaceous gland research. Certainly, the
presence of androgen receptors and PPARg suggest that red deer skin is a valuable tissue to study
not only the mechanism of androgen action in the sebaceous gland, but also the role of PPARg in
sebaceous gland function.
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Activation of Human Keratinocytes by the LPS-Mimetic, Taxol, is likely Mediated
Through Lipopolysaccharide Receptors
H. Jang and C. Reardon
Dermatology, University of Colorado HSC, Denver, Colorado
Keratinocytes play a central role in initiating cutaneous in¯ammation in response to bacterial
products, such as lipopolysaccharide (LPS). We have shown previously that the receptors for LPS,
such as CD14, and the CD11a,b,c/CD18 family of receptors, are present on human and mouse
keratinocytes. Taxol, a potent antitumor agent, is known to stimulate macrophages through the
LPS receptors, but which receptors are important for Taxol stimulation are currently debated. We
assessed if Taxol similarly could stimulate keratinocytes. Human keratinocyte cell lines, including
HaCaT and A431 cells and the telomerase-transduced normal primary keratinocyte line, CL-22, all
of which we have previously shown to express LPS receptors, were incubated with LPS or Taxol
for 72 h. IL-8 production by the cells in the culture supernatants was determined by ELISA to serve
as a measure of cell activation. Taxol stimulated all keratinocyte cell lines, although to a lesser
degree than LPS. The different cell types showed similar optimal stimulatory concentrations of
Taxol (1±4 ng per ml). However, the ranges of stimulatory Taxol doses varied signi®cantly
between the keratinocyte cell lines from 0.1 to 8 ng per ml for HaCaT cells and 0.5±31 ng per ml
for A431 cells. Higher concentrations of Taxol did not stimulate these cells to produce cytokines
but in fact were toxic, as shown by MTT assays. In contrast, concentrations of Taxol that could
stimulate CL-22 cells ranged from 2 to 1000 ng per ml and showed a bimodal distribution of
optimal doses of 4 ng per ml and approximately 1000 ng per ml. Curiously, toxic doses of Taxol
paralleled the stimulatory concentrations in CL-22 cells leading to cytokine production. This
observation may relate to the slower growth kinetics of the CL-22 cells and their relative tolerance
to Taxol toxicity compared to the faster growing transformed cell lines. LPS showed no toxicity at
any tested concentration as expected. We attempted to see if the keratinocyte responses to Taxol
could be blocked by various anti-LPS-receptor antibodies. Although anti-CD14 and anti-CD18
antibodies reduced LPS stimulation in both the HaCaT and CL-22 cells, they only could reduce
Taxol stimulation in the HaCaT cell line. However, both the LPS and Taxol responses by the
A431 cells appeared to be unaffected by the anti-LPS receptor antibodies. The varied effects of
LPS-receptor blockade on these cells may be due to direct signaling through the LPS receptor,
TLR-2.
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Expression of CXCR2 and its Major Ligands In Vitro: a Functional Model for the Study
of Psoriasis
C. Barker, A. Gilles, D. Pearce,* J. Waller,* and J. Pringle
Pathology Department, University of Leicester, Leicester, UK; *Discovery BioScience, AstraZeneca R & D
Charnwood, Loughborough, UK
CXCR2 is an IL-8 receptor on human epidermal keratinocytes. It is not expressed in normal
epidermis, but in the differentiated keratinocytes of the psoriatic plaque. Since a role in the disease
remains unclear, an in vitro model of psoriatic skin expressing CXCR2 was developed, to enable
functional studies. Models were constructed by immobilising ®broblasts in a collagen gel, and
seeding keratinocytes from the same donor onto the gel surface. Cultures were maintained at the
air±liquid interface for 21 days in a fully de®ned medium. Models derived from normal and
psoriatic donors displayed the morphology of in vivo epidermis. Immunohistochemistry showed
that the distribution of Ki67, basal cytokeratin, cytokeratin 10, involucrin and ®laggrin mirrored in
vivo observations. Importantly, CXCR2 expression was also found to mimic that seen in vivo, being
absent in normal skin models (n = 3 donors), but strongly expressed in the differentiated
keratinocytes of psoriatic models (n = 3 donors). CXCR1, which is not expressed by keratinocytes
in vivo, was also absent in vitro. Distribution of the two major CXCR2 ligands, IL-8 and GRO-a,
was identical in psoriatic skin models to in vivo psoriasis: both were present throughout the viable
keratinocyte layers and absent in the stratum corneum. IL-8 levels in conditioned medium from
psoriatic models were quanti®ed by ELISA. Peak levels (1.1 6 0.02 ng per ml) were produced
during the highly proliferative phase of model development (day 7), falling to 0.13 6 0.07 ng
per ml by day 21. These studies demonstrated that unique characteristics of psoriatic keratinocytes
can be retained in vitro in a fully de®ned, serum-free system. Interactions between CXCR2, IL-8
and GRO-a may play a role in the abnormal differentiation of psoriatic keratinocytes. The model
is now being applied to study these interactions, and their implications for psoriasis therapy, using
compounds targeted against the receptor.
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Barrier Disruption and UVB Irradiation have an Opposite Effect on Antigen-Presenting
Function of Langerhans Cells but a Synergistic Effect on Cytokine Production by
Keratinocytes in Mice
T. Ito, N. Seo, K. Tsujimura,* M. Takigawa, and Y. Tokura
Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan; *Laboratory of
Immunology, Aichi Cancer Center Research Institute, Nagoya, Japan
Barrier disruption and UVB irradiation are known to modulate epidermal immunity. It remains
unclear whether UVB exposure alleviates or aggravates barrier disrupted in¯ammatory skin diseases
such as atopic dermatitis. To address this issue, we tape-stripped and/or UVB-irradiated earlobes of
BALB/c mice, and examined the surface expression of immunocompetent molecules, cytokine
expression/production, and antigen-presenting functions of EC from the treated skin. By ¯ow
cytometry, tape-stripping and UVB-irradiation augmented and reduced, respectively, the
expression of CD54, CD80, CD86 and I-A on Langerhans cells (LC) and the sequential
treatments of these two modalities exerted an intermediate effect higher than UVB and lower than
tape-stripping. By RT-PCR of EC and ELISA of EC culture supernatants, each of tape-stripping
and UVB-irradiation slightly up-regulated or unaffected TNF-a and IL-1a production by EC.
However the combination of these treatments markedly increased these cytokine production.
Cultivation of EC in the presence of L cells transfected with CD40L augmented the expression of
IL-1b, suggesting LC as well as keratinocytes (KC) were stimulated to produce cytokines with
tape-stripping plus UVB. Finally, the hapten-presenting ability of LC for trinitrophenyl-immune
lymph node T cells was inhibited by UVB and enhanced by tape-stripping, and the combination of
these two modalities resulted in intermediate T cell responses, consistent with the data of the
surface expression of immunocompetent molecules. These ®ndings suggest that UVB exposure on
tape-stripped skin differentially modulates the immune function of LC and KC: UVB oppositely
inhibits the upmodulated antigen-presenting ability of LC but further enhances the promoted
cytokine production of KC in barrier-disrupted skin.
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a-MSH Peptides Inhibit Cytokine-Stimulated NF-kB/p65 Activation in HaCaT
Keratinocytes
M. Moustafa, S. MacNeil, and J. Haycock*
Section of Medicine, University of Shef®eld, Shef®eld, UK; *Department of Engineering Materials,
University of Shef®eld, Shef®eld, UK
a-melanocyte stimulating hormone (a-MSH), a 13 amino acid peptide derived from the
proopiomelanocortin (POMC) precursor, was originally named for an ability to stimulate
cutaneous pigmentation. However, studies also document additional roles of anti-in¯ammation,
antipyresis and immunomodulation. In particular, a-MSH is able to inhibit the action of
proin¯ammatory cytokines (e.g. TNF-a) in several tissues including skin. We have previously
shown in melanocytes and melanoma cells that a-MSH can inhibit TNF-a stimulated up-
regulation of intercellular adhesion molecule-1 and activation of nuclear factor-kB (NF-kB). The
aim of this study was to investigate whether the anti-in¯ammatory ability of a-MSH extends to
nonpigmentary skin cells and also to compare the inhibitory potency with other POMC peptides.
HaCaT human keratinocytes, which express the melanocortin-1 receptor, were grown in vitro and
stimulated for 60 min with TNF-a in the presence of a-MSH (10-11±10±7 M), MSH 11±13 (L-K-
L-P-L-V; 10-9±10-5 M), MSH 11±13 (L-K-L-P-D-V; 10-13±10-7 M), or adrenocorticotrophic
hormone (ACTH; 10-13±10-7 M). Peptides were added 15 min prior to TNF-a. NF-kB/p65
activation was assessed by digital image tracking of subunit p65 by immuno¯uorescence
microscopy. a-MSH, MSH L-K-L-P-L-V and MSH L-K-L-P-D-V all signi®cantly inhibited
TNF-a stimulated NF-kB activation with maximum inhibition at 37% (10±9 M), 44% (10±9 M) and
43% (10±11 M), respectively (n = 3±5). In contrast, ACTH was found not to be inhibitory. In
conclusion, a-MSH and MSH 11±13 tripeptides are effective at inhibiting cytokine activation of
NF-kB, supporting previous studies on the anti-in¯ammatory actions of a-MSH. Present data
extends ®ndings to nonpigmentary skin cells.
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The Expression of Epidermal Cytokines by The Change of Epidermal Calcium In Vivo
E. Choi, M. Kim, B. Yeh,* S. Ahn, and S. Lee²
Dermatology, Yonsei University Wonju College of Medicine, Wonju, South Korea; *Biochemistry, Yonsei
University Wonju College of Medicine, Wonju, South Korea; ²Dermatology, Yonsei University College of
Medicine, Seoul, South Korea
The skin barrier is composed of corneocytes and intercorneocyte lipid lamellae. Previous research
has investigated the direct relation between the epidermal calcium and the proliferation and
differentiation of keratinocytes. In vitro studies con®rmed that calcium could control the
proliferation and differentiation of keratinocytes. However, there has been no in vivo study due to
the absence of an adequate experimental model. We performed this study in order to con®rm
whether some cytokines are expressed in the epidermis by the change of epidermal calcium
without disruption of the skin barrier. Iontophoresis which induces the change of the epidermal
calcium gradient without disruption of the skin barrier was applied to the skin of 8±12-week-old
hairless mice with a direct current (6 V, 0.8 mA) for 1 h and 2 h. The biopsy specimens were taken
at 1, 2 and 3 h after current for RT-PCR, and 1, 3 and 6 h after current for immunohistochemical
stain. RT-PCR was performed with the primers of IL-1a, TNF-a and TGF-b using isolated
RNA from the separated epidermis. Hairless mice showing acute barrier pertubation with tape
stripping were used as a positive control. The density of PCR products was quantitated with an
image analyzer. In the immunohistochemical stain, IL-1a, TNF-a and TGF-b were used as
primary antibodies. The expression of each cytokines mRNA was increased in the 2 h current
condition compared to the 1 h condition. The expression of IL-1a and TNF-a in
immunohistochemical stain was increased in iontophoresis skin, but TGF-b was decreased. In
conclusion, the change of epidermal calcium may be a direct signal for inducing the expression of
epidermal cytokines in vivo.
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Activation of Epidermal Growth Factor Receptor Modulates Cytokine and Chemokine
Expression in Human Keratinocytes
F. Mascia, S. Pastore, and G. Girolomoni
Laboratory of Immunology, Istituto Dermopatico dell'Immacolata, IRCCS, Rome, Italy
Activation of epidermal growth factor receptor (EGFR) provides signals essential to multiple
aspects of keratinocyte biology, and a growing number of EGFR ligands have been characterized as
autocrine growth factors for keratinocytes. Abnormalities in the expression of EGFR and/or its
ligands transforming growth factor (TGF)-a and amphiregulin (AR) have been found in various
in¯ammatory skin disorders, where cytokines such as IL-1 and TNF-a can up-regulate the
neosynthesis of EGFR agonists. In this study, we have investigated the capacity of EGFR ligands to
modulate the expression of proin¯ammatory cytokines and chemokines in normal human
keratinocytes. Subcon¯uent keratinocytes were cultured for 24 h in the absence of EGF to allow
maximal EGFR expression, prior to stimulation with 1 nM EGF, TGF-a or AR alone, or in
association with 100 ng per ml TNF-a or 100 U per ml IFN-g. A 2±3 fold increase in the amounts
of basal IL-1a, IL-1b, IL-1ra, GM-CSF and IL-8 mRNA, and a marked down-regulation of basal
RANTES and IP-10 mRNA were evident as early as 2 h following EGFR activation, and were
maintained for 24 h. Parallel variations were detected at the protein level by ELISA at 24 h. When
used in equimolar concentrations, TGF-a and EGF were equipotent, whereas AR displayed
reduced activity. Moreover, EGFR ligands signi®cantly synergized with TNF-a or IFN-g in the
induction of IL-1 members, GM-CSF and IL-8, whereas they counteracted TNF-a or IFN-g
induction of RANTES and IP-10 expression. Preincubation with tyrphostin PD153035, a speci®c
inhibitor of the EGFR tyrosine kinase, markedly attenuated the speci®c effects of EGFR ligands.
Of note, basal levels of RANTES and IP-10 mRNA tended to increase in cultures treated with
tyrphostin alone, compared to untreated controls. Our data suggest that EGFR ligands actively
participate in the complex networks of keratinocyte activation during in¯ammatory processes of
the skin.
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Physiological Activities of Keratinocyte-Derived Ciliary Neurotrophic Factor in Human
Skin and its Pathogenic Involvement in Cutaneous In¯ammatory Diseases
M. Toyoda, M. Nakamura, T. Makino, T. Hino, and M. Morohashi
Dermatology, Toyama Medical and Pharmaceutical University, Toyama, Japan
Ciliary neurotrophic factor (CNTF) displayophic activity for parasympathetic, sympathetic,
sensory and spinal motoneurons, and for the cell types associated with these neurons at various
stages in their development. The purpose of this study was to examine whether human
keratinocytes synthesize bioactive CNTF, functional interactions of CNTF with nerve growth
factor (NGF), neuropeptides and proin¯ammatory cytokines, and its pathogenic involvement in
cutaneous in¯ammatory diseases such as atopic dermatitis. Normal human keratinocytes
synthesized CNTF as a nonsecreted cytosolic molecule. CNTF stimulated production of NGF
from keratinocytes in a dose-dependent manner. While CNTF alone had little effect on the
keratinocyte proliferation, CNTF signi®cantly enhanced the trophic activities of NGF to
keratinocytes. CNTF induced mast cell degranulation, substance P release from neuronal cells and
proliferation of ®broblasts. While stimulatory agents of CNTF synthesis in keratinocytes included
substance P, IL-4, IL-6, IL-13, PGE2 and histamine, its suppressive agents were calcitonin gene-
related peptide, TNF-a, and eosinophil cationic protein. Lesional skin of atopic dermatitis patients
contained a higher amount of CNTF compared with controls. These ®ndings suggest that
keratinocyte-derived CNTF interacts with other neurotrophins, cytokines and chemical mediators
in human skin, and takes part in the maintenance of skin homeostasis as well as in pathogenesis of
some cutaneous disorders such as atopic dermatitis.
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Characterisation of Mouse Frizzled-3 Expression in Hair Follicle Development and
Identi®cation of the Human Homolog in Keratinocytes
J. Rothnagel, B. Hung, X. Wang, and G. Cam*
Biochemistry, University of Queensland, Brisbane, Australia; *Livestock Industries, CSIRO, Sydney,
Australia
Frizzled genes encode a family of Wnt ligand receptors, which have a conserved cysteine-rich Wnt
binding domain and include both transmembrane and secreted forms. Work by others has shown
that experimental perturbation of Wnt signaling results in aberrant hair formation, hair growth and
hair structure. However, to date there is no information on the contribution of individual Frizzled
proteins to hair development. We now report that Frizzled-3 (Fzd3) expression in skin is restricted
to the epidermis and to the developing hair follicle. Northern analysis on total mouse skin mRNA
revealed a single Fzd3 transcript of 3.7 kb. RT-PCR and in situ hybridization analysis revealed
Fzd3 expression in epidermal and hair follicle keratinocytes. Fzd3 transcripts are ®rst detected in
discrete foci in the developing epidermis of 13 day embryos and later in the hair follicle placodes of
15 day embryos, suggesting a role for this Frizzled isoform in follicle development. Interestingly, in
17 day embryos and 1-day-old newborn mice Fzd3 expression is limited to suprabasal keratinocytes
and is not seen in pelage follicles until 3 days post partum. In 7-day-old neonatal skin, Fzd3 is
expressed throughout the epidermis and in the outer cell layers of hair follicles. These observations
suggest a role for Fzd3 signaling in some but not all stages of follicle development. We have also
identi®ed the mRNA encoding human Frizzled-3 (FZD3) in epidermal keratinocytes and in the
HaCaT keratinocyte cell line. FZD3 mRNA encodes a 666 amino-acid protein with 97.8%
identity to the mouse protein. The FZD3 gene was mapped using a radiation-hybrid cell line panel
to the short arm of chromosome 8 (8p21) between the markers WI-1172 and WI-8496 near the
loci for the Hypotrichosis of Marie Unna and Hairless genes.
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Expression of Frizzled Genes in Developing Hair Follicles
S. Millar, S. Reddy, T. Andl, M. Lu,* and E. Morrisey*
Departments of Dermatology and Cell and Developmental Biology, University of Pennsylvania, Philadelphia,
Pennsylvania; *Department of Cardiology, University of Pennsylvania, Philadelphia, Pennsylvania
WNT proteins are secreted signaling molecules that act over short distances to change the fate,
shape, movements and proliferation of neighboring cells. Mutations in downstream effector genes
of a WNT signaling pathway cause dramatic hair follicle phenotypes, suggesting that interactions of
WNT proteins with their receptors, the Frizzled (FZ) proteins, regulate hair follicle formation and
hair growth. We have found that Wnts 10b and 10a are expressed in epithelial placode cells at the
earliest stage of hair follicle morphogenesis, and that Wnt5a is expressed slightly later in the dermal
condensate. To determine whether Fzd genes are also expressed in developing follicles and to
identify follicular cells capable of receiving WNT signals, we surveyed for expression of all 10
cloned mouse Fzd genes in embryonic skin. We ®nd that Fzd10 is expressed in the placode and in
the dermal condensate as it forms. Fzd1 and Fzd2 are also expressed in the dermal condensate and
Fzds 1, 2, 3 and 5 are expressed at low levels in placode cells. As hair follicles develop further,
expression of Fzd10, Fzd2 and Fzd1 continues in the epithelial and mesenchymal components of
hair follicles, and Fzd5 is expressed in follicular epithelial cells. Expression of Fzd7 begins later in
morphogenesis, at the bulbous peg stage, when this gene is expressed in the follicular epithelium.
These genes are not expressed in interfollicular epidermis. In contrast, Fzds 3 and 6 are expressed in
basal cells of the epidermis as well as in follicular epithelial cells. These results indicate that both
epithelial and mesenchymal cells of the developing hair follicle are capable of receiving WNT
signals, and that Fzd genes may perform overlapping functions.
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Disruption of WNT±Frizzled Interactions Inhibits Hair Growth
T. Andl, S. Reddy, and S. Millar
Departments of Dermatology and Cell and Developmental Biology, University of Pennsylvania, Philadelphia,
Pennsylvania
Communication between different types of hair follicle cells is necessary for the onset of anagen
and for normal hair growth, but the signaling molecules operating in hair follicles remain poorly
characterized. Several lines of evidence indicate that a paracrine WNT signaling pathway is active
in hair follicles at anagen onset and during full anagen. To determine whether genes encoding
WNT proteins and their receptors, the Frizzled (FZ) proteins, are expressed in postnatal hair
follicles we surveyed for expression of all of the cloned mouse Wnt and Fz genes. We found that
Wnts 10a and 10b are speci®cally expressed in hair follicles at anagen onset. Fz10 is weakly
expressed at this stage. Interestingly, Wnts 10a and 10b and Fz10 are also expressed at the earliest
(placode) stage of hair follicle morphogenesis, suggesting conservation of the signaling pathways
regulating anagen onset and hair follicle morphogenesis. Later in anagen, Wnt3 is expressed in hair
shaft precursor cells, adjacent to precortical cells that express Fz7. Wnts 3a, 10a and 10b, and Fz6,
are expressed in inner root sheath precursors, and Wnts 11 and 5a, and Fzds 5 and 1, are expressed
in subsets of cells in the dermal and outer root sheaths. These results indicate that cells in several
different layers of the hair follicle are capable of receiving WNT signals, and suggest that WNTs
play multiple roles during anagen. To begin to dissect the functions of different WNT proteins in
hair morphogenesis and growth we have made use of endogenous secreted WNT inhibitors that
block subsets of WNT±FZ interactions. Ectopic expression of one of these, secreted Frizzled-
related protein 2 (sFRP2), in the hair follicle outer root sheaths of transgenic mice causes a
phenotype of short hair. We ®nd that this inhibitor does not affect hair follicle morphogenesis or
control of the hair growth cycle, but instead alters hair growth during anagen. These results
indicate that a subset of WNT±FZ interactions is required for normal hair growth in mature
follicles. The functions of other WNT-FZ pairings are likely to be revealed by ectopic expression
of other secreted WNT inhibitors.
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Laminin 10 Plays a Critical Role in the Development of Normal Skin and Hair Follicles
J. Li, Y. Chen,² J. Miner,* and M. Marinkovich²
Dermatology & Cutaneous Surgery, University of Miami, Miami, Florida; *Renal Division, Washington
University, St. Louis, Missouri; ²Dermatology, Stanford University, Palo Alto, California
Laminins are important components of all basement membrane and in¯uence a variety of
important biological processes including cell attachment and migration as well as tissue
development. This study is to evaluate the roles of laminin 10 in normal human skin and hair
development. It has been recently found that laminin 10, which contains a newly discovered
laminin a5 chain, is produced by human keratinocytes and dermal microvascular endothelial cells.
Laminin a5 chain expression is found in normal human keratinocytes, dermal-epidermal junction
and hair follicle out root sheet. We used a laminin a5 chain knockout mouse model to study the
functions of laminin 10. Due to embryonic mortality of laminin a5 chain gene homozygous
knockouts, a full-thickness skin grafting approach, grafting embryonic skins to Nude mice, was
used. In this way, grafts can be maintained on the hosts and develop into fully mature adult skins.
Interestingly, while grafts of wild-type littermates had normal fur develop, there was no hair
formation on the skin grafts of the knockout mice. The skin histological features were examined
on the skin grafts before the grafting and 4 weeks after the grafting. The embryo skin of laminin a5
knockouts showed thin but organized strati®ed epidermis with fewer but normal hair follicles. The
skin grafts of laminin a5 de®cient revealed hyper- or hypo-keratosis in epidermis and thickened
dermis with few immature hair follicles. Electro-microscope analysis identi®ed a discontinuity
along basement membrane of dermal-epidermal junction. This data suggests that the a5 chain of
laminin 10 may be of importance in skin and later stage hair development. The biological
functional studies of laminin 10 a5 chain in skin and hair development are under way both in vitro
and in vivo.
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The Hypothesis of Hair Follicle Predetermination
A. Panteleyev, C. Jahoda,* and A. Christiano
Departments of Dermatology and Genetics & Development, Columbia Universitry, New York, New York;
*Department of Biological Science, University of Durham, Durham, UK
In recent years, substantial progress has been achieved in genetic and molecular studies of hair
follicle biology. But the molecular data, including expression patterns, cannot be properly
appreciated without understanding the basic cellular rearrangements and interactions that maintain
hair follicle cyclic transformations. Here, we present a further attempt to understand the interaction
between different hair follicle cell populations and outline the major cellular processes that take
place during its cyclic progression through periods of growth, regression, and quiescence. The
Hypothesis of Hair Follicle Predetermination, as put forth here, represents an extension of the
previous models of hair follicle cellular kinetics with one critical modi®cation: the timing of the
recruitment of stem cells. The patterns of cell proliferation during anagen-telogen transition,
together with morphological evidence, suggest that there are two separate cell populations with
proliferation potential in the late telogen hair follicle: the cells of the bulge region (stem cells) and
the cells of the hair germ. Further, based on our studies of the hairless phenotype in mice,
immunohistochemistry data, and extensive analysis of the recent literature, we provide evidence to
suggest that the new HF arises not from the bulge region cells, but instead from germinative cells
localized in the hair germ. These germinative cells, in turn, were recruited during the previous hair
cycle from the bulge region progeny, which become committed to produce the hair of the next
generation. During the subsequent catagen and telogen phases, these cells undergo a process of
``maturation'', thus acquiring the ability to respond to dermal papilla signaling and produce a new
hair. Thus, the activity of hair germ cells is the initiating event of anagen, which precedes the
activity of the cells in the bulge region. The hair germ cells give rise only to the ascending part of
the growing hair follicle, including the hair shaft and IRS, while the downgrowing ORS is a
product of the bulge region progeny. Thus, the mature anagen hair follicle has a dual origin. In
conclusion, we suggest that the growth characteristics of the hair follicle and hair shaft are
220
Role of TGF-b in the Hair Cycle I: Dissection of Endogenous Cellular Responses
T. Soma, C. Dohrmann, L. Dobens, K. White, J. Brissette, and L. Raftery
Cutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston,
Massachusetts
TGF-b superfamily members direct organogenesis in organisms ranging from humans to ¯ies. The
hair follicle provides a tractable system to dissect the function of these potent molecules in
mammalian tissue remodeling. We seek to identify endogenous responses to TGF-bs during the
hair cycle. The three TGF-bs, TGF-b1, TGF-b2, and TGF-b3 are expressed in or near the hair
follicle. Addition of TGF-b2 can increase apoptosis in the outer root sheath of cultured human hair
follicles. The best-understood response in other tissues is the phosphorylation of Smads. Anti-
phospho-Smad2 antiserum (provided by P. ten Dijke, Netherlands Cancer Institute) detected an
antigen that was up-regulated in the outer root sheath of human hair follicles cultured in the
presence of TGF-b2. This antiserum showed staining in the outer root sheath during the mouse
hair cycle. We also investigated expression of TSC-22 (TGF-b-stimulated clone 22), which can
potentiate TGF-b-induced apoptosis in gastric carcinoma cells. TSC-22 antiserum detected an
antigen in wild type mouse skin that was absent in TSC-22±/± mice. The dynamic pattern of
TSC-22 protein accumulation was distinct from the pattern of antiphospho-Smad2 staining. Thus,
it is likely that other signals regulate TSC-22 expression in hair follicles. To test for a role in
apoptosis, we compared anti-TSC-22 staining with TUNEL or activated caspase-3 staining
(vendor). These data indicated no correlation between the site of TSC-22 staining and the onset of
apoptosis during late anagen. Some TSC-22-expressing cells were positive for apoptotic markers.
However, strong TSC-22 expression was retained in the dermal papilla and inner root sheath of
the catagen hair follicle. We continue to investigate other proposed mediators of TGF-b signaling,
to better understand the complex roles of these signals in organogenesis.
221
Functional Role of Neutral Endopeptidase (NEP; EC 3.4.24.11) During Rat Hair Cycle
N. Tsuji, A. Ohuchi, S. Moriwaki, Y. Takema, and G. Imokawa
Biological science laboratories, Kao corporation, Ichikai-machi Haga-gun,. Japan
Various enzyme activities have been reported to change in association with the hair-cycle. We
examined the dynamics of neutral endopeptidase (NEP) expression and function during the hair-
cycle in rats. NEP activity and its encoding mRNA in the dorsal skins of SD rats were measured
throughout the hair-cycle (from 3 to 12 weeks). NEP catalytic activity was elevated at early anagen
phase (at weeks 5 and 10) and was decreased during catagen to telogen phases. Simultaneously,
changes in NEP mRNA expression were observed in parallel with NEP enzyme activity.
Immunostaining of NEP in human scalp skin showed the localization of NEP in the connective
tissue sheath in a pattern similar to the distribution of elastic ®bers. To determine whether NEP has
elastase activity, we measured that catalytic function using STANA or remazol Brilliant Blue
labeled insoluble human elastin as synthetic substrates. Intriguingly, we found that elastase activity
and NEP activity in human ®broblasts could be completely immunoprecipitated by the NEP
antibody. This identity was also corroborated by Western blotting analysis. Further, we cloned
NEP cDNA, generated a cDNA expression vector for it and transfected COS cells. The elastase
activity of NEP-transfected COS cells was strikingly elevated as was their NEP enzymatic activity.
These data suggest that NEP plays an important role in the regulation of the hair±cycle in
association with its elastase activity.
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Parathyroid Hormone-Related Protein is Expressed in the Hair Follicle of the Adult
Mouse and Appears to Modulate the Hair Cycle
J. Foley,² Y. Cho, G. Woodard, J. Jimenez, and T. Rosol*
Medical Sciences, Indiana University School of Medicine, Bloomington, Indiana; *Veteranary Biosciences,
The Ohio State University, Columbus, Ohio; ²Dermatology, Indiana University School of Medicine,
Iindianapolis, Indiana
Murine Transgenic models that overexpressed or lacked epidermal Parathyroid hormone-related
protein (PTHrP) manifested complex skin phenotypes with alterations in interfollicular epidermis,
dermis and appendages. In situ hybridization, RNase protection and immunohistochemistry
performed on a series of murine skin samples ranging form E-14 to two years indicate that PTHrP
gene expression is largely con®ned to the hair follicle at all developmental times. In the early
samples (from E-14 to E-16), PTHrP transcripts and immunoreactivity were present throughout
the hair pegs. At birth and three days PTHrP remained in the outer layers of the upper third of the
follicle but was not present in deeper aspects of the structure. At one and two weeks, the peptide
was present in the external root sheath both of the upper portion of the follicle as well as the hair
bulb. PTHrP gene expression was not observed in a large fraction of resting hair follicles in the
adult samples, but could be observed in various stages of anagen hair follicles in a pattern similar to
the one and two week-samples. The dynamic expression pattern of PTHrP during the hair cycle
and relative lack of expression in the interfollicular epidermis suggest that the hair follicle may be
the major functional target for the peptide in postnatal murine skin. Using the K14-PTHrP mouse,
we investigated the impact of overexpression of the peptide upon hair growth. The length of all
hair types was reduced ~50% and ~25%, respectively, in 3 and 10-week-old K14-PTHrP mice as
compared to sex matched wild-type littermates. After morphologically evaluating hair follicles in a
two to three-week-old and a wax-stripped adult series of K14-PTHrP mice and littermates, it
appeared that reduced hair follicle lengths correlated with a shorter anagen phase in the transgenics.
These ®ndings suggest that PTHrP may participate in one of the many signaling cascades that
regulate the growth of the murine hair follicle.
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Neurotrophins Differentially Regulate Growth Factor Secretion by Dermal Papilla Cells
D. Tobin, V. Botchkarev,* P. Welker,² N. Botchkareva,* and R. Paus³
Biomedical Sciences, University of Bradford, Bradford, UK; *Dermatology, Boston University School of
Medicine, Boston, Massachusetts; ²Dermatology, Charite, Humboldt University, Berlin, Germany;
³Dermatology, University Hospital Eppendorf, Hamburg, Germany
Neurotrophins (NT) accelerate hair follicle (HF) regression (catagen), most likely by stimulating
keratinocyte apoptosis via binding to the p75 kDa neurotrophin receptor (FASEB J 13:395, 1999;
14:1931, 2000). However, NT may also modulate growth factor secretion by dermal papilla (DP)
cells that express high af®nity NT receptors TrkB and TrkC during the HF anagen-catagen
transition. To test this hypothesis, six matched cultures of human scalp DP cells and dermal
®broblasts were grown for 48 h in the presence of 0.5±50 ng per ml of NGF, BDNF, NT-3 or NT-
4. Secretion of different growth factors (SCF, VEGF, TGFb2, KGF) known to be produced by DP
cells during anagen was assessed by ELISA. By immunocytochemistry, both DP cells and dermal
®broblasts express TrkA, TrkC, and p75 kDa neurotrophin receptors. TrkB receptors however,
were detected on DP cells but not on dermal ®broblasts. The NT tested had no signi®cant effect
on DP cell or dermal ®broblast proliferation. By ELISA, secretion of SCF by DP cells into
supernatants was signi®cantly down regulated by BDNF and NT-3, while VEGF secretion was
decreased after NT-4 treatment. BDNF also signi®cantly decreased TGFb2 secretion by DP cells.
Secretion of these growth factors by dermal ®broblasts was not affected by NT, suggesting that in
addition to TrkB expression on DP, this secretary response to NT may aid the discrimination of
interfollicular dermal ®broblasts from DP ®broblasts. These data suggest that NT may modulate HF
anagen-catagen transition by altering secretion of DP-derived growth factors that control
proliferation, apoptosis and/or differentiation of hair matrix cells.
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In Vitro and In Vivo Production of Leptin by Human Follicular Papilla Cells and its
Regulation by Cytokines and Growth Factors
M. Iguchi, S. Aiba, Y. Yoshino, H. Manome, and H. Tagami
Department of Dermatology, Tohoku University School of Medicine, Sendai, Japan
Leptin that is secreted from the adipose tissueAÊ A plays a crucial role in the regulation of energy
balance. Although leptin enhances wound reepithelization and mediates a mitogenic stimulus to
human keratinocytes in vitro, its biological role in the skin remains unclear. In this study, we
examined the production of leptin by hair follicular papilla cells (FP). We isolated 6 FP from
human scalp hairs of 2 different donors by the standard microdisection and obtained one clone by
limiting dilution. These cell lines and clone displayed an aggregative behavior at a precon¯uent
density and their expression of a-smooth muscle actin was shown to be stronger than that of an
interstitial dermal ®broblast cell (DF) line by Western blotting. In addition, they did not
differentiate into adipocytes by the culture medium that could induce preadipocytes into
adipocytes. The expression of leptin mRNA by all the FP lines and clone, but not by three
different DF lines, was demonstrated with RT-PCR and also with the direct sequencing of their
products. Moreover, the culture supernatants of these FP lines and clone, but not those of the DF
lines, contained large amounts of leptin protein (300±600 pg per ml), which was revealed by
ELISA. The immunoreactivity with polyclonal antileptin antibody was recognized only around the
hair bulb area, including the follicular papillae. Finally, when the FP lines were cultured with
various cytokines and growth factors, e.g., IL-1b, IL-4, TNF-a, IFN-a, IFN-g, TGF-b1, bFGF,
HGF, KGF, EGF, VEGF, and insulin-like growth factor, the production of leptin was suppressed
by IL-4, TNF-a, IFN-a, IFN-g, TGF-b1, bFGF, or EGF. These data demonstrating the
nonadipose tissue production of leptin by FP in vitro and in vivo and the regulatory roles of
in¯ammatory cytokines and growth factors on its production suggest a crucial role played by leptin
in scalp hair growth.
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Role of TGF-b in the Hair Cycle II: Actibation of Caspase-3 and Caspase-9 by TGF-b2
Y. Tsuji, T. Soma, T. Momoi,* and T. Hibino
Life Science Research Center, Shiseido, Yokohama, Japan; *Division of Development and Differentiation,
National Institute of Neuroscience, Kodaira, Japan
Hair loss is the result of premature entry into catagen by various causes. In male pattern baldness,
we are proposing the involvement of ``catagen cascade'', in which (1) dihydrotestosterone
stimulates TGF-b2 synthesis by dermal papilla cells (DPC), (2) elevated levels of TGF-b2 triggers
caspase activation, (3) resulting in the apoptosis of epithelial cells. In the present study, we analyzed
the role of TGF-b in the induction of catagen. Human scalp tissues were obtained from plastic
surgery. Immunohistochemical study revealed that TGF-b2 but not TGF-b1 or b3 was localized at
the boundary area between germinative cells and DPC during the transition phase from late anagen
to catagen. In the regressing hair follicle, only TGF-b2 was detected at the epithelial strand.
TUNEL-positive apoptotic cells were also observed in the area. To know the role of TGF-b2 in
relation to apoptosis, human hair follicles were cultured in the presence of TGF-b2. Using active
caspase-9 and ± 3 speci®c antibodies, we found that TGF-b2 induced the activation of these
caspases in two regions, including the lower part of germinative matrix cells and outer most layer of
outer root sheath cells. Dual staining for active caspase-9 and TUNEL demonstrated that active
caspase-9 and TUNEL-positive cells were colocalized each other. Active caspase-3 positive cells
were detected in the broader area compared to the TUNEL-positive cells. A substance from a plant
extract, which was capable to suppress TGF-b action, was effective for hair elongation in the organ
culture. Moreover, this substance inhibited caspase activation. Collectively our results suggest that
TGF-b2 plays an essential role in the induction of catagen via activation of caspases.
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The RhoA GTPase is Differentially Expressed in the Stem Cell Compartment of the
Human Hair Follicle
S. Lyle, Q. Tao, and G. Cotsarelis*
Pathology, Harvard Medical School, Boston, Massachusetts; *Dermatology, University of Pennsylvania,
Philadelphia, Pennsylvania
We previously showed that human hair follicle stem cells reside in the hair follicle bulge, which is
delineated by keratin 15 expression. The purpose of this study was to identify genes which are
speci®cally expressed in the stem cell compartment of the human hair follicle so that we may better
understand the molecular requirements for the maintenance of the stem cell phenotype. Hair
follicles were plucked from Dispase-treated human scalp skin. Total RNA from telogen hair
follicle bulges and from anagen bulbs was labeled and hybridized to cDNA expression arrays
(Clontech), which were then developed by autoradiography. RhoA was one of 13 genes present in
the stem cell-enriched telogen follicle and not in the anagen bulb. Immunostaining in frozen tissue
sections shows that RhoA is coexpressed in the K15 bulge area of both telogen and anagen human
hair follicles. In addition, RhoA and K15 expression colocalized in clonogenic keratinocytes,
cultured from telogen follicles. Therefore, RhoA appears to be differentially expressed in the
keratinocyte stem cells of the human hair follicle. Rho GTPases are small protein switches which
mediate a variety of essential cellular responses such as gene transcription, cell-cycle progression,
cell adhesion and actin reorganization. Future characterization of RhoA's function within hair
follicle stem cells should lead a better understanding of the signaling pathways involved in stem cell
maintenance.
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Hair Follicle Involution (Catagen) is Accompanied by Apoptosis-Driven Regression of
the Cutaneous Microvasculature
L. Mecklenburg, D. Tobin,* and R. Paus
Dermatology, University Hospital Eppendorf, Hamburg, Germany; *Biomedical Sciences, University of
Bradford, Bradford, UK
Recently we have shown that the murine hair cycle offers an excellent model for the study of
physiologically occuring angiogenesis during synchronized anagen-development. This physiolo-
gical angiogenesis contrasts with pathological (e.g. tumor-associated) angiogenesis in that
eventually the newly formed blood vessels regress again, typically associated with involution of
the perfused tissue. Since we had previously shown that the density of cutaneous microvessels
declines during synchronized hair follicle regression (catagen) in mice, we speculated that catagen
development is associated with partial regression of the cutaneous microvasculature. Using
histomorphometry, double-immuno¯ourescence staining techniques and transmission electron
microscopy, we here demonstrate that apoptosis and degeneration of endothelial cells are indeed
detectable during catagen development. This is followed by a decline in the cutaneous microvessel
density which is still detectable long after all hair follicles have spontaneously transformed from
catagen to the telogen stage of the hair cycle. This sugests that the murine hair cycle not only is
idealy suited to study the controls of physiological angiogenesis in mature mammalian skin, but also
provides a most instructive and easily accessible model for dissecting the molecular controls that
critically regulate blood vessel homeostasis. Murine skin vasculature is clearly altered as a result of
primary changes in the hair growth cycle, and appeares to be regulated, at least in part, by factors
secreted by the hair follicle itself. Therefore, the apoptosis-driven catagen-associated regression of
cutaneous blood vessels in murine skin allows one to dissect the as yet obscure molecular controls
that determine normal blood vessel regression. Systematic use of this model may provide novel
clues to treatment strategies for, e.g. hemangiomas, vascular malformations as well as for the
induction of vascular regression around solid tumors.
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Spatio-Temporal Distribution of Apoptosis in Developing Human Hair Follicles
C. Chang, H. Yu, and C. Chuong*
Dermatology, Kaohsiung Medical University, Kaohsiung, Taiwan; *Pathology, University of Southern
California, Los Angeles, California
Morphogenesis of human hair follicle is a continuous process that has been divided into ®ve
morphologic stages: prefollicle, pregerm, hair germ, hair peg, and bulbous peg. In this study, we
analyzed the distribution of apoptotic cell death in developing human hair follicle using the
terminal deoxynucleotidyltransferase-mediated deoxyuridine triphosphate-biotin nick labeling
(TUNEL) method. In the prefollicle stage, TUNEL-positive cells were identi®ed in the periderm,
basal layer keratinocytes and mesenchymal cells. TUNEL-positive cells were seen in the pregerm
and hair germ, and condensing mesenchyme around them. In the hair peg stage, TUNEL-positive
cells were detected in its outer layer and core cells, presumptive matrix epithelial cells, dermal
papilla, and follicle sheath. In bulbous peg stages, TUNEL-positive cells were enriched along hair
canals including epidermal, infundibulum, and isthmus portion. In the hair cone area TUNEL-
positive cells were identi®ed in the inner root sheath and hair cortex. TUNEL-positive cells were
identi®ed in dermal papilla, matrix, and outer root sheath during hair follicle elongation. In
sebaceous gland and bulge area, TUNEL-positive cells were also detected. The distribution of
apoptotic cells in developing human hair follicles is much more prevalent than in adult. This
suggests a generally high cell turnover during embryonic development, in consistence with the
highly dynamic tissue remodeling during hair follicle morphogenesis. Apoptosis is associated with
speci®c cell behaviors in at least two aspects. One is association with terminal differentiation of hair
keratinocytes. In this case, apoptosis is observed in the keratogenic zone of hair cortex and inner
root sheath. This is essential for the formation of hair shaft. The other is association with separation
of two tissues. In this case, apoptosis is observed in keratinocytes within the epidermal and
subepidermal portion of hair canal. This process is essential to create a space between hair shaft and
hair follicle/epidermis so the hair shaft is free to grow out of the skin. In general, the spatio-
temporal occurrence of apoptosis is used to sculpt out the morphology of hair follicles.
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p53 Mediates Apoptotic Cell Death During Hair Follicle Regression (Catagen)
F. Siebenhaar,² V. Botchkarev, A. Sharov, E. Komarova,* N. Botchkareva, P. Komarov, M.
Maurer, A. Gudkov, and B. Gilchrest
Dermatology, Boston University School of Medicine, Boston, Massachusetts; *Molecular Genetics, University
of Illinois at Chicago, Chicago, Illinois; ²Dermatology, University of Mainz, Mainz, Germany
The p53 transcription factor mediates a variety of biological responses including apoptotic cell
death. p53 is known to control apoptosis in the hair follicle induced by ionizing radiation and
chemotherapy, but its role if any in physiological hair follicle regression (catagen) remains to be
elucidated. Here, we show that in C57BL/6 mice p53 protein is strongly expressed and colocalized
with TUNEL in the regressing hair follicle compartments during catagen. In contrast to the wild-
type mice, p53 knockout mice show signi®cant retardation of catagen (p < 0.05) accompanied by
the signi®cant decrease in the number of apoptotic cells (p < 0.01) in the hair matrix. Furthermore,
p53 null hair follicles had altered expression of proteins encoded by p53 target genes that are
implicated in the control of catagen (decrease of Bax and insulin-like growth factor binding
protein-3, and increase of Bcl-2). These data suggest that p53 is involved in apoptosis control
during physiological hair follicle regression and that p53 antagonists may prove useful for the
management of hair growth disorders with premature entry into the catagen, such as androgenetic
alopecia, alopecia areata, and telogen ef¯uvium.
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p53 and its Target Genes are Essential for Chemotherapy-Induced Hair Loss
V. Botchkarev, E. Komarova,* F. Siebenhaar,² N. Botchkareva, A. Sharov, P. Komarov, M.
Maurer, A. Gudkov, and B. Gilchrest
Dermatology, Boston University School of Medicine, Boston, Massachusetts; *Molecular Genetics, University
of Illinois at Chicago, Chicago, Illinois; ²Dermatology, University of Mainz, Mainz, Germany
Anticancer drugs induce apoptosis in the hair follicles and hair loss, the most common side-effect of
chemotherapy. In a mouse model for chemotherapy-induced hair loss, we demonstrate that p53 is
essential for this process: (i) by immunohistology, p53 was up-regulated in the hair follicles after
cyclophosphamide treatment, (ii) in contrast to wild type mice, p53-de®cient mice show neither
hair loss nor apoptosis in the hair follicle keratinocytes that maintained active proliferation after
cyclophosphamide treatment, (iii) hair follicles in p53 knockout mice are characterized by down-
regulation of Fas and insulin-like growth factor binding protein-3, and increased expression of Bcl-
2. To con®rm a role for Fas as a p53 target gene in chemotherapy-induced hair loss, we show that
Fas knockout mice display signi®cant (p < 0.05) retardation of cyclophosphamide-induced hair
follicle regression. Furthermore, administration of Fas-ligand neutralizing antibody signi®cantly
reduced a number of apoptotic cells in the hair follicle and retarded a rate of hair follicle involution
induced by cyclophosphamide. These observations indicate that local pharmacological inhibition
of p53 and/or its target genes may be useful to prevent chemotherapy-associated hair loss.
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Fibroblast Growth Factor 5 Inhibits Hair Growth by Blocking Dermal Papilla Cell
Activation
Y. Ota, Y. Saitoh, S. Suzuki, K. Ozawa,* and T. Imamura*
POLA Laboratories, Yokohama, Japan; *Biosignaling Department, National Institute of Bioscience and
Human Technology, AIST, Tsukuba, Japan
Fibroblast growth factor (FGF)-5 inhibits hair growth and induces catagen in mouse hair follicles in
vivo. As the receptor for FGF-5 (FGFR1) is expressed in dermal papilla cells (DPCs) that stimulate
proliferation of outer root sheath cells (ORSCs), we examined whether FGF-5 attenuated the
DPC-stimulated ORSC proliferation using these cells isolated from rat vibrissae. We found,
however, that FGF-5 did not directly affect the ability of DPCs to stimulate ORSC proliferation.
In contrast, when DPCs prior to their treatment with FGF-5 were activated by FGF-1, a prototype
member of FGF family that is expressed in hair follicles during anagen, the ORSC-proliferating
activity in the conditioned medium of DPCs was highly enhanced, and FGF-5 clearly attenuated
this activity. Thus, the results suggest that FGF-5 inhibits activation of DPCs by FGF-1. We
interpret that dermal papillae require activation before they will stimulate hair growth in vivo, and
that blockage of this activation with FGF-5 results in inhibition of hair growth and induction of
catagen.
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Choleratoxin but not Isoproterenol Inhibits Human Hair Follicle Growth In Vitro
E. Peters, I. Moll, V. Alt,* D. LoÈf¯er,* and R. Paus
Dermatology, University Hospital Eppendorf, Hamburg, Germany; *Plastic Surgery, KoÈ-Klinik, DuÈsseldorf,
Germany
Human hair growth requires complex controls that coordinate the proliferation of hair matrix
keratinocytes with the differentiation of hair shaft, inner root sheath and outer root sheath
keratinocytes. The second messenger cyclic adenosine monophosphate (cAMP) may stimulate
keratinocyte growth in low concentrations and inhibit keratinocyte growth while stimulating
differentiation in high concentrations. Basal epidermal keratinocytes are known to express b2-
adrenoreceptors, and undifferentiated keratinocytes in culture are more susceptible to b2-
adrenoreceptor mediated cAMP-induction than differentiated keratinocytes. Here we used
immunhistochemistry of human scalp skin samples to investigate b2-adrenoreceptor expression in
anagen hair follicles. In addition we tested the impact of the selective b2-adrenoreceptor-agonist
Isoproterenol, the selective b2-adrenoreceptor-antagonist propranolol, and nonselective cAMP
induction by choleratoxin on human hair growth in vitro, utilizing cultured androgen-insensitive
scalp hair follicles. We found strong and selective b2-adrenoreceptor expression in outer root
sheath keratinocytes of the dermal compartment in the isthmus and bulge region and weaker
expression in selected layers of the proximal inner and outer root sheath, but not in matrix
keratinocytes. However, 10±6, 10±9, or 10±12 M isoproterenol or propranolol showed no signi®cant
modulatory effect on human hair follicle growth when compared to controls. In contrast,
choleratoxin signi®cantly inhibited hair growth at 10±8 and 10±9 M. Thus, while b2-adrenoreceptor
stimulation in the inner and outer root sheath does not appear to alter hair growth, strong
nonselective cAMP-up-regulation by choleratoxin, e.g. in the hair matrix, may stimulate
premature keratinocyte differentiation in the hair follicle, thus inhibiting hair growth. This suggests
that targeting second messenger systems like cAMP is a promising strategy for the manipulation of
human hair growth.
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Hair Growth Inhibition by Prolactin and Expression Pattern of Prolactin and its
Receptor in Isolated Human Hair Follicles
K. Krause, T. Spexard, I. Moll, R. Paus, and K. Foitzik
Dermatology, University Hospital Hamburg-Eppendorf, Hamburg, Germany
The maternity hormone prolactin (PRL) has recently been implicated in hair growth regulation, is
expressed also in extrapituitary tissues, and exerts a wide variety of growth-regulatory effects.
Recently, we have shown that prolactin is expressed in a hair cycle-dependent manner in mice and
that treatment of anagen hair follicles with prolactin resulted in catagen-induction in murine skin
organ culture. Here, we provide the ®rst study of prolactin and prolactin receptor expression in
human hair follicles (HF), and study the in¯uence of prolactin on hair growth in human follicles.
Human HF from scalp hair transplants were isolated and cultured for up to eight days in Williams E
medium and prolactin (20 ng, 200 ng, 400 ng per ml) was added every other day. Hair shaft
elongation was measured and photodocumented at regular intervals. By immunohistochemistry,
prolactin immunoreactivity (IR) was detected in human anagen VI HF in the inner root sheath
(IRS), matrix cells of the hair bulb, and outer root sheath (ORS). The dermal papilla ®broblasts
were negative. Prolactin receptor IR showed a very similar pattern, as it was detected in the ORS,
proximal IRS, and in most of the matrix cells. The dermal papilla and distal IRS of anagen VI HF
were negative for prolactin receptor IR. In catagen HF, prolactin and PRL receptor expression
appeared to be up-regulated. ORS and matrix cells showed IR, while in the dermal papilla and
IRS no prolactin expression could be detected. Treatment of human HF with high dose of
prolactin (400 ng per ml) resulted in signi®cant inhibition of hair growth and induction of a
catagen-like HF transformation. Ki-67/TUNEL double-staining showed a signi®cantly reduced
number of proliferating and increased number of apoptotic cells in the hair bulb of PRL-treated
HF, compared to vehicle controls. These data support the hypothesis that the human HF is a
source and target of PRL, that PRL is an autocrine hair growth modulator which inhibits
proliferation and induces apoptosis in HF keratinocytes, and raises the question whether PRL is
involved in the pathogenesis of androgenetic alopecia, at least in females.
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The Potassium Channel Openers Minoxidil and Diazoxide Stimulate Hair Growth in
Whole Organ Culture
G. Davies, T. Jenner, Y. Chen, V. Randall, and M. Thornton
Department of Biomedical Sciences, University of Bradford, Bradford, UK
Although potassium channel openers such as minoxidil and diazoxide promote hair growth in vivo,
the mechanisms by which they do so are unclear. Currently, there is no readily available model
system since human skin is limited. Therefore, we have investigated the effects of varying
concentrations of minoxidil and diazoxide in a red deer whole hair follicle culture system. Anagen
follicles were microdissected from the mane region of 10 adult stags at the same time of year,
washed with sterile phosphate buffered saline and incubated in Williams medium E with 5 mM
glucose, 100 U per ml penicillin and 2.5 mg per ml amphotericin B. A minimum of six follicles were
incubated in each experimental group; control vehicle (0.01% dimethylsulphoxide), 0.1, 1, 10,
100 mM minoxidil or diazoxide. Growth was measured by micrometry every 24 h. Red deer
follicles grew under all conditions for up to 8 days. All concentrations of minoxidil (5 animals)
signi®cantly (p < 0.01) increased follicle length compared to the control. Diazoxide (5 animals) had
no signi®cant effect, although 0.1 and 10 mM tended to increase growth. The in vitro response of
the potassium channel openers in this study re¯ect the clinical response to these drugs. These results
con®rm deer follicles as a system to examine the mechanism of action of potassium channel openers
and assess the effects of other stimulators or inhibitors of hair growth in vitro.
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Remodeling of Desmosome (DS) and Hemidesmosome (HD) During Human Hair
Follicle Development
M. Akiyama, I. Matsuo, and H. Shimizu*
Department of Dermatology, Teikyo University School of Medicine, Ichihara Hospital, Ichihara, Japan;
*Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
Major cell attachment structures of epidermal keratinocytes, DS and HD, are thought to play
important roles in regulation of cell growth and differentiation during hair follicle morphogenesis.
We investigated the expression of major components of DS and HD including desmogleins,
desmoplakins, plakoglobin, laminin 5, b4 integrin, BPAG1 & 2, plectin, in the developing human
hair follicles of skin samples from human fetuses of a series of estimated gestational ages (EGAs)
(65±163 days EGA). In the hair germ (65±84 days EGA) and the hair peg (85±104 days EGA), the
inner cells being not in contact with the basement membrane zone (BMZ) showed strong
membranous immunoreactivities for DS components. Positive stainings for HD components were
continuously observed in BMZ of the hair germ and the hair peg, although, in lower portion of the
hair peg, the stainings were weak or negative. In the bulbous hair peg (105±135 days EGA) and the
differentiated lanugo hair follicle (135 days EGA), the DS components were expressed in the entire
hair follicle, although the expression was weak in the outermost layer of the outer root sheath, the
bulge cells and the matrix cells. The HD components were expressed in BMZ continuously from
the interfollicular epidermis to the mid portion between the bulge and the bulb, and also in the
contact area between the matrix cells and the dermal papilla cells. The HD components were
absent in the bulbar region under the mid point between the bulge and the bulb. Ultrastructurally,
formation of DS and HD was con®rmed at the expression sites of their components. These ®ndings
indicated that expression of DS components was weak in the cells in contact with BMZ and that
expression of HD components was weak or absent in the elongation site of developing hair
follicles, all the time during human hair follicle morphogenesis.
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The Type I Keratin 17 is Crucial to the Formation and Structural Rigidity of the Hair
K. McGowan, E. Colucci-Guyon,* X. Tong, C. Babinet,* and P. Coulombe
Biological Chemistry, Johns Hopkins University, Baltimore, Maryland; *Biologie du Developpement, Institut
Pasteur, Paris, France
During development onset of keratin 17 (K17) synthesis marks the adoption of an appendageal fate
within the embryonic ectoderm. In adult skin, K17 persists in speci®c subset of epithelial cells
within hair, glands, and nail. The K17 gene is induced following epidermal injury, in in¯ammatory
lesions and basal cell carcinoma. Inherited mutations in K17 can cause either type 2 pachyonychia
congenita or steatocystoma multiplex, two distinct ectodermal dysplasias. We inactivated the
mouse keratin 17 gene through gene targeting and homologous recombination to de®ne its
function(s) in skin epithelia. A subset of K17 null mice show a striking delay in the postnatal
emergence of the fur coat. This phenotype appears during the ®rst week postbirth and correlates
with the appearance, as seen through histology, of melanin pigment aggregates, destruction of the
inner and outer root sheaths, and of twists and breaks in hair shafts. These structural aberrations in
the hair were con®rmed by electron microscopy. Hair breaks occurred spontaneously during the ex
vivo manipulation of hairs from K17 null but not wildtype mice. The hair phenotype normalizes to
a signi®cant extent in many of these mice with the onset of the ®rst postnatal hair cycle. Nail
structure and histology is comparatively normal. While such hair alterations are seen in two
independent transgenic lines, the phenotype is not fully penetrant in the original mixed genetic
background. Normal-looking K17 null mice exhibit an increased amount of K16 protein in hair
extracts when compared to either phenotypic K17 null mice or wildtype mice, raising the
possibility that this related keratin gene, which is also wound-inducible, could compensate for the
absence of K17. Preliminary studies con®rm that the impact of the K17 null mutations depends
upon the genetic background, a ®nding that could have important implications for our
understanding of the variable phenotype of patients whose genome harbor similar K17 mutations.
These ®ndings point to a very critical role for the K17 protein in the formation and structural
rigidity of the hair.
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Overexpression of Nitric Oxide Synthase in the Skin of Transgenic Mice
V. Reddy, K. Kounga, C. Kramer, J. Park, H. Baden, and E. Lerner
Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, Massachusetts
Nitric oxide (NO) is produced in cells by nitric oxide synthase. Low concentrations of NO serve as
a signaling molecule while high concentrations lead to apoptosis and cytotoxicity. We have
hypothesized that high concentrations in the skin may be manifest as GVH, toxic epidermal
necrolysis, scleroderma, alopecia areata, graying of hair and vitiligo. Transgenic mouse models
constitutively expressing nitric oxide synthase will be useful in the study of these clinical
conditions. Transgenic mice have been generated that express the murine inducible nitrix oxide
synthase (iNOS) under the control of keratinocyte- and melanocyte-speci®c promoters. Three
different DNA constructs were made to generate the transgenic mice. In the ®rst construct, a 2-kb
long mouse K14 promoter fragment was linked to the 3.9 kb mouse iNOS cDNA followed by a
2.1-kb hGH poly A sequence. In the second construct, a 3.7-kb involucrin promoter fragment was
linked to mouse iNOS cDNA and a 0.2-kb SV40 poly A fragment. In the third construct, a 0.3-kb
tyrosinase promoter fragment was linked to mouse iNOS cDNA and the SV40 poly A fragment. It
is expected that the K14 and involucrin promoters would be active in keratinocytes while the
tyrosinase promoter would be active in melanocytes. Fertilized B6C3F1 (C57B6/6 3 C3H) mouse
embryos were microinjected with the three constructs and transgenic founder mice (F0) were
screened by PCR and Southern blots. F1 mice were generated by crossing littermates of different
transgenes as well as with wild type B1/6C57 mice. Northern blot analysis and in situ hybridization
revealed that some of the transgenic mice showed iNOS mRNA expression in skin. Several of the
involucrin and tyrosinase transgenic mice exhibited various clinical and histologic phenotypes
including loss of facial and abdominal hair consistent with alopecia areata, loss of hair color
consistent with vitiligo, apparent thickening of the dermis suggestive of scleroderma, and a
dermatitis. These results are consistent with the hypothesis that NO contributes to the pathogenesis
of a number of skin conditions.
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Hair Morphogenesis Analysis of Follistatin-De®cient Mice and BMP-7 Knockout Mice
M. Nakamura, K. Foitzik, S. Liotiri, M. Matzuk,* R. Godin,² E. Robertson, and R. Paus
Department of Dermatology, University Hospital Eppendorf, Hamburg, Germany; *Department of
Pathology, Molecular and Cellular Biology, and Molecular and Human Genetics, Baylor College of Medicine,
Houston, Texas; ²Department of Molecular and Cellular Biology, Harvard Univeristy, Cambridge,
Massachusetts
Members of TGF-b/BMP family are involved in the control of hair follicle morphogenesis. The
activity of several members of this family (activin, BMP-2, 4, 7) is usually antagonized by follistatin.
The expression of BMP-7 has been reported in the inner root sheath cells and outer root sheath
cells and the dermal papilla cells. Since follistatin-de®cient mice show abnormalities in vibrissae
follicles, we have further explored the role of follistatin and BMP-7 in hair follicle development
with the analysis of knockout mice. Compared to wild type controls, follistatin knockout mice
showed a signi®cant retardation of hair follicle morphogenesis (p < 0.01). The follistatin null
mutation also signi®cantly reduced keratinocyte proliferation in stage 1-2 hair follicles. In contrast,
BMP-7-de®cient mice showed no signi®cant abnormalities in hair follicle morphogenesis,
keratinocyte proliferation, hair follicle density, or epidermal thickness. Immunohistological analysis
of apoptotic cells (TUNEL), selected adhesion molecules (NCAM), morphogens (KGF), or
growth factor receptors (FGFR-2, m-met) failed to reveal any substantial changes in both
knockout strains. In organ culture of human anagen VI scalp hair follicles, recombinant human
follistatin inhibited hair shaft elongation and induced hair follicle regression (catagen). Taken
together, follistatin is involved in the control of both hair follicle morphogenesis and hair cycling.
BMP-7 does not play an indispensable role in hair follicle development, possibly due to
redundancy among various BMP family members.
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Androgens Modulate the Connective Tissue Phenotype of the Nipple
A. Abdahlkhani, R. Sellers,² J. Gent, S. Richadson, E. Farmer,* and J. Foley
Anatomy and Cell Biology, Indiana University School of Medicine, Bloomington, Indiana; *Dermatology,
Indiana Univeristy School of Medicine, Indianapolis, Indiana; ²Veterinary Biosciences, The Ohio State
Univeristy, Columbus, Ohio
The humoral hypercalcemia of malignancy factor parathyroid hormone-related protein (PTHrP)
regulates a wide variety of developmental processes including tooth eruption, linear growth of long
bones, branching morphogenesis of the mammary gland and patterning of the skin. Recently, we
have demonstrated that keratin 14 (K14) promoter-mediated overexpression of PTHrP in the basal
keratinocytes during development converts the entire murine ventral skin to hairless nipple sheath.
At this point very little is known about the molecular basis for the morphologic differences
between the nipple and surrounding skin or the role of sex steroid hormones in the patterning of
this structure. In this study, we use electron microscopy, histochemistry, immunohistochemistry
and image analysis to evaluate the murine nipple, as well as the ventral skin of male and female
K14-PTHrP mice and ovarectomized and ocharectomized K14-PTHrP mice. The connective
tissue of the nipple and the ventral dermis of female K14-PTHrP mouse have an increased number
of cells, and is enriched in laminin, ®bronectin and proteoglycans as compared to the ventral
dermis of wild-type littermates. The increased cellularity of the nipple or nipple-like connective
tissues was due in part to a signi®cant increase in number/unit area of mast cells, capillaries and
nerve ®bers in the connective tissue. The adult male K14-PTHrP mouse also lacks hair on the
ventral epidermis but does not manifest the nipple-like characteristics in the dermis. A
developmental survey suggests the unique characteristics of nipple connective tissue appear 3
weeks after birth, suggesting a role for sex-speci®c steroid hormones in the ®nal morphogenesis of
this structure. Ovarectomy or ocharectomy had no impact on the dermal phenotype of the female
or male K14-PTHrP mouse. Thus, it appears that the unique connective tissue phenotype of the
mammalian nipple requires developmental expression of PTHrP but can be modulated by
androgens.
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Lesions in Growth Factor Expression May Underlie Defects in Melanocyte Proliferation
in Hair of Vitiligo Mice
K. Kurita, H. Shimogaki, and K. Takada
Life Science Research Center, LION Co, Odawara, Japan
The coat color of vitiligo mice C57BL/6 J-Mitfmi-vit, in which there is a spontaneous mutation at
the mi(microphthalmia) locus, lightens progressively with aging. The change in coat color with
aging in vitiligo mouse bears some resemblance to senile hair changes in humans.
Immunohistochemistry and molecular biology tools were employed to investigate melanocyte
changes, such as density and localization, in vitiligo mice as a function of age. For localization of
melanocytes in hair, antibodies speci®c for tyrosinase-related protein-2, were employed. In the
black hair of two month old vitiligo mice, elevated levels of follicular melanocytes were detected in
the outer root sheath and in the hair bulb. A few scattered melanocytes were detected in the white
hairs of vitiligo mice at 9 months of age. This decrease in numbers of melanocytes correlated with
hair graying in vitiligo mouse. Using quantitative RT-PCR, we next examined gene expression of
growth factors and their receptors associated with melanocyte proliferation. These included stem
cell factor (SCF), Endothelin, nerve growth factor, hepatocyte growth factor, and basic ®broblast
growth factor. Gene expression of 2, 6 and 11-month-old vitiligo mice were compared.
Quantitative RT-PCR demonstrated that melanocyte gene expression was markedly decreased not
only for growth factor receptors, but also for two paracrine factors, SCF and Endothelin. These
results suggest that the mutation at the mi locus induce down regulation of gene expression not
only for tyrosinase and tyrosinase-related protein-1 in melanocytes but also for growth factors
associated with melanocyte proliferation, and their receptors.
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Unique Form of Murine Alopecia: A Mouse Model for Human Hair Disorders
L. Tang, M. Surbey,* J. Jacob,² L. Cao, H. Lui, and J. Shapiro
Medicine, University of British Columbia, Vancouver, BC, Canada; *Psychology, James Cook University,
Townsville, Australia; ²Psychology, Mount Allison University, Mount Allison, NS, Canada
The rodent has been a useful model and biomedical tool for studying human hair disorders. An
undocumented form of alopecia in CD±1 mice has been maintained over several years by selective
breeding. Spontaneous alopecia occurs in 25±30% of the selected population and affects females 3
times more often than males. The process of hair loss normally begins after sexual maturity in both
sexes. In affected mice, normal hair growth occurs until approximately 40 days of age and is
subsequently followed by rapid hair loss (few days) from a rectangular area between the ears. This
localized alopecia lasts for months and the bald patches appear to ®ll in a majority of mice following
a variable period of time. Over the generations, some individuals became thinned rather than bald
in the rectangular area. Histopathology from the established bald patches reveals an absence of
matured hair follicles and exhibits no peri- or intrafollicular lymphocyte in®ltration. Initial
pedigree analysis suggests the involvement of two or more recessive alleles, with further genetic
analysis necessary to elucidate the mode of transmission. This localized and rectangular pattern of
murine alopecia may be a potentially useful model for the major types of human alopecias.
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Developmental and Breed-Related Changes in the Canine Hair Follicle
K. Credille, C. Lupton, G. Davenport,* and R. Dunstan
Pathobiology, Texas A & M University, College Station, Texas; *Research and Development, The Iams
Company, Lewisburg, Ohio
The diversity of hair morphology and growth seen in different murine strains is approached, if not
exceeded, only by the coat differences in canine breeds; however, little is known about hair growth
in the dog. In this study we de®ne breed- and age-related differences in the follicular morphology
and hair cycle in 36 male dogs from three canine breeds (12 Siberian Huskies, 12 Labrador
Retrievers and 12 Miniature Poodles). From 10 weeks to 81 weeks of age, the dogs were
periodically sampled. The hair follicles were assessed using (1) optical-based ®bre diameter and
curvature analysis; and (2) vertically and horizontally sectioned 6 mm punch biopsy samples to
de®ne the morphology, number of hairs/compound follicle and anagen:telogen ratios. Evaluation
of horizontal histologic sections con®rmed the compound nature of the canine follicle. Compound
follicles were present in groups we termed a follicular unit. Each compound follicle had the largest
diameter follicles present anterior and the smallest posterior. In each breed there was an increase in
the number of follicles until week 45. Siberian Huskies had the greatest number of follicles/
follicular unit. Optical-based ®bre diameter and curvature analysis identi®ed Labrador Retrievers as
the breed with the largest mean diameter of hairs and the least degree of curvature. Miniature
Poodles had the smallest mean hair diameter throughout the study and the greatest curvature after
week 54. As Labrador Retrievers and, to a lesser extent, Siberian Huskies matured (i.e. ``lost their
puppy coat''), there was a transient production of coarser, straighter hairs. The trend in Siberian
Huskies and Labrador Retrievers was an increase in the number of telogen follicles. By week 81,
both breeds had approximately 70% of their hairs in telogen. For Miniature Poodles there was a
decrease in the number of telogen follicles and by week 81 only 7% of the follicles were in telogen.
These data indicate that the profound gross differences in the pelage of canine breeds can be
de®ned morphologically and morphometrically. The breed differences, the unique orientation of
the canine compound follicle (larger hairs anterior, smaller hairs posterior) and the recognition of
breeds with anagen-predominant and telogen-predominant hair cycles suggest the dog hair follicle
may be used to answer questions about hair growth not easily asked in murine or human systems.
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An Investigation into the Effects of Testosterone on Follicular Development Using a
Novel In Vitro Culture Model of Antler Velvet
N. Croft and V. Randall
Biomedical Sciences, University of Bradford, Bradford, UK
The skin (velvet) covering growing deer antlers is an unique example of de novo development of
new skin and hair follicles, i.e. ``neogenesis'' (a process directly equivalent to skin development in
an embryo) occurring in an adult. Red deer velvet is being investigated as a novel model in which
to study follicular embryogenesis. Immunohistological investigations have shown similar follicle
development and characteristics to other mammalian systems. A particularly important feature of
velvet is that several stages of follicular development are present in the same section due to the
antlers very rapid growth. Since an in vitro system would be useful for investigating the roles of
speci®c factors in embryogenesis, samples of antlers velvet have been cultured. As the antler is an
androgen responsive organ the effects of testosterone on this system was also investigated. Skin
biopsies (4 mm) from the tips of red deer (Cervus elaphus) antlers were cultured in DMEM in the
presence or absence of 10 nM testosterone. Samples were supported in absorbable gelatine sponge
(Gelofoam(r)). Samples were removed every 2 days up to day 7/8 and frozen. Frozen sections (6±
7 mm) were stained with the histological stain SACPIC and antibodies to cytokeratin 6, the
mesenchymal marker, vimentin and the cell proliferation marker, Ki67. The histology remained
good until at least day 7 and under conditions with and without testosterone samples retained good
morphology with Ki67 staining as normal at day 2 and still present at day 6. By day 6 cytokeratin 6
expression was found to be normal in the centre whereas at the biopsy periphery evidence of
wound healing events was evident. Mesenchymal ®broblast aggregations stained for vimentin
appeared normal at day 6. Results with, and without, testosterone were indistinguishable. These
studies show that antler velvet can be cultured successfully and that testosterone does not have an
appreciable affect on follicular development in antler velvet. Cultured antler skin should be a useful
model system to investigate molecules involved in intercellular signalling in developing hair
follicles without the ethical dif®culties often associated with such research.
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Gene Therapy of Growing Hair Shafts
R. Hoffman,* N. Saito, M. Zhao, L. Li, E. Baranov, M. Yang, Y. Ohta,* and K. Katsuoka*
AntiCancer, Inc., San Diego, California; *Department of Dermatology, Kitasato University, Kitasato, Japan
A novel gene therapy technology of hair follicles has been developed which results for the ®rst time
in ef®cient genetic alteration of the hair shaft phenotype. Mouse anagen skin fragments in
histoculture were transduced at high ef®ciency by adenoviral-green ¯uorescent protein (GFP) with
subsequent grafting of the skin fragments to nude mice. The histocultured skin fragments were
treated with collagenase which made hair follicles accessible to the adenoviral-GFP gene allowing
high-ef®ciency transduction. Without collagenase treatment, GFP expression was negligible. The
extent of GFP expression in the hair follicle depended on adenoviral titer and time of adenoviral
treatment. After transplantation of the GFP-transduced skin to nude mice, GFP was readily
visualized in as many as 75% of hair follicles including large numbers of GFP-¯uorescent growing
hair shafts. High-level transgene expression was maintained in vivo in hair follicles suf®ciently such
that growing hair shafts were phenotypically altered as demonstrated by speci®c GFP ¯uorescence
in the hair shaft. RT-PCR measurement of GFP-gene expression con®rmed GFP-gene transfer
and expression in the hair follicle. This novel technology demonstrates the feasibility of ef®cient
genetic modi®cation of the hair shaft.
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Gender Difference in Autoimmune Alopecia of New Zealand Black/KN Mouse
A. Hiroi, T. Ito,* T. Yosimasu, T. Otani, and F. Furukawa
Dermatology, Wakayama Medical University, Wakayama, Japan; *Dermatology, Hamamatsu University
School of Medicine, Hamamatsu, Japan
New Zealand Black (NZB)/KN mouse is an SLE-prone mouse associated with arthritis, and male
mouse shows alopecia spontaneously. We have reported that the male NZB/KN mouse is an
autoimmune alopecia model, which suggests that the gender is an important factor in¯uencing the
development of alopecia. To verify the male predominance, we studied the relationship among
alopecia, gender, and other clinical symptoms using NZB/KN, the F1 hybrid mouse with NZ
White(NZW) mouse and the F2 hybrid mouse of (W/BKN F1AÊ ~W/BKN F1). The incidence of
alopecia of male NZB/KN, W/BKN F1, B/WKN F1, and F2 mice at 12 months (mo) were 88%,
9.5%, 0%, and 44%, respectively. Male NZB/KN mouse initially developed hair loss and a slight
indurative change around the tail, and then on the upper back. Hair density at alopecia lesion of
male NZB/KN mouse was lower than it's peripheral skin and control skin, although there was no
difference about diameter. Histologically, intrafollicular lymphocyte in®ltration were seen at the
primary lesion and intradermal perivascular mononuclear cell in®ltration were observed in the fully
developed lesion. In the serum mainly Ig M type antibodies against follicular structure were
detected at 3 month, and 75% of male NZB/KN showed the positive titer until 12 month.
Immuno¯uorescence study revealed IgM deposition at basement membrane zone of both
epidermis and/or hair follicle. In female NZB/KN mice a slight hair loss was found in 24% on the
upper back at 12 month, but the lesion was not fully developed. Female W/BKN F1, B/WKN F1,
and F2 mice showed alopecia in 6%, 0%, and 7.3%, respectively. F2 mice showed signi®cant
correlation among gender, alopecia and proteinuria, but not among alopecia, H-2, and
splenomegaly. The alopecia in male NZB/KN mouse is a novel model of autoimmune alopecia
and found to be closely associated with male gender based on the studies on F1 and F2 hybrid
mice.
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Restoration of Hair Growth with Topical Anthralin in Alopecia Areata Rats: Ef®cacy
and Molecular Mechanisms
J. Shapiro, L. Tang, L. Cao, and H. Lui
Medicine, University of British Columbia, Vancouver, BC, Canada
Anthralin has been suggested to have potential ef®cacy in alopecia areata (AA). It may have a
nonspeci®c immunomodulating effect on AA as it does in the topical treatment of psoriasis. The
aim of the present study was to investigate the therapeutic effects of anthralin on AA-affected rats
and the underlying mechanisms at the molecular levels. The Dundee experimental bald rats
(DEBR) were treated daily for 11 weeks on half of the dorsal skin with 0.1% anthralin ointment
and the contra-lateral sides were treated with the vehicle ointment. All 15 rats showed near
complete hair regrowth on the treated sides, while the control sides remained balding. At the end
of the treatment, skin biopsies were collected from both treated and control sides. RNA and
proteins were extracted. Proteins were used for KinetworkTM analytical screens for cell signaling
proteins (Kinexus, Canada) to determine the expression of various protein kinases and kinase
activities which might be responsible for the signal transduction mediated by anthralin in rat skins.
RNA protection assay was performed to determine the gene expression of various cytokines
mediated by anthralin. Among the cytokines we have tested by RPA, IL-1RA and INF-g showed
remarkable reduction after anthralin treatment. We conclude that anthralin is 100% effective on
restoring hair in DEBR rats with AA-like hair loss. The molecular mechanism underlying the
ef®cacy of anthralin on hair regrowth in AA rats might be mediated by the interplay of cytokines
and protein kinases produced locally in the skin upon anthralin treatment.
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Genetic Analysis of the Interleukin-1 Receptor Antagonist and its Homologue IL1-L1 in
Alopecia Areata: Strong Disease Associations and Possible Gene Interaction
R. Tazi-Ahnini, A. McDonagh,* A. Cox, F. di Giovine, A. Messenger,* G. Duff, and M. Cork
Division of Genomic Medicine, Royal Hallamshire Hospital, University of Shef®eld, Shef®eld, UK;
*Department of Dermatology, Royal Hallamshire Hospital, Shef®eld, UK
Alopecia areata is an in¯ammatory hair loss disease with a major genetic component. The presence
of focal in¯ammatory lesions with perifollicular T-cell in®ltrates re¯ects the importance of local
cytokine production in the pathogenesis. In addition to its fundamental pro-in¯ammatory role, the
IL-1 system has major effects on hair growth regulation in vitro, with the inhibitory actions of IL-
1a and IL-1b being opposed by the receptor antagonist, IL-1ra. The novel interleukin-1 like
molecule 1 (IL-1L1) which has greatest gene sequence homology with IL1RN, the gene encoding
IL-1ra, is another potential IL-1 antagonist. In view of previous studies suggesting a signi®cant role
for IL1RN polymorphisms in the pathogenesis of autoimmune/in¯ammatory disease, we have
analysed polymorphisms of IL-1ra (IL1RN + 2018) and its homologue IL-1L1 (IL1L1 + 4734) in a
case±control association study on 165 patients and a large number of matched controls.
Homozygosity for the rare allele of IL1RN (IL1RN*2) was signi®cantly associated with alopecia
areata [odds ratio (OR) = 1.89, 95% CI (1.09,3.28); p = 0.02] con®rming our previous ®ndings of
signi®cant association with the IL1RN VNTR. The results also revealed a novel association
involving a polymorphism of the interleukin-1 receptor antagonist homologue IL1L1 at
position + 4734, IL1RN + 2018 and alopecia areata. Genotypes combining at least 3 copies of
the rare alleles for IL1RN & IL1L1 conferred a more than additive increase in the risk of disease
compared to IL1RN + 2018 or IL1L1 + 4734 alone [OR 3.37 (1.60, 7.06); p = 0.002], suggesting
possible synergy between IL1RN and IL1L1. This effect was stronger in patients with severe
disease (alopecia totalis/universalis) [OR 4.62 (1.87, 11.40), p = 0.0022], and in those with early
age at onset (< 20 year.) [OR = 6.38 (2.64, 15.42), p = 0.0002]. Our results suggest that these
polymorphisms of IL1RN & IL1L1 themselves or a gene in linkage disequilibrium with IL1RN &
IL1L1 predispose to the more severe forms of alopecia areata.
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Human Gene Expression Mapping in Alopecia Areata
A. Sinha and H. King
Dermatology, Weill Medical College of Cornell University, New York, New York
Alopecia areata (AA) is a disease characterized by the loss of hair that affects approximately 2±4
million individuals in the US, including men, women, and children. Numerous studies have
suggested a genetic predisposition to AA and increasing experimental evidence suggests that AA is
autoimmune in nature. However, mechanisms of disease initiation and development are not fully
understood. Although the expression levels of several genes have been shown to be altered in scalp
tissue affected by AA, a broad perspective on the gene expression abnormalities characterizing AA
has been unavailable. In this study, we have used microarray analysis to determine the gene
expression differences between normal scalp and AA affected scalp at a genome-wide scale. Total
RNA was prepared from lesional and site-matched nonlesional scalp biopsy samples from 5 patients
with alopecia areata. The total RNA was enriched for mRNA, and cDNA was then synthesized,
radiolabeled, and hybridized to Atlas Human Cytokine/Receptor Arrays. These arrays allow the
simultaneous analysis of expression of 265 genes. Expression was quantitated using a Storm 840
PhosphorImager and analysis was performed using ImageQuant 1.2 software (Molecular
Dynamics). Preliminary results show that approximately 20 genes exhibited differential expression,
de®ned as a two-fold or greater difference in expression between lesional and nonlesional tissue.
Differentially expressed genes include the interleukin-1 receptor antagonist protein precursor, the
hepatocyte growth factor agonist, the keratinocyte growth factor, the interleukin-6 receptor a
subunit, and the interferon-g receptor. We are currently con®rming these results on a larger
number of samples using Affymetrix Human Genome U95A Arrays, which permit the
simultaneous analysis of expression of approximately 12 500 sequences. We expect these studies
to enhance our understanding of basic disease mechanisms and illuminate potential therapeutic
targets.
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Melanocyte Associated Antigens can Serve as Autoantigens for Alopecia Areata
A. Gilhar,* M. Landau,² B. Assy,* R. Shalaginov,* S. Sera®movich,* and R. Kalish
Dermatology, SUNY @ Stony Brook, Stony Brook, New York, New York; *Skin Research Laboratory,
Flieman Medical Ctr, Technion Institute Technology, Haifa, Israel; ²Dermatology, Elias Sourasky Medical
Ctr, Tel Aviv, Israel
Alopecia areata (AA) is an tissue restricted autoimmune disease affecting the hair follicle, resulting
in hair loss. It has been hypothesized that the autoantigens of alopecia areata are melanocyte
associated. The goal of this study was to determine if melanocyte associated antigens can activate
T-cells from alopecia areata patients to induce hair loss. The role of CD8+ T-cells in transferring
hair loss directed the search to HLA-A2 restricted melanocyte epitopes. Potential autoantigens
were tested in the human scalp explant/Prkdc(SCID) mouse transfer system. Human, and animal
protocols were approved by the appropriate institutional committees. Scalp T-cells from lesional
AA scalp, were cultured with APC and a source of potential antigen, along with IL2. The T-cells
were then injected into autologous scalp grafts, and hair loss measured. Hair follicle homogenate
was used as a positive control for inducing hair loss. (1) In the initial experiment with 4 AA
patients, human melanoma homogenate (MeWo cells) was used as a source of potential antigen. T-
cells cultured with melanoma homogenate induced statistically signi®cant reduction in hair growth
(p < 0.01 by ANOVA). (2) HLA-A2 restricted melanocyte T-cell epitopes were then tested with 6
HLA-A2 positive AA patients. PBMC proliferation was used as a guide for selecting peptides for
scalp T-cell stimulation. Peptide activated T-cells reduced the number of hairs re-growing in 2
experiments with 6 patients (Exp 2: p < 0.001 by ANOVA). The most consistent peptide
autoantigens in this series were the Gp100 derived G9-209, and G9-280 peptides, as well as
MART-1 (27-35). Melanocyte peptide epitopes can function as autoantigens for AA. Multiple
peptides were recognized, suggesting epitope spreading.
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Can Alopecia Areata-Like Hair Loss be Transferred to NaõÈve Mice with IgG from
Alopecia Areata-Affected Animals?
S. Gardner, T. Olivry,* N. Lindsey, and D. Tobin
Biomedical Sciences, University of Bradford, Bradford, UK; *Companion Animal and Small Species
Medicine, College of Vet. Medicine, NC State University, Raleigh, North Carolina
Alopecia areata (AA) is a presumptive autoimmune hair loss disorder affecting humans and several
other mammalian species. Previously we have demonstrated the presence of antihair follicle (HF)
auto-antibodies in humans, horses and dogs with AA as well as in the C3H/HeJ AA mouse model.
However, it is unclear whether these antibodies are pathogenic. Some suggest they result secondary
to follicular damage, although anti-HF antibodies can appear prior to the onset of hair loss.
Recently, we reported limited telogen arrest and shedding in murine skin after passive transfer of
equine AA immunoglobulin and now extend this investigation by passively transferring puri®ed
IgG from a new case of equine AA into murine haired skin. The serum used for this study were
selected on the basis of high titer anti-HF antibodies by indirect immuno¯uorescence and Western
blotting with reactivity re-tested after IgG puri®cation. Eight C57Bl/10 mice in anagen III/IV
were injected intradermally with 5 mg IgG twice weekly for 44 days. Thereafter, dorsum skin was
harvested at both 7 h and 10 d, 3 mths and 5 mths post ®nal injection for H&E and TEM. Full hair
regrowth was observed around the injection site in all mice by 12 days post ®rst injection.
However, the injection site itself remained hairless for a further 14 days in mice treated with
normal IgG but did not regrow until 57 days later in mice treated with AA IgG. The AA IgG-
treated peri-injection site skin revealed a spatially restricted catagen-precipitation of hair follicles
that was associated histologically with the massive mixed-cell peri/intrafollicular and dermal
in¯ammatory in®ltrate. Furthermore, the affected hair follicles exhibited a telogen arrest while
distant follicles continued to cycle normally. Other notable ®ndings included epidermal hyperplasia
at the AA IgG-treated site. None of these features was observed in normal IgG-treated skin.
Isolated areas of pigmentation loss were observed in both AA-treated and control IgG-treated
mice. While this study suggests that AA IgG injected into murine haired-skin can have local effects
on hair cycling consistent with an in¯ammatory response; a pathogenic role for antihair follicle
antibodies in AA awaits con®rmation.
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The Role of Fas and Fas Ligand in Alopecia Areata of C3H/HeJ Mice
P. Freyschmidt-Paul, K. McElwee, V. Botchkarev,* J. Sundberg,² R. Happle, and R. Hoffmann
Department of Dermatology, Philipp University, Marburg, Germany; *Department of Dermatology, Boston
University School of Medicine, Boston, Massachusetts; ²The Jackson Laboratory, The Jackson Laboratory,
Bar Harbor, Maine
Interaction of Fas ligand (FasL) with its receptor Fas leads to apoptosis of the Fas-expressing cell.
Fas has been shown to be expressed on hair follicles and FasL on cells of perifollicular in®ltrates in
alopecia areata (AA) patients. Fas-de®cient Faslpr/Faslpr and Fas ligand-de®cient Faslgld/Faslgld mice
are relatively resistant to induction of T-cell mediated autoimmune diseases. Spontaneous AA
develops in 20% of C3H/HeJ mice, but grafting AA affected skin to normal haired C3H/HeJ mice
or mice from other histocompatible strains will induce the disease in graft recipients. Because AA is
regarded as a T-cell mediated autoimmune disease, we addressed the question whether Faslpr/Faslpr
and Faslgld/Faslgld mice are resistant to the induction of AA. Lesional AA skin was grafted onto
C3H.MRL-Faslpr mice, C3H/HeJ-Faslgld mice and control C3H/HeJ+/+ mice. Control mice
developed AA within 10 weeks, whereas C3H.MRL-Faslpr and C3H/HeJ-Faslgld mice did not
develop AA within 20 weeks after grafting. Immunohistochemistry revealed a peri- and
intrafollicular lymphocytic in®ltrate of CD4+ and CD8+ T-cells around anagen hair follicles and
an aberrant expression of MHC class I and II on hair follicle epithelium in control mice. In
contrast, C3H.MRL-Faslpr and C3H/HeJ-Faslgld had no perifollicular in®ltrate and no aberrant
expression of MHC class I and II. Immuno¯uorescence staining revealed an increased expression of
Fas on hair follicles in control mice with AA while Fas expression was absent in C3H.MRL ±
Faslprmice. TUNEL staining showed an increased number of apoptotic cells in control, AA affected
mouse hair follicle eptihelium, whereas in C3H.MRL-Faslpr and C3H/HeJ-Faslgld mice there were
almost no apoptotic cells in hair follicles. Our results show that C3H.MRL-Faslpr and C3H/HeJ-
Faslgld mice are resistant to induction of AA. These ®ndings suggest an important pathogenetic role
of the Fas-Fas ligand system in AA.
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A Family Case of Alopecia Universalis Congenita is Not Linked to Hairless Gene
Y. Takahashi, O. Mori, M. Morita, and T. Hashimoto
Department of Dermatology, Kurume University School of Medicine, Kurume, Japan
Inheritied forms of hair loss without associated skin or internal abnormalities are rare diseases. Two
autosomal recessive types of this condition have been described: alopecia universalis congenita and
atrichia with papular lesions. The two diseases have been shown to results from a mutation in the
human hairless gene. We report a Japanese family of alopecia universalis congenita with autosomal
dominant mode of inheritance, in which a 28-year-old father and his two sons were affected. No
associated ectodermal defects were noted. In mutation analysis for the father, no mutation was
identi®ed in hairless gene. These results suggest that there may be another gene responsible for
alopecia universalis congenita.
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Recapitulation of the Hairless Mouse Phenotype using Catalytic Oligonucleotides
P. Cserhalmi-Friedman and A. Christiano*
Dermatology, Columbia University, New York, New York; *Dermatology and Genetics and Development,
Columbia University, New York, New York
Ribozyme technology is widely used to target mRNA in a sequence speci®c fashion, and thus
change the expression pattern of cells or tissues. While the goal of mRNA targeting is usually the
cleavage of mutant mRNA with the prospect of gene therapy for inherited diseases, in certain
instances targeting of wild-type genes can be used therapeutically. Lack of expression of the mouse
hairless gene due to inherited mutations leads to the complete loss of hair, known as atrichia. We
designed this study to recapitulate the hairless phenotype in a restricted manner by topical
application of deoxy-ribozyme targeting molecules to speci®cally cleave the mouse hairless
mRNA. The targeting oligonucleotides were delivered on the back of C57Bl/6 J mice using a
commercially available liposome reagent. The delivery began immediately after birth, and was
repeated daily until day 16. Samples for pathology were taken at days 22 and 35, processed and
stained using standard techniques. The pathology samples of the treated area from day 22
demonstrated a decreased number of hair follicles, involution of the remaining follicles and
separation of the dermal papillae, all characteristic of the hairless phenotype. In contrast, the
pathology samples from the nontreated area of the same animal did not show these alterations. The
pathology samples of the treated area from day 35 demonstrated the presence of large dermal cysts
characteristic of the hairless phenotype, but not normally present in the skin of C57Bl/6 J mice. In
this study, we successfully recapitulated the hairless phenotype using topically applied target speci®c
catalytic oligonucleotides designed to cleave the mouse hairless mRNA. Our results demonstrate
the feasibility of using ribozyme technology to alter gene expression in the skin via topical
application, and provide proof of principle for the development of this strategy for permanent hair
removal.
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Atrichia Caused by Mutations in the Vitamin D Receptor Gene is a Phenocopy of
Generalized Atrichia Caused by Mutations in the Hairless Gene
J. Miller, K. Djabali,* T. Chen,³ M. Ioffreda, S. Lyle,² A. Christiano,§ M. Holick,§ and G.
Cotsarelis§
Department of Dermatology, Hershey Medical Center, Hershey, Pennsylvania; *Departments of
Dermatology and Genetics and Development, Columbia University, New York, New York; ²Department
of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; ³Department of Endocrinology,
Boston University, Boston, Massachusetts; §Department of Dermatology, University of Pennsylvania School
of Medicine, Philadelphia, Pennsylvania
Generalized atrichia with papules is a rare disorder characterized by loss of hair shortly after birth
and development of cutaneous cysts. Mutations in the hairless gene (HR) cause this phenotype in
both mouse and human. Here we present a case of atrichia with papules in a patient with a normal
HR gene, but with mutations in both alleles of the VITAMIN D RECEPTOR (VDR). The
patient exhibited vitamin D resistant rickets, which was con®rmed by an absent response of her
®broblasts to 1,25 dihydroxyvitamin D3 in vitro. Strikingly similar to individuals with HR
mutations, her skin showed an absence of normal hair follicles and the presence of cysts and
follicular remnants containing keratin-15 positive cells suggesting epithelial stem cells are still
present. Although hair loss has been reported in association with hereditary vitamin D resistant
rickets (HVDRR), we now characterize this alopecia as clinically and pathologically
indistinguishable from generalized atrichia with papules, which was previously thought to be
caused only by mutations in HR. These ®ndings suggest that VDR and HR, which are both zinc
®nger proteins, may interact and control postnatal cycling of the hair follicle.
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Atrichia with Papular Lesions Resulting from Compound Heterozygous Mutations in
the Hairless Gene: A Lesson for Differential Diagnosis of Alopecia Universalis
W. Henn, H. Lam,* and A. Christiano*
Institute of Human Genetics, Saarland University, Homburg/Saar, Germany; *Dermatology and Genetics
and Development, Columbia University, New York, New York
Atrichia with papular lesions (APL) is a rare, autosomal recessive form of total alopecia, in which
mutations in the hairless (h) gene have been shown to underlie the phenotype. We suspect that
APL is actually much more common that previous population estimates suggest, because we
believe the disorder is frequently misdiagnosed as alopecia universalis. To date, mutations identi®ed
in the hairless gene have all been homozygous mutations in probands within families with
extensive consanguinity, where identity-by-descent (IBD) was anticipated. We sought to
investigate whether APL might also be found among patients in small families without obvious
IBD, particularly those giving a history of (1) normal hair at birth which was shed and never
regrew; and (2) ``alopecia universalis'' that is recalcitrant to any treatment. In this study, we
identi®ed a small family of German origin in which two of four siblings were affected and gave this
clinical history. Direct sequence analysis of the h gene in one proband revealed distinct mutations
on each allele. The ®rst was a 2-bp deletion of the splice acceptor site of intron 13 (2847±2delAG),
and the second was a nonsense mutation in exon 19 (Q1176X). This is the ®rst demonstration of
compound heterozygous mutations in the h gene. These ®ndings support the hypothesis that APL
can exist in small families without IBD, and underscore the possibility that APL may be
masquerading clinically as alopecia universalis. We anticipate that increased recognition of this
disorder will result in accurate discrimination between APL and alopecia universalis, thus sparing
unnecessary treatment to patients affected with APL.
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Clinical and Molecular Diagnostic Criteria of Congenital Atrichia with Papular Lesions
A. Zlotogorski,² A. Panteleyev, V. Aita, and A. Christiano*
Dermatology, Columbia University, New York, New York; *Dermatology and Genetics and Development,
Columbia University, New York, New York; ²Dermatology, Hadassah University Medical Center,
Jerusalem, Israel
Congenital atrichia with papular lesions is a rare, autosomal recessive form of total alopecia and
mutations in the hairless (h) gene have been implicated in this disorder. Published estimates of the
prevalence of this disorder remain surprisingly low considering pathogenetic mutations in h have
been found in distinct ethnicities around the world. Therefore, it is likely that congenital atrichia
with papular lesions is far more common than previously thought and often mistaken for its
phenocopy, the putative autoimmune form of alopecia universalis. To clarify this discrepancy, we
propose criteria for the clinical diagnosis of congenital atrichia with papular lesions. Among these is
the novel report of the consistent observation of hypopigmented whitish streaks on the scalp
surface of affected individuals. Additionally, we report the identi®cation of a novel missense
mutation in h from a family of Arab Palestinian origin that exhibit the pathognomonic symptoms
of atrichia with papular lesions. Collectively, we anticipate that an increased recognition of this
disorder will result in more accurate diagnosis and the sparing of unnecessary treatment to patients.
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Computer-Assisted Histomorphometric Evaluation of Scalp Biopsies
D. Shum, M. Martinka, O. Bernardo, J. Faila, H. Lui, and J. Shapiro
Dermatology, University of British Columbia, Vancouver, BC, Canada
A major challenge in the histophathologic examination of scalp biopsies is to adequately visualize
and evaluate as many of the hair follicles present in the tissue. While routine vertical sections are
easier to process and exhibit familiar histological landscape, oblique orientation of the follicular
structures precludes any means of quantitation even if multiple serial vertical sections are available.
To improve on the diagnostic yield of conventional vertical sections, the use of transverse sections
of a scalp punch has been suggested. The demonstration of all the follicular structures
simultaneously in one transverse tissue section allows morphometric analysis of parameters such
as hair density and diameter. An obvious disadvantage of transverse sectioning is that a very limited
cross-section of each follicle is shown in each microscopic section and numerous sections are
needed to examine the follicles in their entirety and to determine follicular growth activity. In the
management of patients with alopecia, accurate morphometric analysis of hair growth is required.
Recent advances in PC-based computing have enabled ef®cient processing of large number of
images and this technology is well suited for the study of transverse sections of scalp biopsies. To
ensure complete coverage of all the follicular structures, scalp biopsies from 12 patients with
nonin¯amatory, nonscarring alopecia have been serially sectioned in 0.1 mm interval, resulting in
30±50 sections in average for each case. Imaging software including Align(r), Trace(r) and 3D
exploration(r) are then used to evaluate and quantify the follicular structures, and the results are
presented in a 3 dimensional graph format using Excel(r). In addition a computer generated 3
dimensional model of each biopsy tissue core is generated, allowing easy visualization of all hair
structures. Out data suggests that the anatomy of follicular structures and scalp hairs, including
density and diameter, is more variable than previously reported. Up to 55 hairs have been counted
in a 4.0-mm punch and our 3D models demonstrate the occasional merging of follicular
infundibulae and existence of dystrophic follicular units. Patients with nonscarring, nonin-
¯ammatory alopecia may suffer from overlap of diseases which can only be revealed by detailed
histomorphometric studies. We believe computer assisted analysis of the scalp biopsy is the best
means to further elaborate variations of human scalp hair and to investigate cases of alopecia.
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TrichoScan: Combining Epiluminescence Microscopy with Digital Image Analysis for
the Measurement of Hair Growth In Vivo
R. Hoffmann
Dermatology Philipp University, Marburg, Germany
Numerous methods have been reported to assess the rate of hair growth, but most techniques are of
little use to the clinician, because they are time consuming, costly or dif®cult to perform.
Therefore, an operator- and patient-friendly, inexpensive, validated and reliable method is a
rational need. Such a method must be able to analyze the biological parameters that constitute hair
growth, which are: 1: hair density (n per cm2), 2: hair diameter (mm), 3: hair growth rate (mm per
day) and 4: anagen/telogen ratio. We have developed such a method which combines an
epiluminescence microscopy with a newly programmed digital image analysis. The application of
the technique is demonstrated in 30 volunteers (with or without AGA) where a scalp area of
1.8 cm2 was clipped, dyed and landmarked with a central, single black tattoo. Images were taken at
20 and 40-fold magni®cation immediately and 2 days after shaving, in three monthly periods. Our
results show that the technique is able to automatically analyze the anagen/telogen ratio (<18%
telogen hairs in scalp unaffected by AGA) and hair growth rate (mean 0.31 mm per day). We were
able to demonstrate that within the very small analyzed area (0.225 cm2) the total hair number and
hair thickness at the occiput did not change during 6 months, but we observed a decrease in hair
number (±0.43 hairs) and total thickness (±1.85 mm) in AGA-affected untreated scalp in contrast to
an increase in hair number (+4.7 hairs; p = 0.059) and total hair thickness (+4.85 mm; p = 0.039)
after six months of treatment with ®nasteride. The advantage of this technique is that it can be used
for clinical studies to compare placebo versus treatment, or to compare different capacities of
different hair-growth-promoting substances. This technique can be used for studying AGA or
other forms of alopecia, but in addition can be adopted to study the effect of drugs or laser
treatment on hypertrichosis or hirsutism.
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E¯ornithine Hydrochloride Cream 13.9% Disrupts Actin Filaments of the Beard Hair
Follicle in Men of African-American Descent with Pseudofolliculitis Barbae (PFB)
M. Ericson, C. Boeck, and M. Hordinsky
Dermatology, University of Minnesota, Minneapolis, Minnesota
The purpose of this study was to obtain information on the mechanism of action of e¯ornithine
hydrochloride cream 13.9% in the treatment of Grade 3 PFB in adult males of African-American
descent. In cultured keratinocytes, treatment with a-di¯uoromethionine (e¯ornithine hydro-
chloride) not only inhibits ornithine decarboxylase (ODC), but also disrupts cytoplasmic actin
organization and ODC localization. We hypothesized b.i.d. application of the cream for 16 weeks
to the beard region of 10 men would alter the cytoskeleton of the beard hair follicle and translate
into altered hair follicle growth and integrity. Two 4-mm punch biopsy specimens were obtained
pre- and post-treatment from lesions in the beard region. Biopsy samples were ®xed in Zamboni's
®xative for 24 h at room temperature or 4°C and later stored in cryopreservative at 4°C until
stained. Biopsies were cut into 400-micron vertical sections and stained as ¯oating sections with
multiple labels including phalloidin, conjugated to the red ¯uorophore Texas Red, that labels actin
bundles/stress ®bers. Fluorescent-stained sections were analyzed using laser scanning confocal
microscopy (LSCM). At the end of the treatment course, clinical severity of PFB improved in the
majority of patients, the number of miniaturized hair follicles increased and the number of large
curved follicles decreased. LSCM analysis revealed changes in actin ®lament architecture in the
keratogenous zone of the outer root sheath of anagen beard hair follicles. The keratogenous zone is
an area above the hair bulb through which enlarged hair matrix cells are funneled, resulting in
condensation and elongation of these cells. After treatment the actin ®lament bundles appeared
very disorganized and lost their parallel orientation. Actin ®lament bundles of anagen follicles are
analogous to stress ®bers of nonmuscle cells, such as red blood cells, providing mechanical support,
cell adhesion, and contractile functions. We suggest that e¯ornithine hydrochloride cream 13.9%
disrupts the actin cytoskeleton of the actively growing beard hair follicle. Disruption of this
scaffolding could lead to subsequent loss of follicle integrity and alteration of growth characteristics
of the beard hair follicle.
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Inhibition of Ornithine Decarboxylase: Effect on the Hair Follicle and Epidermis of
Patients with Pseudofolliculitis Barbae (PFB) Treated with E¯ornithine Hydrochloride
Cream 13.9%
M. Hordinsky, A. McGinn, C. Boeck, and M. Ericson
Dermatology, University of Minnesota, Minneapolis, Minnesota
E¯ornithine hydrochloride is an irreversible inhibitor of the enzyme ornithine decarboxylase. In
this study, we examined the effect of b.i.d. application of e¯ornithine hydrochloride cream 13.9%
on the hair follicle, hair ®ber, and epidermis of men with PFB. Our hypothesis was that alterations
in epidermal thickness, hair follicle structure and ®ber would occur following therapy. Thirteen
participants with at least a two year history of PFB, who shaved at least once weekly and who had a
PFB severity rating of at least Grade 3 were enrolled; 10 completed the study which consisted of a
2-week pretreatment phase followed by visits at Days 0, 2, 7±10, 28, 56, 84, 112, 114, 121±124,
and 140. Photographs, beard hair samples and 4-mm skin biopsies were obtained from PFB lesions
at Days 2 and 114. Beard hair ®bers were nonspeci®cally stained with Alexa Fluor(r) 594 C5
maleimide, sodium salt from Molecular Probes. Cuticular, cortical and medullary staining was
examined using conventional epi¯uorescence microscopy. Biopsy samples were ®xed in 10%
buffered formalin, embedded, cut into 7 micron sections and stained with either hematoxylin and
eosin or antibody to Ki67. This antibody binds to nuclear antigen(s) and is associated with cell
proliferation throughout the cell cycle. The number and type of follicles were counted, samples
were examined for changes in in¯ammation, epidermal thickness and differentiation. No
signi®cant differences in cuticular, cortical, or medullary staining was seen. In the post-treatment
samples (1) miniaturized follicles were noted in 6 of the 10 biopsy samples, (2) epidermal thickness
remained the same in all samples and (3) epidermal differentiation appeared more organized.
Examination of Ki-67 staining in the epidermis revealed a decrease in epidermal staining in all but
2 patients. These observations are consistent with our knowledge that e¯ornithine hydrochloride is
an irreversible inhibitor of ornithine decarboxylase and should be an effective drug to use in the
management of PFB and possibly other skin diseases characterized by abnormal cell proliferation.
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Soymilk Reduces Hair Growth and Hair Follicle Dimensions
M. Seiberg, J. Liu, and S. Shapiro
Skin Research Center, J & J CPWW, Skillman, New Jersey
Soybean extracts and the soybean-derived serine protease inhibitors STI and BBI were shown to
reduce skin pigmentation, suggesting that soymilk could be used as a natural alternative to skin
lightening. To examine the possible effect of STI, BBI and soymilk on hair pigmentation we used
the mouse induced hair cycle model system. C57Bl/6 and C3H mice, age 9 weeks, were wax
depilated to induce a new hair cycle, and were treated daily with soymilk, STI and BBI.
Interestingly, we found that these agents affect not only hair pigmentation, but also the rate of hair
growth, the dimensions of the hair follicle and hair shaft, and the appearance of the hair. For the
®rst time it is demonstrated both morphological and histologically that soymilk and the soybean-
derived serine protease inhibitors could be used to prevent unwanted hair growth. These agents
could reduce the rate of hair growth, decrease hair shaft dimensions and alter the pattern of
melanogenic gene expression.
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The Vertical Hair Density in Japanese Male with Androgenetic Alopecia is not
Signi®cantly Different from that in Nonbald Male
M. Tajima, A. Ishino, T. Takahashi, and J. Suzuki
Basic Research Center, Shiseido Research Center, Yokohama, Japan
Androgenetic alopecia (AGA) is the most common type of baldness with vellus hairs and
completely atrophic follicles. The duration of hair cycle of vellus hair is shorter than that of
terminal hair. The balding process is usually gradual the miniaturization of hair follicle (vellus hair)
and successive hair shading. However the contributions of population of miniaturized or lost hairs
on the AGA progressing are still unclear. We investigate the hair density and hair diameter in
Japanese male with or without AGA to discuss the relationships between these data and overall hair
appearance. The subjects between 15 and 62-year-old with (n = 258) or without (n = 123) AGA
were studied. The subjects with AGA classi®ed in classes III-vertex, IV, V or VI on the Hamilton-
Norwood classi®cation. The inspected alopecia scores were evaluated on the top view photographs
according to compare with the prevalidated reference scale from 1 (slightly bald) to 10 (bald). The
vertex hairs in areas of 5 3 5 mm were cut with scissors to record the images by video microscope.
The hair cut area and the number of cut hairs calculated as the pixel numbers and counted on the
images, respectively. The hair diameter also calculated as the pixel numbers on magni®ed images.
The hair density distributed approximately from 125 to 325 cm-2 in both the nonbald and bald
subjects. The average of density in bald subjects is not signi®cantly different from that on nonbald
subjects. In contrast the average of hair diameter correlate with the alopecia scores. It is concluded
that the appearance of hair loss on the AGA progressing at least until the class VI on the Hamilton-
Norwood classi®cation results mainly from the miniaturization of hair follicle, but not from the
hair shading. We therefore believe that the prolongation of anagen duration is important to
improve AGA.
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Reversibility of Hair Follicle Changes Before 30Months of Androgenetic Alopecia
N. Konstantinova, N. Konstantinova,* N. Korotkii,* E. Barhunova,* N. Sharova,* and D.
Gaevski
Nioxin Research Laboratory, Lithia Springs, United States; *Moscow Medical University, Moscow, Russian
Federation
We studied horizontal and vertical biopsy from 15 caucasian 24±41-year-old males diagnosed with
bitemporal recession Androgenetic Alopecia (AA) for 1.5±18 years (average 7.4 years). All 15
biopsies were stained with H&E, Van Gieson and with other phenol speci®c stainings. We
found (1) decreased number of hair follicles (HF) 1.75±2.45 per sq. mm from 3.5 to 5 per sq. mm
in control group, (2) infundibulum of HF dilatated 124±192 mm and most of them covered with
keratinazed plug lacking normal hair shaft growth. (3) Eleven pts with AA longer than 3 years had
severe perifollicular ®brosis ± collagen ®bers were compact and formed a small scar-like formation
around each anagen hair follicle. Two patients ± 33-year-old with 18 month AA and 23-year-old
with 20 month AA did not have these hair follicle changes. Two 26-year-old patients with 30 and
36 month AA, respectively, were found to have some not so severe collagen ®ber changes. (4)
None of Anagen HF was situated in subcutaneous fat. The result of this study is that any available
treatment of AA is recommended to start earlier than 30 months from ®rst signs of AA, to avoid
irreversible collagen changes associated with loss of normal blood supply, innervation, etc. And
leading to miniaturization and preventing hair from normal cycling.
264
17a-Estradiol Induces Aromatase Activity in Isolated Human Hair Follicles
S. Niiyama, A. Huth, and R. Hoffmann
Dermatology, Philipp University, Marburg, Germany
Women tend to develop AGA later and milder than men, but with the decline of serum estrogens
during the menopause many women show an accelerated progression of AGA. Estrogens may play
a protective role against the development of AGA, because pregnant women are in some way
protected form androgenetic hair loss, but lose their hairs again postpartum. In Europe, topically
applied estrogens such as 17b-estadiole are used to treat androgenetic alopecia, both in women and
men. The femal hormone 17b-Estradiol can be used only in women, whereas the hormonally
almost inactive isomer 17a-estradiol can be used in men as well. Although some clinical studies
show considerable success of such an approach, the underlying pathways of 17a-estradiol-induced
hair regrowth are unknown. It is likely not a receptor mediated hormon effect, since 17b-Estradiol
is an hormon and 17a-estradiol not. Recently it has been shown that hair follicles from women
with AGA express more aromatase activity compared to male hair follices, and interestingly those
women taking aromatase inhibitors tend to develop rapidly progressive AGA. These circumstantial
lines of evidence indicate a role of aromatase during the pathogenesis of AGA. In order to unravel
the pathways of 17a-estradiol-mediated effcets on the hair follicles, we measured aromatase activity
in isolated intact human occipital hair follicles by incubating hair follicles with H3±1b-
androstenedione with or without 17a-estradiol (1 nM, 100 nM, 1 mM) for 24 or 48 h. In
comparison to the controls (female, 444 fmol per mm3 = 100%), we noticed a concentration- and
time-dependent increase of aromatase activity in 17a-estradiol-incubated female hair follicles (e.g.
24 h: 1 nM = +18%, 100 nM = +25%, 1 mM = +57%; 24 h: 1 nM = +18%, 48 h: 1 nM = +25%).
Our ex vivo results suggest that under the in¯uence of 17a-estradiol an increased conversion of
testosterone to 17b-estradiol and androstendione to estrone takes place. In theory this pathway may
diminish the amount of intrafollicular testosterone available for conversion to DHT, and because
DHT is the major mediator of AGA, this pathway may explain the bene®cial effect of 17a-
estradiol on the development and progression of AGA.
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Prevalence of Hair Disorders in the Women's Interagency HIV Study (WIHS)
P. Mirmirani, N. Hessol, T. Maurer, T. Berger, R. Greenblatt, and V. Price
Dermatology, UCSF, SF, California
Hair disorders that have been reported in HIV-infected patients include diffuse hair loss, changes in
hair texture, and trichomegaly. The prevalence of these disorders is unknown. Our objective was
to determine the prevalence of hair disorders in a cohort of HIV-infected women and a
comparison cohort of HIV-uninfected women. We analyzed a questionnaire administered to
women enrolled in the Northern California Women's Interagency HIV Study (WIHS). Questions
were asked about personal and family history of hair loss, current amount of hair, changes in hair
texture, changes in eyebrow or eyelashes length, and hair grooming practices. 196 HIV-infected
women and 50 HIV-uninfected women completed the questionnaire. In bivariate analyses, HIV-
infected women were more likely to report changes in hair texture (47%) as compared to HIV-
uninfected women (22%) (p < 0.05). 23% of the HIV-infected women reported thinner hair, 12%
coarser, 6% curlier, 2% dryer and 1% straighter. Multivariate logistic regression showed both HIV-
infection and older age to be independent predictors of change in hair texture (OR 3.1 CI 1.5±6.5
and OR 1.5 CI 1.1±2.2, respectively) Race was not associated with hair texture change. Five HIV-
infected patients compared to no HIV-uninfected women reported longer eyelashes. Older age
(but not HIV status) was associated with reported decreased hair density (OR 1.5 CI 1.1±2.2)
There were no signi®cant differences in family history of hair loss, eyebrow length, or hair
grooming. In conclusion, the prevalence of hair texture change in this cohort of HIV-infected
women is high (47%) and is signi®cantly greater than in the comparison cohort of HIV-uninfected
women (22%) (p < 0.05). Reports of longer eyelashes were exclusive to the HIV-infected women.
Decreased hair density was associated with increased age but not HIV status in this cohort. Possible
etiologies of hair texture change in HIV-infection may include HIV-viremia or medication use;
further investigation is warranted.
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Histology and Hormonal Activity in Senescent Thinning in Males
V. Price, M. Sawaya,* J. Headington,² and M. Kibarian³
UCSF, SF, California; *ARATEC Clinics/University of Miami, Miami, Florida; ²University of
Michigan, Ann Arbor, Michigan; ³George Washington University, Washington, District of Colombia
Senescent thinning of the scalp hair, or thinning that occurs after age 60, is poorly understood, and
it is unclear if it is a distinct entity or a continuum of androgenetic alopecia (AGA). In a previous
study, males age 18±30 with AGA had higher levels of 5a-reductase type 1 and 2, more androgen
receptors, and lower levels of cytochrome p-450 aromatase in frontal hair follicles than in occipital
follicles. This study in males age 60 years and older was designed to determine the histology and
hormonal ®ndings in older males with hair thinning. Males who experienced the onset of scalp hair
thinning after age 60 were compared to age-matched males (controls) without hair thinning. Four
scalp biopsies, two from the frontal and two from the occipital scalp, were obtained for horizontal
sections and biochemical assay. Histologic ®ndings were primarily follicular downsizing. Follicular
drop out was not detected using elastic tissue stains; there was no signi®cant difference in follicle
number in frontal compared to occipital scalp. Senescent thinning was indistinguishable from
androgenetic alopecia in older males. In¯ammatory changes were not a signi®cant feature.
Biochemical analysis for androgen receptors, 5a-reductase type 1 and 2, and aromatase, in scalp
biopsies from older males showed nearly a two fold decrease in levels compared to young males
with AGA. In males over 60, androgen receptor and aromatase levels were low and comparable in
frontal and occipital scalp regions with and without thinning. The 5a-reductase type 1 and 2 levels
were only slightly higher in males with thinning hair than in males without thinning hair in both
frontal and occipital regions, but the differences were not signi®cant. Histologic and hormonal
®ndings suggest that senescent thinning is a diffuse process that is histologically similar to AGA, but
hormonally different and may not be entirely androgen dependent. We hypothesize that senescent
alopecia is distinct from AGA.
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Guidelines and Techniques for the Accurate Classi®cation of Chemotherapy-Induced
Hair Follicle Dystrophy
B. Handjiski, S. Mueller-Roever, E. Peters, and R. Paus
Dermatology, University Hospital Eppendorf, Hamburg, Germany
In order to recognise even subtle forms of hair follicle dystrophy after pharmacological
manipulation, it is critically important to be able to identify and accurately classify the distinct stages
of the follicular response to damage and the corresponding degree of hair follicle dystrophy. Here,
we have developed a set of simple and pragmatic classi®cation criteria for chemotherapy-induced
hair follicle dystrophy, using the C57BL/6 J mouse model of cyclophosphamide-induced alopecia.
We suggest to divide murine hair follicle dystrophy into six distinct stages: healthy anagen VI (HA),
light dystrophic anagen VI (LDA), moderately dystrophic anagen VI (MDA), severe dystrophic
anagen VI (SDA), dystrophic catagen (DC), and dystrophic telogen (DT). The basic classi®cation
criteria include: the structure and pigmentation of the hair shaft (continuous shaft and normal
pigmentation during HA and LDA; broken shaft and disrupted pigmentation during SDA, DC and
DT), the location and volume of ectopic melanin granules, the location, volume and shape of the
dermal papilla (large and oval during HA and LDA; swollen during SDA; round and compacted
during DC and DT) as well as abnormal widening of the hair canal (DC, DT). In addition, the
following immunohistochemical markers aid in dystrophy classi®cation: the number of
TUNEL + keratinocytes in the bulb as a marker for the level of dystrophy-associated apoptosis
(HA: no; LDA 3; MDA 5, DC 10), and the immunoreactivity for neural cell-adhesion molecule
(NCAM) as well as alkaline phosphatase activity as a marker for the level of damage to the DP.
These staging parameters not only offer a useful tool in murine models for chemotherapy-induced
alopecia, but also when screening drug-treated mice for even discrete hair follicle dystrophy in a
highly standardised, reproducible, easily applicable, and quanti®able manner.
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Complex Cytogenetic Rearrangement of Chromosome 8q in a Case of Ambras
Syndrome
M. Tadin, E. Braverman,² S. Cianfarani,³ D. Warburton,² and A. Christiano*
Genetics and Development, Columbia University, New York, New York; *Dermatology and Genetics and
Development, Columbia University, New York, New York; ²Pediatrics, Columbia University, New York,
New York; ³Pediatrics and Public Health, University of ``Tor Vergata'', Rome, Italy
Ambras syndrome (AMS) is a unique form of congenital universal hypertrichosis. In patients with
this syndrome, the whole body is covered with ®ne, long vellus hair, except for areas where no hair
normally grows. There is accompanying facial dysmorphism and abnormalities of the teeth,
including retarded ®rst and second dentition, and absence of some teeth. No endocrine or
metabolic defect has been detected. Multiple affected family members suggest a genetic basis for the
syndrome. Ambras syndrome has been found in association with an inversion of chromosome 8 in
two isolated cases. One of these patients was reported in association with an apparently balanced
paracentric inversion of chromosome 8 (8)(q12q22). Our cytogenetic analysis of this patient
revealed that the rearrangement is more complex than initially reported. We found a relatively
large deletion in 8q13, as well as a smaller deletion in 8q23. We also detected an insertion of the
q23-q24 region into a more proximal region of the long arm of chromosome 8. Given the large
number of breakpoints and the presence of substantial deletions, it is surprising that the proband did
not exhibit phenotypic features other than those characteristic of Ambras syndrome.
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The Cytokeratin Pro®le of Loose Anagen Syndrome
J. Greenberg, A. Hanly,* G. Elgart, and L. Schachner
Dermatology & Cutaneous Surgery, University of Miami School of Medicine, Miami, Florida; *Pathology,
University of Miami School of Medicine, Miami, Florida
Loose anagen syndrome (LAS) typically presents in early childhood with signi®cant hair loss. LAS
is associated with easily removable anagen hair follicles and tends to improve with age. Histologic
examination demonstrates a nonin¯ammatory alopecia in which intracellular discohesion with cleft
formation is identi®able between various follicular epithelial layers. Likewise, epidermolysis bullosa
simplex (EBS) also presents as a nonin¯ammatory disease, which tends to improve with age. The
histology of EBS demonstrates similar intracellular discohesion with cleft formation involving
epidermal epithelial layers. EBS is associated with a genetic abnormality leading to abnormal
keratin 5 and keratin 14 formation. Henceforth, we decided to study the cytokeratin (CK) pro®le
of LAS to see if an analogous process could explain the pathophysiology of this condition.
Immunohistochemistry using antibodies to CK5/6, CK7, LMWK, CAM5.2, CK14, HWMK,
CK20, and AE1/3 was applied to two cases of clinically proven LAS. The follicular epithelium of
normal anagen follicle and loose anagen syndrome demonstrated a similar cytokeratin-staining
pattern. Follicular epithelium reacted with CK5/6, CK14, HMWK, and AE1/3 and failed to stain
with CAM5.2, CK20, CK7 and LMWK. In conclusion, the cellular discohesion of LAS does not
appear to be related to abnormal follicular cytokeratins.
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Hair-Growth Promotion of Stigmastanol Maltoside: Experimental and Clinical Studies
T. Yamamoto, M. Shishido, M. Syaku, M. Suzuki, J. Shibatani, and T. Maeda
POLA Laboratories, Yokohama, Japan
The sterols isolated and identi®ed by fractionating the medicinal plants from India showed hair-
growth promoting effects in mice. To enhance water solubility and skin penetration, the sterols
were glycosylated. Among the various glycosylated sterols tested, Stigmastanol Maltoside (SM) was
found to be most promising in promoting hair growth. SM signi®cantly promoted hair growth in
the cultured rat vibrissa follicles. The expression of acidic ®broblast growth factor (aFGF) was
especially enhanced in the outer root sheath of the cultured rat vibrissa follicles, which was
con®rmed by immunohistochemical staining. When SM was applied to the dorsal skin of 9-week-
old C3H mice, on which anagen stage transition induced by hair shaving was inhibited by the
topical application of dihydrotestosterone (DHT), the inhibitory effect of DHT was cancelled and
hair growth was promoted. The mRNA expression of aFGF, con®rmed by in situ hybridization,
was reduced by the application of DHT on the mice dorsal skin, which was also cancelled by the
application of SM. From the results obtained, it is suggested that the sustained expression of aFGF
in hair follicles by the antiandrogen-like action of SM promotes hair follicle formation, resulting in
hair growth. Precise mechanism of the action of SM is being investigated. Clinical studies of the
SM on alopecia androgenetica patients were conducted. Treatment of the patients with 0.1% SM
tonic lotion for a four-month period was found to be as effective as the treatment using 1%
Minoxidil. These ®ndings clearly suggest that SM is an effective active ingredient for hair-growth
preparations.
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Species-Speci®c Expression of Stearoyl-CoA Desaturase (SCD) in the Pilosebaceous
Unit
J. Luo, L. Ge, C. Hsuan, K. Stenn, and S. Prouty
Skin Biology TRC, Johnson & Johnson, Skillman, New Jersey
Stearoyl-CoA Desaturase (SCD) is the major enzyme that produces endogenous monounsaturated
fatty acids. It plays important roles in lipid metabolism, membrane ¯uidity, and signal transduction.
Previous studies from our laboratory indicate that three SCD genes are expressed in mouse skin.
The lack of SCD1 expression results in defective growth of the pilosebaceous unit (PSU) in the
asebia (ab) mouse. These ®ndings implicate the importance of SCD in skin biology and hair
growth. This comparative study was designed to determine the possible functions of SCD in
human pilosebaceous unit. SCD was highly expressed in human hair follicle, especially in matrix
keratinocytes, cortex, cuticle of the hair shaft and cuticle of internal root sheath (IRS). SCD was
also detected in the inner layer of outer root sheath (ORS) and in eccrine sweat glands. Except for
a few cells, the sebaceous gland was devoid of SCD mRNA expression. This pattern is dramatically
different in mouse and pig where SCD is highly expressed in sebaceous and meibomian glands.
Additionally, some apocrine glands express SCD in pig. This difference in SCD expression pattern
may not be related to the number of SCD genes. Mouse has at least 3 functional SCD genes,
whereas human has one functional SCD gene and pig may have only one SCD locus. These results
suggest that SCD may have both conserved (sweat gland) and nonconserved (hair bulb) functions
in the PSU and skin.
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Sebaceous Gland Apoptosis Induced Selectively by Liposomal 5-a-Reductase Inhibitor
in Hamster Model
R. Hoffman, L. Li, L. Tang, E. Baranov, and M.Yang
AntiCancer, Inc., San Diego, California
Numerous side-effects occur from current acne therapy. Thus, there is a need for developing a
selective, effective, topically applied 5-a-reductase inhibitor to modify pathological processes in
the pilosebaceous unit. 5-a-reductase plays a critical role in normal and pathological androgen-
dependent processes, including acne. The 5-a-reductase inhibitor, ®nasteride, is currently used as
an oral treatment for speci®c inhibition of type II 5-a-reductase for androgenetic alopecia as well as
for benign prostatic hypertrophy (BPH). However, the potential for systemic side-effects from oral
®nasteride is dose limiting and therefore decreases ef®cacy. We have previously developed a
selective liposome hair follicle targeting system. We demonstrate in this report that the 5-a-
reductase inhibitor N,N-diethyl-4-methyl-3-oxo-4-aza-5a-androstane-17b-carboxamide (4-MA)
incorporated into liposomes induces apoptosis and inhibits growth of the dihydrotestosterone
(DHT)-dependent hamster ¯ank organ sebaceous gland. We have compared topical application of
liposome 4-MA and solvent-formulated 4-MA and observed selective ef®cacy of topical
application of liposome 4-MA by the reduction of size and induction of apoptosis only in the
treated hamster ¯ank organ. Apoptosis induced by liposome 4-MA in the treated ¯ank organ
sebaceous gland cells was observed both by ¯uorescent assays for DNA fragmentation (TUNEL)
and by observation of condensed and fragmented nuclei. When 4-MA was topically applied
formulated in ethanol and glycerol, the selective ef®cacy was lost. Topical liposome 4-MA did not
signi®cantly affect prostate weight, T/DHT ratios or body weight gain compared to controls
indicating safety as well as ef®cacy. Liposome 4-MA will be further developed as a topical agent to
treat acne as well as androgenic alopecia.
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Decreased Serum Ferritin is Associated with Alopecia in Women: A Case-Control Study
J. Kantor, L. Jay,* D. Brooks,* and G. Cotsarelis²
Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia,
Pennsylvania; *Division of Medical Genetics, University of Pennsylvania School of Medicine, Philadelphia,
Pennyslvania; ²Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia,
Pennsylvania
Hair loss in women is a common problem. Observational data have suggested that alopecia in
women may be associated with decreased body iron stores. Our aim was to evaluate whether
common types of alopecia (telogen ef¯uvium, alopecia areata, and androgenetic alopecia) are
associated with decreased tissue iron stores (as measured by serum ferritin) utilizing a case-control
methodology. Cases were obtained by selecting 45 consecutive patients treated at the University of
Pennsylvania hair and scalp clinic in the year 2000. Patients with elevated erythrocyte
sedimentation rates were excluded. Control patients consisted of individuals without hemochro-
matosis gene (HFE-1) mutations who presented to the Hospital of the University of Pennsylvania
Division of Medical Genetics. Data were analyzed utilizing the unpaired Student's t test assuming
unequal variances in order to assess whether the mean ages of controls differed from the mean age
of each individual case group. The t test was then used to determine whether the ferritin level in
each of the individual alopecia groups was lower than the mean ferritin level in controls. The ages
of cases and controls did not differ signi®cantly when grouping all cases together or when
comparing individual case groups to the controls, suggesting that any differences in ferritin levels
between cases and controls are not secondary to differences in age. Using the t test, we found that
the mean ferritin level (stated as ng per ml [95% con®dence intervals]) in cases with androgenetic
alopecia (31 [14, 48]), telogen ef¯uvium (39 [24, 55]) and alopecia areata (21 [5,38]) were
statistically signi®cantly lower than levels in normal controls (61 [38, 84]), with p-values of 0.015,
0.049, and 0.003, respectively. This is the ®rst study to utilize a case-control methodology to
address the relationship between ferritin levels and alopecia, and our ®ndings may have
implications in terms of therapeutics and developing a better understanding of the etiology of these
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Binding of Oncogenic Human Papillomavirus (HPV) 16 Capsids to Keratinocytes is
Independent of a-6 Integrin Expression
R Kirnbauer, S. Shafti-Keramat, and G. Meneguzzi*
Immunodermatology, University of Vienna Medical School ± AKH, Vienna, Austria; *Inserm U385,
Faculte de Medicine, Nice, France
Infection with mucosotropic human papillomaviruses (HPV) causes benign and malignant
epithelial lesions of the anogenital mucosa. The cellular receptor for HPV has not yet been
identi®ed due to dif®culties to obtain infectious virions and the lack of a permissive tissue culture
system, and thus the determinants for the tissue and species speci®city of papillomavirus infection
remains elusive. Recently, a-6 integrin has been proposed as a binding protein for the low-risk
HPV6 using the transformed human keratinocyte cell line HaCaT. To determine if high-risk HPV
infection is dependent on a-6 integrin expression, we have used HPV16 virus-like particles (VLP)
expressed in insect cells to determine binding of a high-risk HPV capsid to (SV-40 transformed)
``normal'' or a-6 integrin de®cient human keratinocytes or HaCaT cells. The absence of a-6
integrin expression was determined by FACS using GoH3 antibody. Using biochemical assays
binding of HPV16 VLP to cell lines was detected independent of cell-surface expression of the a-6
integrin. Binding of VLP was inhibited by preincubation with heparin or antibodies directed
against neutralizing and conformation-dependent surface epitopes of HPV16, but not by control
antibodies directed against the heterologous HPV6. In addition, preincubation of ``normal''
keratinocytes with antibodies to a-6 or b-4 integrin did not reduce HPV16 VLP to cell binding.
Together these data indicate that the a-6 integrin is not required for HPV16 binding to the natural
host cell and thus is not a primary candidate for the evolutionary conserved cell surface receptor for
oncogenic HPV types.
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Non-Invasive Topical Immunization by a Peptide Vaccine Against Hepatitis B and
Rubella Virus
S. Tao, M. Dajee, S. Wee, and P. Khavari
VA Palo Alto and Department of Dermatology, Stanford University, Stanford, California
Immunogenic peptides are excellent tools in vaccine research since they are extensively used for
de®nition of T- and/or B-cell epitopes. Topical delivery of peptides for immunization is attractive
because it offers convenience, increased patient compliance, and reduced costs. Progress in topical
peptide vaccination, however, has been hindered by concerns about penetration through the
epidermal permeability barrier. We applied immunogenic peptides to nonpretreated normal back
skin of immune competent mice. Ruby 9, a nine amino acid peptide from rubella virus protein E2,
and HBsAg 24mer, a sequence between residues 124 and 147 of hepatitis B surface antigen
(HBsAg), induced speci®c serum IgG antibodies without cross-reactivity to each other or to other
irrelevant peptide controls. Induction of speci®c immune responses was observed whether or not
immunogenic peptide was coupled to a oligoarginine protein transduction sequence (PTS). In each
case 5 mice were treated with the peptide in aqueous solution in the presence and absence of
topical adjuvant (cholera toxin). In both cases cholera toxin did not seem to enhance the immune
responses. Interestingly, in the case of HBsAg 24mer, speci®c serum IgG were approximately 3 fold
higher than those produced by intramuscular injection of the commercially marketed recombinant
HBsAg vaccine. Antibody levels in the case of rubella were in the same order of magnitude as those
produced by intraperitoneal injection of the commercial live rubella virus vaccine. These topical
immune responses could be achieved with minute amounts of antigen. As little as 50 ng of topically
applied peptide could elicit speci®c antibody production. These data demonstrate induction of
immune responses in animals via simple, painless and economical application of immunogenic
peptides to intact skin.
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Induction of HIV-1 Replication by Human Herpesvirus-8 (HHV-8)
K. Foreman, M. Mercader, and B. Nickoloff
Pathology and Skin Cancer Research Laboratories, Loyola University, Maywood, Illinois
HIV-1 infected individuals are commonly infected with herpesviruses including cytomegalovirus,
herpes simplex virus, varicella-zoster virus and HHV-8. Previous studies have shown that
coinfection with herpesviruses can modulate HIV-1 replication. This can occur either through a
direct interaction between the two viruses infecting the same cell or through a secondary
stimulation by cellular factors released in response to the herpesvirus infection. In addition, a
reciprocal interaction can occur resulting in altered herpesvirus replication in the presence of HIV-
1. HHV-8 is the newest member of the g2-herpesvirus family and has been consistently associated
with Kaposi's sarcoma. As AIDS-related KS is well recognized as a particularly aggressive form of
the disease, we have begun a series of studies to investigate the potential interaction between HIV-
1 and HHV-8. We have recently demonstrated that coculture of HIV-1 infected T cells with cell
lines latently infected with HHV-8 results in HHV-8 replication, a response that was mediated, at
least in part, by in¯ammatory cytokines. In the present study, we investigated HIV-1 replication in
the presence of HHV-8 in both an in vitro and in vivo model system. The results demonstrate a
signi®cant increase in HIV-1 replication following culture of HIV-1 infected T cells in the
presence of HHV-8 infected B cell lines, but not control, uninfected B-cells. In addition, HIV-1
replication in T-cells injected into human skin transplanted on SCID mice was signi®cantly
increased in mice also injected with puri®ed HHV-8, but not in animals injected with PBS as a
control. While the mechanism responsible for induction of HIV-1 replication remains to be
identi®ed, the results from our in vivo model system involving normal human skin transplanted on
immunode®cient mice indicate that immune responses to the injected virus would be minimal and
that the effects are more likely due to endogenous factors and not the result of recruitment of
in¯ammatory cells into the skin. These results also indicate that these two viruses may interact at
the molecular level in coinfected patients, which may underscore the unexpectly high frequency
and aggressive nature of AIDS-related KS.
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Chemically Modi®ed RANTES Analogues Block CCR5-Mediated HIV Infection of
Langerhans Cells Within Epithelial Tissue Explants: Implications for Blocking Sexual
Transmission of HIV
A. Blauvelt and T. Kawamura
Dermatology Br, NCI, Bethesda, Maryland
Initial biologic events that underlie sexual transmission of HIV are poorly understood, although it is
believed that mucosal Langerhans cells (LC) are initial targets for virus. Furthermore, it is known
that the majority of transmitted HIV strains utilize CCR5 as a coreceptor for entry into cells
(labeled R5 viruses). To model these events, we recently reported that LC within epithelial tissue
explants could be preferentially infected with R5 HIV isolates (Kawamura et al, J Exp Med 2000).
Here, to help elucidate the most potent inhibitor of HIV infection in LC, we directly compared
the HIV blocking ability of four chemically modi®ed chemokines that bind CCR5 (AOP-
RANTES, NNY-RANTES, QST-DIH-RANTES, UCB-RANTES) using our explant model.
As quanti®ed by intracellular HIV p24 staining and ¯ow cytometry of LC, all analogues could
block R5 HIV in a dose-dependent manner (1±100 nM) when preincubated with explant tissue for
20 min prior to HIV exposure. In addition, all analogues could inhibit LC-mediated HIV infection
of CD4+ T cells that were cocultured with LC. Importantly, the newer analogues (NNY-
RANTES, QST-DIH-RANTES, and UCB-RANTES) performed at least 10-fold better than
AOP-RANTES. In summary, we document R5 HIV infection in single LC following exposure to
virus within epithelial tissue and show that this infection can be blocked by preincubation of tissue
with drugs that compete with virus binding and entry into cells. Importantly, these results suggest
that a topical microbicide containing a chemically engineered RANTES analogue may be a useful
agent to block sexual transmission of HIV.
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HIV Envelope Glycoprotein gp120 Secreted by HIV-Infected Dendritic Cells Impairs T
Cell Proliferation and IL-2 Production: Implications for HAART-Treated Patients
T. Kawamura and A. Blauvelt
Dermatology Br, NCI, Bethesda, Maryland
It is known that highly active antiretroviral treatment (HAART) for HIV-infected patients often
leads to complete suppression of plasma viremia, yet it is not known why HAART commonly fails
to completely restore immune function. Our laboratory has long been interested in the role of
dendritic cells (DC) in the immunopathogenesis of HIV disease, and here we examined the
mechanisms underlying HIV-mediated dysfunction of DC. HIV-infected DC were signi®cantly
impaired in their ability to stimulate proliferation (mean stimulation indices = 0.46 and 0.24 for
macrophage-tropic HIVBaL and T cell line-tropic HIVIIIB, respectively) and IL-2 production
(mean production vs. controls = 0.66 and 0.45 for the same 2 viruses) in cocultured allogeneic
CD4+ T cells. MHC class II and costimulatory molecule expression was normal on HIV-infected
DC and, consistent with this, paraformaldehyde-®xed HIV-infected DC exhibited similar antigen
presenting cell (APC) capacity when compared to ®xed uninfected DC. Interestingly, HIV-
infected DC still exhibited poor APC capacity in the presence of potent combinations of
antiretroviral drugs (the reverse transcriptase inhibitors AZT and ddI and the protease inhibitor JE-
2147) that blocked transfer of HIV infection to T cells. However, when soluble CD4 (capable of
binding to gp120) was added to DC-T cell cocultures, APC capacity of HIV-infected DC was
completely restored. Western blot analysis and ELISA of supernatant proteins revealed that
antiretroviral drugs blocked mature HIV virion production (81±100% inhibition), but not gp120
production (contained in immature defective virions). In summary, HIV-infected DC induced T
cell dysfunction through a gp120-mediated negative growth signal, a process that was blocked by
soluble CD4, but not by conventional antiretroviral drugs. These ®ndings may be important in
understanding immune dysfunction in the setting of HAART and may contribute to the design of
novel immunotherapeutic approaches for HIV disease.
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Direct Involvement of Human Immunode®ciency Virus Type I in Kaposi's Sarcoma-
Associated Herpesvirus (KSHV) Reactivation
R Merat, A. Amara,² C. Lebbe, H. De The,* P. Morel, and A. Saib
Dermatology, Saint-Louis University Hospital, Paris, France; *CNRS UPR9051, Paris, France; ²UniteÂ
d'Immunologie Virale, Pasteur Institute, Paris, France
Kaposi's sarcoma-associated herpesvirus (KSHV) is a gammaherpesvirus etiologically linked to
primary effusion lymphoma (PEL), to a subset of multicentric Castleman's disease, and to Kaposi's
sarcoma (KS), the most common neoplasm associated with AIDS. Among KSHV-infected
individuals, the risk of KS is much higher in HIV-1-infected ones than among those with other
types of immunosuppression, which could suggest a direct action of HIV-1 on KSHV replication.
We show that BC-3 cells, a chronically KSHV-infected B cell line, are permissive to HIV-1. In
these cells, HIV-1 infection leads to reactivation of latent KSHV genomes, as demonstrated by the
expression of KSHV lytic viral mRNAs. While recombinant HIV-1 gp120 fails to enhance
herpesvirus expression, transient transfection of the HIV-1 trans-activator Tat suf®ces to reactivate
latent KSHV. By showing that HIV-1 infection directly reactivates latent KSHV, our results
suggest a direct role of HIV-1 on the onset of KS in coinfected individuals.
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A Wound-Isolated Pseudomonas Aeruginosa Grows a Bio®lm In Vitro and is Visualized
by Light Microscopy
C. Harrison-Balestra, A. Cazzaniga, A. Rabassa, and P. Mertz
Department of Dermatology & Cutaneous Surgery, University of Miami School of Medicine, Miami, Florida
In chronic wounds, bio®lms probably play a vital role in protecting bacteria from host defenses and
antimicrobial medications by creating a barrier of exopolysaccharide that is dif®cult for the immune
system and antibiotics to penetrate. A bio®lm is an exopolysaccharide matrix that is produced and
secreted by certain species of bacteria. The exopolysaccharide from many nearby bacteria can
convalesce and form a thick slime layer, or bio®lm, that shelters the bacteria from the immune
system and antibiotics. Bio®lms have been found to exist in many diseases; most notably, cystic
®brosis that is chronically infected with a bio®lm-secreting Pseudomonas aeruginosa. The goal of
this study was to visualize by light microscopy a growing bio®lm secreted by Pseudomonas
aeruginosa that was isolated from a burn wound. Pseudomonas aeruginosa was added to 200 ml of
sterile Tryptic soy broth to create a concentration of approximately 2.2 3 105 organisms per
milliliter of nutrient broth. This concentration correlates with 105 colony-forming units that some
clinicians use to de®ne the presence of an infection. Clean plastic cover slips were washed in
isopropyl alcohol and then suspended in the Pseudomonas-innoculated Tryptic soy broth and
allowed to grow in a 37°C shaker. Cover slips were carefully removed with sterile instruments at 3,
5, 7, 8, 9, 10, 11, 12 and 24 h, washed on one side with isopropyl alcohol and a sterile cotton swab,
and placed on glass slides. Slides were stained with a modi®ed Congo Red/Ziehl Carbol Fuschin
staining technique. The bio®lm stained orange/pink and the cells stained purple/red. The slides
demonstrate bio®lm growth that initially shows exopolysaccharide surrounding only individual
Pseudomonas bacteria, and then the exopolysaccharide grows and merges with that of many nearby
bacteria to form a thicker slime layer, which is the bio®lm. This staining method may be used to
detect bio®lms in samples obtained from chronically infected wounds.
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Gram Negative Staphylococci Isolated from the Warm Facial Skin of Patients with
Rosacea Secrete Excessive Lipase at Higher Temperatures
M. Dahl, A. Ross,* and P. Schlievert*
Dermatology, Mayo Clinic Scottsdale, Scottsdale, Arizona; *Medicine, Universtiy of Minnesota,
Minneapolis, Minnesota
Pustules on the faces of patients with rosacea suggest a bacterial infective process, and indeed they
often resolve after treatment with topical or systemic antibiotics. However, no abnormal bacteria
have been isolated from the skin surface or from the pustules. Bacteria of the normal skin ¯ora
might produce pustules if they behaved abnormally in the warmer-than-normal milieu of red and
¯ushed facial rosacea skin. We hypothesized that these bacteria might produce different virulence
proteins at these different temperatures. Coagulase-negative bacteria were isolated from pustules of
patients with untreated rosacea. Bacteria were cultured at both 30°C and 37°C. Growth rates were
identical. All isolates secreted more protein at 37°C. One protein was highly up-regulated at 37°C.
This protein was the dominant secreted protein from all four isolates on all gels. The protein was
isolated and sequenced and identi®ed as a lipase. Its lipase gene was up-regulated by elevated
temperatures and by the presence of oxygen in the late logarithmic phase; the lipase was
predominantly made when organisms were begining to encounter nutrient depletion. As controls,
four coagulase negative staphylococci were isolated from the skin surface of individuals without
rosacea. Two of the four isolates also secreted the lipase and two did not. Bacteria behave
differently at different temperatures. Normal constituent bacteria of the skin surface and pustules
may become pathogenic when they secrete abnormal or abnormal amounts of temperature-
dependant virulence factors. Abnormal activities of bacteria could create pustules of rosacea and the
``dryness'' often associated with rosacea (rosacea dermatitis).
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Lifestyles of Bacteria in Wounds: Presence of Bio¯ims?
S. Davis, V. Serralta, C. Harrison-Balestra, A. Cazzaniga, and P. Mertz
Department of Dermatology & Cutaneous Surgery, University of Miami School of Medicine, Miami, Florida
Bio®lms consist of bacteria and other organisms that live within a matrix of extracellular
polysaccaride (EPS) and have been implicated in bacterial diseases such as otitis media, dental
plaque and cystic ®brosis. The purpose of this study was to examine wounds for the formation of
bacterial bio®lms. Partial thickness wounds were made on three pigs with a dermatone. Wounds
were challenged with Pseudomonas aeruginosa and covered with either a polyurethane dressing or
plastic cover slip. At 72 h each wound was vigorously ¯ushed three times with sterile saline to
dislodge any nonadherent bacteria. The ¯ushed wounds were then cultured with a surfactant
solution using a scrub technique. Both the ¯ushed and scrubbed samples were plated on
Pseudomonas isolation agar for quantitation. Cover slips were removed from the wounds at 72 h
and wound curettage was obtained. Congo red staining procedure, which detects EPS was used to
stain both. A thick dark red to a yellow orange amorphous EPS matrix was seen surrounding
bacteria indicating a bio®lm. Wounds cultured with saline or surfactant demonstrated that there
were two distinct populations of bacteria living in the wound area. The nonadherent population
displayed a variation from wound to wound whereas the adherent population had a narrower range
suggesting some sort of critical mass for those bacteria, which adhered to the wound. This
preliminary work has demonstrated that bacterial bio®lms do form in wounds. This in vivo assay
system will provide a means to examine therapeutic modalities for bacteria living in a protective
bio®lm.
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Are Bio®lms Present in Chronic Wounds?
Y. Bello, A. Falabella, A. Cazzaniga, C. Harrison-Balestra, and P. Mertz
Dermatology, University of Miami, Miami, Florida
Bio®lms are made up of groups of microorganisms, which live within a polysaccharide matrix and
are adhered to biological or nonbiological surfaces. Organisms that live within bio®lms are resistant
to both host defense mechanisms and to systemic and topical antimicrobial agents and have been
implicated in many bacterial diseases, such as otitis media, cystic ®brosis, and tuberculosis. Chronic
wounds have been shown to harbor many species of pathogens in colonized and clinically infected
wounds. The association between chronic wounds, the organisms they contain and the
mechanisms to prevent infection and promote wound healing are major concerns. We hypothesize
that chronic wounds that are frequently covered by ®brinous tissue could provide an excellent
matrix for the formation of microbial bio®lms. Two patients with nonhealing wounds, with signs
of infection, were cultured. Cultures on both patients grew pseudomonas. Both patients were
treated with antibiotics according to sensitivity as per antibiogram, but neither wound improved. A
preliminary evaluation of these two chronic human wounds for bio®lm formation is reported here.
After receiving patient's informed consent, the two chronic wounds were scrapped with a blade to
remove the ®brinous tissue. The curetted tissue was smeared onto a glass slide and preserved in
10 mM cetylpyridinium chloride. The tissue was stained with a modi®ed Congo red staining
technique. Bacterial cells were observed in the smear and stained dark red. An orange pink material
was also observed surrounding the bacteria, presumptively indicating the presence of an
extracellular polysaccharide material, bio®lm. Further studies are planned to con®rm these ®nding
and to develop treatment strategies for bacteria living within bio®lms in chronic wounds.
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Increased Numbers of Methicillin Resistant Staphylococcus Aureus Isolated from
Pediatric Impetigo Lesions in a Public Health Clinic
P. Mertz, Y. Piovanetti,* and W. Eaglstein
Department of Dermatology & Cutaneous Surgery, University of Miami School of Medicine, MIami, Florida;
*San Juan Puerto Rico Community Health Center, San Juan, Puerto Rico
Over the last decade we have observed signi®cant increasing levels of antibiotic resistance in
Staphylococcus aureus isolates from impetigo lesions in otherwise healthy patients in San Juan,
Community Health Center In 1989 S aureus was isolated from 46 of the 53 patients cultured and
susceptibility to 10 antibiotics was determined by a modi®ed Bauer Kirby disc diffusion. Five
percent of the isolates were resistant to methicillin. In a similar population and site in 1993, six
percent of the isolates from 30patients were resistant to methicillin. We report here the results of
cultures from a large cohort of impetigo patients from the same local Community Health Center in
the year 2000. To this date 193 patients have been cultured and 170 patients were culture positive
for either S. aureus and or Streptococcus pyogenes. Ninety percentage of culture positive lesions
grew S. aureus, which continued to be the most prevalent pathogen in this community setting.
Direct plating techniques were used to recover Streptococcus with selective media of blood and
crystal violet. Twenty-two percentage of positive lesions contained both staphylococcus and
streptococcus and 10% were positive for streptococcus only. There was an increase in MRSA to
12% of the total 153 Saureus culture positive patients. When Methicillin resistance was evaluated
for patients that grew only S. aureus, the rate of resistance climbed to 15%. This alarming increase
(300% in 11 years) of MRSA from community pediatric impetigo patients may have surpassed the
trends seen in other community acquired MRSA infections.
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Hyphae and Yeast of Candida Albicans Differentially Regulate IL-12 Production by
Human Blood Monocytes: Inhibitory Role of Candida Albicans Germination
L. Liu, K. Kang, M. Takahara, K. Cooper, and M. Ghannoum
The Center for Medical Mycology, Dermatology, University Hospitals of Cleveland, the VA Medical Center,
Cleveland, Ohio
Interleukin-12 (IL-12) is essential for inducing type 1 immune responses, and the development of
IFN-g producing T cells, which in turn are associated with host resistance to candidal infection.
Early work from our group demonstrated that Candida albicans (CA) and less virulent C. krusei
differentially induced IL-12 production by human monocytes, with CA inability of inducing the
production of this cytokine. In this study, we further explore the mechanism/s involed in this
inhibition process focusing on the role of yeast-to-hyphal transition. To investigate the in¯uence of
germination on production of IL-12 by monocytes, we incubated monocytes with isogenic strain
pairs of C. albicans that differ in their ability to germinate and the yeast Saccharomyces cerevisae.
Following incubation, supernatants were collected and the levels of IL-12 determined by ELISA.
Additionally, the effects of incubating monocytes with different strains on IL-12 mRNA
expression levels was also assessed. Our data showed that unlike S. cerevisae, which induced IL-12
production by monocytes (162 6 41 pg per ml, n = 3), live germinating C. albicans failed to induce
this cytokine (23 6 7 pg per ml, n = 7). Moreover, C. albicans suppressed IL-12 production induced
by heat-killed C. albicans. Monocyte viability assay revealed that inhibition of IL-12 production is
not due to monocyte killing by C. albicans. Comparison of the ability of germinating C. albicans
parent strain, HLC54 germinating deleted mutant, and the germinating HLC84 revertant strain, to
inhibit/induce IL-12 production by monocytes showed that both the parent and the revertant
strains failed or partially to induce IL-12 production (23 6 7 pg per ml and 223 6 16 pg per ml,
respectively). In contrast, the non®lamenting deleted mutant induced signi®cantly higher IL-12
production than the other two ®lamenting strains (p < 0.05). Our data indicate that C. albicans
modulates IL-12 production by monocytes through multiple mechanism/s, in which germination
plays a critical role in inhibition of IL-12 production.
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In Vivo Confocal Microscopy, a Noninvasive Tool for Quantitative Evaluation of
Comedolysis
K. Nakano, K. Kiyokane,* and S. Gonzalez
Dermatology, Harvard Medical School, Boston, Massachusetts; *Dermatology, Osaka Medical College,
Osaka, Japan
Near-infrared re¯ectance confocal microscopy (CM) provides noninvasive real-time images of en
face tissues sections with high resolution and contrast to a depth of 200±350 mm. This study was
designed to evaluate this evolving technique as a noninvasive imaging tool for monitoring
comedolytic agents. We have utilized the rhinomouse model from Charles River (Portage, MI)
and Jackson Laboratories (Bar Harbor, ME) in combination with topical application of
comedolytic agents, all-trans retinoic acid (RA, 0.025% and 0.0025%) and all-trans retinol (Rol,
0.025%). In vivo CM was performed at baseline, one and two weeks during the treatment protocol.
Major morphometric parameters for in vivo monitoring of comedolysis included diameter and
numericle density of utricles. Our results showed signi®cant morphometric differences among
animals from Charles River Labs. After one-week application, the number and diameter of utricles
signi®cantly decreased in animals treated with 0.025%RA or 0.025%ROL. After two-week
application, utricles disappeared in both groups. At that time, animals treated with 0.0025%RA
showed a signi®cant reduction in number but not in size of the utricles. In conclusion, in vivo CM
represents a useful tool in the quantitative evaluation of utricles and could also be used for real-time
noninvasive assessment of comedolysis induced by pharmacologic agents.
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Induction of Th1 Responses and Resistance to Leishmania major in Susceptible BALB/c
Mice with Interleukin 4
M. RoÈcken, T. Biedermann, S. Zimmermann,* H. Himmelreich,³ O. Egeter, I. Seegmuller, A.
Levine, H. Wagner, K. Heeg, and J. Louis
Dermatology and Allergology, Ludwig-Maximilians-University, Munich, Germany; *Microbiology,
Technical University, Marburg, Germany; ²Microbiology, Technical University, Munich, Germany;
³Institute of Biochemistry, University of Lausanne, Lausanne, Switzerland; §Gastroenterology, Case
Western Reserve University, Cleveland, Ohio
Resistance and susceptibility to intracellular pathogens are regulated by interleukin (IL-)12, which
mediates Th1 responses and resistance, and IL-4, which induces Th2 cells and susceptibility. Thus,
inhibition of IL-4 with mAb or injection of IL-12 can prevent the development of Th2 responses
after infection with the intracellular parasite Leishmania major (L. major) and induce resistance in
otherwise susceptible BALB/c mice. Here we show that, paradoxically, IL-4 can instruct dendritic
cells (DC) to produce high levels of IL-12p70 and promote T cell differentiation towards a Th1
phenotype in vitro and in vivo. Treatment of susceptible BALB/c mice with IL-4 during the ®rst 8 h
of infection with L. major, prior to detectable ligand recognition by T cells, induces IL-12
dependent Th1 responses and resistance to L. major. In contrast, extending the action of IL-4 into
the period of T cell activation results in Th2-differentiation and development of progressive
leishmaniasis, even in resistant mice. Since immune responses evolve via the consecutive activation
of ®rst DC and, subsequently, T cells, the contrasting effects of IL-4 on DC and T cell
differentiation can lead to the maturation of T cells with opposing functional phenotypes. These
®ndings may impact on the design of cytokine-based immune therapies currently studied in
humans with melanoma or psoriasis.
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In Experimental Leishmaniasis De®ciency of CD18 Results in Unimpaired IL12 Release
by Macrophages, but also in a Dissociated Th1 Response
C. Sunderkoetter, K. Scharffetter-Kochanek,² S. Seeliger,* C. Schlesiger,* S. Grabbe, F.
Schoenlau, and C. Sorg
Department of Dermatol., Muenster, Germany; *Institute of Exp. Dermatol., Muenster, Germany;
²Department of Dermatol., Cologne, Germany
We have previously shown that: (i) CD18±/±, but not WT mice, are susceptible in experimental
leishmaniasis, and that (ii) neither decreased phagocytosis and leishmanicidal activity of CD18±/±
macrophages nor reduced recruitment of T cells were suf®cient to explain susceptibility. Thus, we
now analysed the nature of the speci®c T cell response. In lymphnodes of infected CD18±/± mice
we found very low production of IFN-g and none of IL2 or IL4 (ELISA). After coincubation with
bone marrow-derived DC pulsed with L.major-Ag, T cells from infected CD18±/± mice released
intermediate amounts of IFN-g, little IL4 or IL2, and they did not proliferate (3H-Thymidine
incorporation). By adding IL-2 (10 ng per ml) we were able to bypass this proliferation de®cit and
to markedly increase release of IFN-g exclusively by T cells from infected mice. Thus, infected
CD18±/± mice mount a L.major-speci®c Th1-like response in which IFN-g release and
proliferation are dissociated. Since this Th1-like cytokine response developped surprisingly despite
lack of CD11a/CD18 we searched for a costimulant which would substitute for LFA-1. Expression
of B7-2, B7-1 or MHC II did not differ between infected CD18±/± and WT cells (FACS).
However, release of IL12, which is usually suppressed after uptake of L.major by macrophages
from susceptible as well as resistant mice, was not suppressed in CD18±/± macrophages (ELISA).
Blocking different receptors for L.major revealed that parasites were only able to inhibit IL12
release when taken up via their major receptor CD11b/CD18. Neutralization of IL12 in vivo
abolished emergence of IFN-g releasing Th1-like cells. Thus (i) uptake of L.major by receptors
other than CR3 prevents impaired IL12 release and helps to induce Th1-like cells despite lack of
LFA-1 in CD18±/±mice; (ii) increased release of IL12, however, does not restore the reduced
proliferation of CD18±/± Th1-like cells, so that their low number results in insuf®cient control of
L.major infection in CD18±/± mice.
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A Role for the Antimicrobial Protein Granulysin in Host Defense in Leprosy
M. Ochoa, S. Stenger,* P. Sieling, S. Thoma-Uszynski, A. Krensky,² and R. Modlin
Dermatology, University of California, Los Angeles, Los Angeles, California; *Microbiology, Immunology,
Hygiene, Universitat Erlangen, Erlangen, Germany; ²Pediatrics, Stanford University, Stanford, California
A novel mechanism by wich T cells contribute to host defense against microbial pathogens is by
release of the antimicrobial protein granulysin. We investigated the role of granulysin in human
infectious disease using leprosy as a model. Granulysin-expressing T-cells were detected in
cutaneous leprosy lesions, at a six-folder greater frequency in patients with the localized
tuberculoid as compared with the disseminated lepromatous form of the disease. In contrast,
perforin, a cytolytic molecule that colocalizes with granulysin in cytotoxic granules was expressed
at similar levels across the spectrum of disease. Immuno¯uorescence labeling of leprosy lesions,
revelead that cells containing granulysin were CD3+ T cells and expressed the CD4 but not the
CD8 marker.We found that CD4+ T-cell lines derived from tuberculoid skin leprosy lesions lysed
antigen-pulsed targets by the granule exocytosis pathway, expressed perforin and granulysin and
reduced the viability of mycobacteria in infected targets. These data point for a novel role for
CD4+ T cells in host defense and provide evidence that T cell release of granulysin contributes to
host defense at the site of infection in human disease.
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Cathelicidin Antimicrobial Peptides are a Critical Defense Mechanism Against Group A
Streptococcal (GAS) Necrotizing Cellulitis
R. Gallo, T. Ohtake, R. Dorschner,² V. Pestonjamasp, J. Rudsill,² and V. Nizet*
Dermatology, University of California San Diego, San Diego, California; *Pediatrics, University of
California San Diego, San Diego, California; ² Dermatology, VA San Diego, San Diego, California
Recent discoveries in mammals of peptides with in vitro antimicrobial activity have led to theories
that these molecules are important to innate immune defense. Cathelicidins are one family of such
peptides that are directly expressed in keratinocytes and other epithelial and lymphoid cell types.
Humans and mice contain a single cathelicidin gene whose mature products are the structurally
similar peptides LL-37 and CRAMP, respectively. To test if cathelicidins are important for
cutaneous defense against the common human pathogen GAS, we generated mice null for the gene
encoding CRAMP. Within 6 days of sc injection of wild-type GAS, wild-type 129/SVJ mice (+/
+) develop lesions of necrotizing cellulitis measuring from 4 to 9 mm2, ±/+ littermates develop
larger lesions (8±12 mm2), and ±/± animals have the most severe infections (14±21 mm2). Tissue
biopsy and quantitative culture of lesions 7 days after injection show +/+ mice have few colonies
of GAS while ±/+ and ±/± have active infection, with ca 2X more colonies per mg tissue in ±/±
than ±/+ mice. To con®rm the apparent conclusion that CRAMP limits GAS growth in skin, we
used random transposon mutagenesis to produce 2 genetically distinct GAS clones resistant to
inhibition in vitro by either LL-37 or CRAMP. Injection of the resistant GAS clones in normal
Balb/c (+/+) mice resulted in signi®cantly larger lesions and greater bacterial survival at 5 days than
did injection of wild type GAS in identical animals. These observations are the ®rst proof for
mammals that antimicrobial peptides play a role in vivo to prevent infection. Our ®ndings suggest
that the expression and function of cathelicidins limits bacterial pathogenicity and works together
with other components of immune defense to clear infection and prevent disease.
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The Expression of Functional CD14 and Toll-Like Receptors on Human Keratinocytes
P. Song, Y. Park, T. Abraham, B. Harten, A. Zivony, C. Armstrong, and J. Ansel
Dermatology, Emory University School of Medicine, Atlanta, Georgia
CD14 and Toll-like receptors (TLRs) have been known to play an important role in LPS-
mediated cellular responses in bacterial infections. Although CD14 and TLRs expression has been
demonstrated on a number of myeloid cells, little is known about the expression and function of
these LPS receptors on nonleukocytes such as keratinocytes. In this sutdy we tested the possibility
that the human keratinocytes are capable of expressing both functional CD14 and TLRs. Using
quantitative RT-PCR and Northern blot, we found that the cultured human keratinocytes
constitutionally express CD14 and TLR2/TLR4 mRNA, and that LPS treatment (100 ng per ml)
increases the mRNA expression of these receptors. Cell surface expression of CD14 and TLR4 was
veri®ed by FACS analysis. To assess the functional activity of these receptors in human
keratinocytes, we measured intracellular Ca++ and NF-kB activity in response to LPS. LPS
treatment triggered a rapid induction of human keratinocyte intracellular Ca++, which could be
blocked by speci®c antibodies to each receptor. The rapid increase in intracellular Ca++ in response
to LPS was followed by the nuclear translocation of NF-kB. This study indicates for the ®rst time
that cultured human keratinocytes express both functional CD14 and TLRs which can be up-
regulated by LPS. These results have important implications for our understanding of the
pathophysiology of cutaneous infections.
292
Activation of Human Dendritic Cells by Platelet Activating Factor is Maturation
Dependent
S. Dichmann, H. Rheinen, J. Simon, and J. Norgauer
Department of dermatology, University of Freiburg, Freiburg, Germany
Dendritic cells (DCs) are characterized by their ability to migrate into target sites, process antigens
and activate naive T cells. Effector functions induced by platelet activating factor (PAF) and the
cytokine macrophage in¯ammatory protein 3-b (MIP3-b) as well as the mRNA-expression of
their receptors were analyzed in human DCs during lipopolysaccharide (LPS)-promoted
maturation. Immature human dendritic cells were differentiated in vitro from monocytes with
interleukin-4 and granulocyte macrophage colony stimulating factor. Platelet activating factor
induced calcium transients, actin polymerization and chemotaxis in these cells. In addition, RT-
PCR experiments indicated mRNA-expression of the PAF receptor. Cell studies and mRNA
analyses further revealed that immature DCs neither respond to MIP3-b nor express its speci®c
receptor, called CCR-7. Induction of cell differentiation by LPS lead to the loss of the mRNA-
expression of the PAF receptor accompanied by decreasing intracellular calcium release, actin
polymerization and migration after stimulation with PAF. In contrast, LPS treatment induced
increasing responsiveness towards MIP-3b and mRNA expression of CCR-7. Comparable data
regarding mRNA expression of PAF receptor and PAF-responsiveness were also obtained with an
other maturation protocol using TNFa instead of LPS. The direct comparison between the two
different protocols showed a slower decrease of PAF-responsiveness induced by TNFa compared
to LPS. These results show the loss of PAF responsiveness together with down-regulation of PAF
receptor mRNA expression during maturation of human DCs. Therefore, these ®ndings point to a
functional relevance of PAF in recruiting immature DCs, whereas MIP3-b might regulate the
migration of DCs to secondary lymphoid organs.
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Induction of Proin¯ammatory Cytokines by Activation of the Capsaicin Sensitive
Vanilloid Receptor VR-1 on Human Keratinocytes
G. Burbach, A. Zivony, D. Kalden, C. Armstrong, and J. Ansel
Dermatology, Emory University, Atlanta, Georgia
Capsaicin, one of the pungent ingredients of hot chili peppers, induces a subpopulation of sensory
neurons to release neuropeptides by activating the recently cloned vanilloid receptor-1 (VR-1).
Vanilloid receptors are also triggered by acidic and thermal stimuli that could occur during
cutaneous in¯ammation and wound healing. To date, in the skin, VR-1 receptors have only been
identi®ed on cutaneous nerves. The aim of this study was to examine the direct effect of capsaicin
on keratinocyte proin¯ammatory cytokine production and to determine if this effect is mediated
by the VR-1 vanilloid receptor. Our results demonstrate for the ®rst time that normal human
keratinocytes express functional VR-1 receptors. Real time quantitative RT-PCR studies indicate
that VR-1 mRNA is constitutively expressed in human keratinocytes and is not modulated by
capsaicin treatment. Furthermore, capsaicin (0.1±100 mM) induced up to a 25-fold expression of
the proin¯ammatory cytokines IL-1a, IL-1b, IL-6 and TNF-a. Pretreatment of keratinocyte
cultures with capsazepine, a speci®c competitive antagonist of vanilloid receptors, prior to
capsaicin, completely blocked cytokine mRNA expression to control levels indicating that
capsaicin induces the expression of keratinocyte proin¯ammatory cytokines by activating the VR-1
vanilloid receptor. Thus, our data indicate that the activation of capsaicin-sensitive vanilloid
receptors located on keratinocytes may directly promote cutaneous in¯ammatory responses. These
results have important implications for the role of vanilloid receptors in normal and diseased skin.
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Local Skin Lesions in Rat After Asubcutaneous Deposition of Capsaicin
J. Wallengren, D. Chen, and F. Sundler
Departments of Dermatology and Physiology, Lund University, Lund, Sweden
This study describes the time course of development, regional distribution and innervation of
spontaneous lesions in adult Sprague-Dawley rats desensized to capsaicin. In one group, capsaicin
was administered subcutaneously by injection in the neck skin. In the second group capsaicin was
injected with a long needle in the skin of the back skin and deposited in the subcutaneous fat of the
neck. Occurrence and distribution of dermal nerve ®bers was monitored using immuno-
histochemistry with antibodies against calcitonin gene-related peptide (CGRP) and a pan-neuronal
marker, protein gene product 9.5 (PGP 9.5). In the ®rst group rats developed spontaneous wounds
in the neck area. In the second group, lesions appeared in the skin of the back and occasionally in
the neck area. Development of wounds in the af¯icted areas was paralleled by a reduction of the
CGRP immunoreactive nerve ®bers by 80% in the ®rst group and 72% in the second group. The
number of PGP-immunoreactive ®bers was reduced by 39% and 41% resp. The density of CGRP-
IR innervation of the wound area was the same as in the adjacent, nonlesional skin in both groups.
The healing of the spontaneous wounds was delayed compared to surgical wounds on control
animals The wounds healed with hypertrophic scars which was paralleled by proliferation of
CGRP in the skin of the back. The study shows that cutaneous lesions in rats systemically treated
with capsaicin appear in the region of subcutaneous deposition of capsaicin. An even depletion of
capsaicin-sensitive nerve ®bers in the area of deposition suggests that an additional factor is needed
to induce lesions. Hypothetically, an impaired nociception in the af¯icted area may result in a more
vigorous grooming behavior inducing a local skin damage.
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Cutaneous In¯ammation Induced by Endothelin-1 is Mast Cell-Dependent
M. Metz, J. Knop, and M. Maurer
Department of Dermatology, University of Mainz, Mainz, Germany
We have recently shown, that endothelin-1 (ET-1), a potent vasomodulatory peptide, induces
pronounced in¯ammatory responses in murine skin. Since mast cells (MC) express functional
receptors for ET-1, we have used genetically MC-de®cient KitW/KitW-v-mice to characterize
the role of MC in ET-1 induced cutaneous in¯ammation. ET-1 (10±6 M, 20 mL, left ears) and
vehicle (20 mL, right ears) were injected intracutaneously into the ears of KitW/KitW-v-mice and
normal +/+ mice. Ear thickness was measured for 6 h at various time points after injection. Ear
swelling in ET-1-injected ears was markedly reduced in the absence of mast cells (KitW/KitW-v -
mice: 58 6 6 mm vs. +/+ mice: 118 6 5 mm at 1 h, p < 0.001). In addition, MC degranulation in
ET-1-treated ears of +/+ mice was signi®cantly increased 1 h and 6 h after injection as compared
to vehicle treated control ears (p < 0.05). To test, whether the adoptive transfer of MC to the ears
of MC-de®cient KitW/KitW-v-mice would restore impaired in¯ammatory responses to ET-1, we
injected ET-1 into KitW/KitW-v-mice reconstituted with bone marrow-derived cultured MC
(left ears, KitW/KitW-v + BMCMCs) or vehicle (right ears, KitW/KitW-v + Veh). Earswelling in
MC-reconstituted ears after ET-1 injection was signi®cantly increased as compared to ET-1-
treated control ears (KitW/KitW-v + BMCMCs: 100 6 6 mm vs. KitW/KitW-v + Veh:
45 6 5 mm at 1 h, p < 0.001) and virtually the same as in ET-1-injected ears of +/+ mice.
These data suggest that ET-1 induced in¯ammation in murine skin is MC-dependent and thus
provide a novel mechanism of ET-1 induced in¯ammatory responses.
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Characterization of Substances from the Itch Inducing Plant Macuna Pruriens
E. Lerner, K. Kounga, V. Reddy, R. Suchdev, and Y. Bello
Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, Massachusetts
An itch inducing ``proteinase'' termed mucunain was described as the active ingredient in the
spicules of the seedpods of the cowhage plant Macuna pruriens. This work, by Shelley and Arthur,
in the 1950s, was not continued. We have obtained spicules from Macuna pruriens and made
extracts under both aqueous and organic conditions. The extracts have been analyzed using a
variety of biochemical approaches including anion exchange, gel electrophoresis, thin-layer
chromatography, reverse-phase HPLC and MALDI-TOF MS (matrix-assisted laser desorption
time-of-¯ight mass spectrometry). The extracts and puri®ed material have also been subjected to
protease digestion without lost of the itching activity. Pruritic activity appears to be maintained in
the whole extract and in at least one of the several peaks under reverse-phase HPLC. No peaks
absorb at 280 nm. MALDI analysis has determined that the molecular masses associated with the
peaks are between 200 and 1000 amu. No substance with the mass of histamine, 111, was noted.
No bands are present on gel electrophoresis of the total extract or of the HPLC peaks. These results
suggest that the active ingredient is not histamine and, in contrast to the results of Shelley and
Arthur, is not a protein, and for that matter, not a proteinase. Further analysis is necessary to
identify the active component(s) in cowhage. This substance may be a useful tool to determine the
mechanism of itch induction.
297
Identi®cation of Novel Genes Involved in Cytokine-Mediated Keratinocyte Activation
and Dendritic Cell Costimulation of T Lymphocytes Using an Antisense
Oligonucleotide Library-Based Genomics Approach
J. Karras, T. Condon, B. Monia, and C. Bennett
Antisense Drug Discovery, Isis Pharmaceuticals, Carlsbad, California
We have developed 96-well microtiter, cell-based assays to identify novel genes required for
activation of keratinocytes (KC) and functional stimulation of T lymphocyte responsiveness by
dendritic cells (DC). KC have been shown to be an important cell type in the development of
psoriasis, overexpressing certain cytokines and chemokines as well as displaying abnormal
proliferative behavior. In our studies, we used pooled human neonatal epidermal keratinocytes
treated with potent, validated antisense oligonucleotides (ASO) that inhibit various human genes.
Forty-eight hours after ASO treatment the KC are induced with TNF-a overnight and then
assayed for ICAM-1 cell surface expression and IL-8 secretion by ELISA. The results of screening
80 optimized ASO inhibitors and 8 control ASO provided us with a list of 8 genes that signi®cantly
inhibit ICAM-1 and/or IL-8 expression. A primary DC-based T cell costimulation assay
measuring IL-2 production was also utilized to identify several active ASO from a library of 240
separate sequences. We then performed detailed dose±response and apoptosis assays in order to
determine which genes block cell activation or differentiation without inducing programmed cell
death. Several genes were found to mediate both KC activation by TNF-a and DC-induced
costimulation of T cells and thus represent novel therapeutic targets for psoriasis and other
in¯ammatory skin diseases.
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SB-203347, a 14-Kilodalton, PLA2 Inhibitor, Reduces Ear Edema, Neutrophil In¯ux,
and Epidermal Proliferation in a Murine Phorbol 12- Myristate 13-Acetate-Induced Ear
In¯ammation Model
C. Davenport, B. Bolognese, E. Webb, D. Griswold, E. Capper, C. Stevenson, and L. Marshall
Immunology, GlaxoSmithKline, King of Prussia, Pennsylvania
Elevated levels of secretory PLA2 (sPLA2) have been detected in the epidermis of psoriatic patients
and are associated with increased production of leukotrienes and platelet activating factor (PAF). A
14-kDa sPLA2 inhibitor, SB-203347, was previously shown to block PLA2 activity of acid
extracted human neutrophil homogenates (IC50 = 4.7 mM) and inhibit release of free arachidonic
acid with subsequent reduction of leukotrienes and PAF generated by A23187-stimulated human
neutrophils. Previous studies in vivo demonstrated that SB-203347 inhibited endotoxin-induced
mortality without alteration of serum TNFalevels. Here we demonstrate that type IIA PLA2 is
present in ear homogenates following treatment with Phorbol 12- Myristate 13-Acetate (PMA) by
both ELISA and Ca2+-dependent Sn-2 acylhydrolysis of 3H-AA E. coli substrate. Topical treatment
with SB-203347 immediately prior to epicutaneous administration of PMA dose-dependently
inhibited Sn-2 acylhydrolysis of 3H-AA E. coli substrate with an IC50 of 12.4 mM. Furthermore,
topically administered SB-203347 inhibited ear edema, neutrophil in¯ux, and epidermal
proliferation resulting from PMA treatment. The ability of SB-203347 to inhibit both
in¯ammation and epidermal proliferation suggests that 14 kDa sPLA2 inhibitors may be ef®cacious
in the treatment of psoriasis.
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Expression of CD44 and its Isoforms in In¯ammatory Skin Diseases
G. Kaya, L. TcheÂreÂmissinoff, E. Augsburger, and J. Saurat
Department of Dermatology, DHURDV, University Hospital of Geneva, Geneva, Switzerland
CD44 is a transmembrane glycoprotein which exists as multiple isoforms resulting from alternative
splicing of 10 variant exons (v1-v10) and post-translational modi®cations. The main or standard
CD44 form without variant exon is CD44s which has a broad cellular distribution. The isoforms of
CD44 are found on cells of epithelial origin and their function is unknown. CD44s functions as the
predominant cell-surface receptor for hyaluronate (HA). In a recent study we have shown that the
major role of CD44 in the skin is the regulation of keratinocyte proliferation and local HA
metabolism in transgenic mice with keratinocyte-speci®c CD44 expression defect. Recently we
have also observed a decrease in epidermal CD44 expression in lichen sclerosus et atrophicus. In
this study we examined the expression of CD44s and different CD44 isoforms (CD44v3, CD44v4,
CD44v5, CD44v6, CD44v7, CD44v7v8 and CD44v10) in in¯ammatory skin diseases such as
seborrheic dermatitis (SD), acrodermatitis chronica atrophicans (ACA), drug eruption (DE),
erythema multiforme (EM), toxic epidermal necrolysis (TEN) and graft vs. host disease (GVHD)
by immunohistochemistry. In SD, ACA, DE and GVHD, CD44s is highly expressed in the basal
and suprabasal layers of epidermis as well as in the lymphocytes of the dermal in¯ammatory
in®ltrate. However, the expression of CD44s is markedly decreased or absent in the epidermis and
in the lymphocytes of the in¯ammatory in®ltrate in EM and TEN. In the epidermis, CD44v3 is
expressed in SD, ACA and DE, decreased in GVHD, and absent in EM and TEN; CD44v4 is
expressed in ACA, decreased in SD, DE, EM and GVHD, and absent in TEN; CD44v5, CD44v6
and CD44v7 are expressed in SD, ACA, DE and GVHD, and absent in EM and TEN; CD44v7v8
is expressed in SD and GVHD, and absent in ACA, DE, EM and TEN; CD44v10 is expressed in
SD and ACA, decreased in DE and GVHD, and absent in EM and TEN. In the lymphocytes of the
in¯ammatory in®ltrate CD44v4 is highly expressed in all diseases; CD44v6 is faintly expressed in
DE, EM, TEN and GVHD, and absent in SD and ACA; CD44v7 is faintly expressed in DE, TEN
and GVHD, and absent in SD, ACA and EM; CD44v10 is expressed in SD, EM, TEN and faintly
in GVHD, and absent in ACA and DE; CD44v3, CD44v5 and CD44v7v8 are absent in all
diseases. These results show that the expression of CD44 molecules in the epidermis and
lymphocytes is differentially regulated in in¯ammatory skin diseases.
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Chemotaxis and Actin Polymerization of Human Dendritic Cells Depend on Rho
Proteins
H. Rheinen, S. Dichmann, K. Aktories,* and J. Norgauer
Experimental Dermatology, University of Freiburg, Freiburg, Germany; *Department of Clinical
Pharmacology and Toxicology, University of Freiburg, Freiburg, Germany
Dendritic cells (DCs) are one of the principle initiators of immune responses. They are able to
migrate into target sites, process antigens and activate naive T cells. The intracellular signalling
cascade regulating the recruitement of DCs into target site is not well understood. However,
several chemotaxins relevant for this process have previously been identi®ed. Reorganization of the
actin cytoskeleton by ¯ow cytometry and activation of small GTPases of the Rho protein familily
by prezipitation with rhotecine in human DCs after stimulation with chemotaxins such as C5a and
PAF has been revealed in the present study. To show the relevance of the actin cytoskeleton
reorganization in DCs Clostridium botulinum C2 toxin has been used. This toxin inhibits the
migration and actin response through ADP-ribosylation of actin molecules, but did not interfere
with other intracellular signalling events such as the mobilization of Ca2+ from intracellular stores.
The function of Rho proteins was analyzed with the fusion toxin C2IN-C3. This exoenzyme
selectively modi®ed Rho proteins by ADP-ribosylation and blocked the actin and migration
response in a concentration dependent manner. To our best knowledge we have shown for the
®rst time that migration and reorganization of the actin cytoskeleton of dendritic cells is regulated
by Rho GTPases.
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Blood Levels of Soluble Vascular Adhesion Molecules, VCAM-1 and E-Selectin, are
Increased in Clinically Amyopathic Dermatomyositis
R. Sontheimer and D. Racila
Dermatology, University of Iowa Hospitals and Clinics, Iowa City, Iowa
Patients with classical dermatomyositis (CDM) express VCAM-1 and E-selectin in the microvessels
of in¯amed muscular and cutaneous tissue. In addition, patients with CDM have recently been
reported to display elevated blood levels of VCAM-1 and E-selectin. Whether these soluble
vascular adhesion molecules re¯ect activation of the muscular or dermal microvasculature (or both)
has not been determined. To examine the component of soluble adhesion molecules contributed
by in¯ammation predominately involving the dermal microvasculature, we measured levels of
soluble VCAM-1 and E-selectin in the serum of 12 clinically amyopathic DM patients (C-ADM)
(i.e. patients having the hallmark cutaneous manifestations of DM for 6 months or longed without
clinically signi®cant evidence of in¯ammatory myositis [i.e. No proximal muscular weakness and
normal muscle enzymes]. In addition, 17 CDM patients were also studied for comparison. Stored
patient and control serum samples were analyzed by ELISA. Optical density values greater than 3
s.e.m. Above the mean produced by normal control sera were considered abnormal. Elevated
levels of VCAM-1 were observed in 9/17 (53%) CDM and 5/12 (42%) C-ADM patients
(p = 0.8845 by chi square). Elevated E-selectin levels were found in 3/17 (18%) CDM and 9/12
(75%) C-ADM patients (p = 0.0077 by chi square). The presence of similar rates of elevation of
soluble VCAM-1 in CDM and C-ADM patients suggests that circulating levels of this vascular
adhesion molecule could re¯ect activation of the muscular or dermal microvasculature (or both).
The much higher rate of elevated soluble E-selectin levels in C-ADM patients suggests that
circulating levels of this vascular adhesion molecule might better re¯ect (or be limited to) activation
of the dermal microvasculature. In addition, if soluble E-selectin levels can be shown to correlate
positively with the extent of clinical cutaneous in¯ammation, soluble E-selectin levels could
represent a quanti®able surrogate marker of the degree of cutaneous vascular in¯ammation in
CDM and C-ADM.
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Discovery of Novel JAK Kinase Inhibitors with Cell-Based Assays
B. Rich, H. Zhuang,² B. Sophina,* and X. Xiao²
Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; *Scripps Research Institute, La Jolla,
California; ²ChemRx, La Jolla, California
Several observations indicate that keratinocyte-derived IL-7 supports the viability and modi®es the
behavior of T cells within the skin. Therefore the IL-7 signaling pathway may be a useful
pharmacological target for the treatment of in¯ammatory skin disease. Tyrphostins are a class of
chemical compounds that block cytokine signal transduction by inhibiting the Janus family of
cellular kinases (JAK). The most potent of these, AG490 or B42, blocks the responses of various
cells to a number of cytokines by inhibiting both JAK2 and JAK3 kinases. Cellular responses to IL-
3, ±5, ±6, ±12, IFN-gamma and GM-CSF depend upon JAK2 while responses to IL-2, ±4, ±7, ±9
and ±15 require JAK3. By inhibiting both of these kinases, AG490 exerts broad suppressive effects
on the immune system. In an effort to identify compounds that are more selective and potent
inhibitors of the JAK kinases a library of 600 distinct derivatives of AG490 were synthesized using a
combinatorial approach involving radiofrequency tagging and directed sorting of solid phase
reactors. Simple cell proliferation assays were used to evaluate the effectiveness of each of these
compounds as inhibitors of JAK2 and JAK3. The IL-3 dependent Baf3 cell line was used to
measure the inhibition of JAK2 and the IL-7 dependent 2E8 cell line was used to measure the
inhibition of JAK3. Two closely related compounds were identi®ed which are approximately 8
times more potent inhibitors of JAK3 and one of these is a signi®cantly less potent inhibitor of
JAK2. This may limit the inhibitory effects of these compounds to T cells and reduce their effects
on other cells, thereby minimizing immunosuppression.
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Enhanced Contact Hypersensitivity in TP-De®cient Mice: Implication of TXA2 as an
Essential Negative Feedback Regulator in Skin Immune Response
K. Kabashima, M. Nagamachi, S. Narumiya,* and Y. Miyachi
Dermatology, Kyoto university, Kyoto, Japan; *Pharmacology, Kyoto university, Kyoto, Japan
Thromboxane A2 (TXA2) is a potent stimulator of platelets and constriction of vascular smooth
muscle. However, the TXA2 receptor (TP) mRNA is abundant in lymphocytes and the TX
synthase is especially abundant in cells of macrophage lineage, which suggests that TXA2 plays an
important role in immune system. To ascertain the essential functions of TXA2, we generated and
characterized the TP-de®cient mice, which exhibit an enhanced (about two fold) and prolonged
contact hypersensitivity (CHS) response elicited with DNFB. This phenotype was pharmacolo-
gically reproduced by TP antagonist administration during the sensitization phase but not during
the challenge phase, indicating that TXA2-TP functions at the sensitization phase. In CHS model,
the number of cervical lymphocytes, especially Th1 cytokine producing cells, of TP-de®cient mice
was signi®cantly larger than that of WT mice. But TP-de®cient mice do not have defects in
Langerhans cell function, such as migration and costimulatory molecule expression. Therefore we
examined the interaction of APC-T cell response in vitro. DNBS induced T cell proliferation of
DNFB sensitized lymph node cells of TP-de®cient mice was more than that of WT mice. The
puri®ed naive CD4 cell proliferation induced by con A with APC was signi®cantly suppressed
(40%) by a TP agonist. This phenomenon was seen in T cells from WT mice but not from TP-
de®cient mice and the suppression in WT cells was observed irrespective of the origin of
cocultured APCs. In this model, TP agonist affected neither the IL-2 production nor the receptor
expression. On the other hand, TP agonist signi®cantly suppressed the proliferation by the addition
of exogenous IL-2. These ®ndings indicate that TXA2 acts as a negative feedback regulator on skin
in¯ammatory response on T cells but not on APCs, by suppressing the IL-2 responses during
sensitization phase.
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Protective Role Played by CD39 on Langerhans Cells Against Chemically Induced Skin
In¯ammation
N. Mizumoto, T. Kumamoto, S. Robson,* and A. Takashima
UT South-western, Dallas, Texas; *Harvard University, Boston, Massachusetts
Although ecto-ATPase/ADPase activities have been widely used 30 years as useful markers of
epidermal Langerhans cells (LC), the molecular identity or physiological function of these activities
remain unknown. CD39, which was originally described as an obscure activation marker expressed
by B cells, dendritic cells, and endothelial cells, has been recently identi®ed as a vascular ecto-
ATPase/ADPase, now termed collectively as ecto-nucleoside triphosphate diphosphohydrolase
(NTPDase). We detected CD39 mRNA and/or protein expression almost exclusively within the
IA+ population in mouse epidermis and in LC-derived XS52 and XS106 lines, but not in
keratinocyte or epidermal gd T cell lines. Moreover, CD39-de®cient mice showed normal surface
densities of IA+/DEC205+ LC, whereas these CD39±/± LC lacked apparent ecto-NTPDase
activities. Thus, we conclude that CD39 alone is responsible for LC-associated ecto-NTPDase
activities. With respect to function, CD39±/± mice developed signi®cantly (p < 0.01, 10 mice per
panel) exacerbated ear swelling responses to topically applied croton oil, benzalkonium chloride
(BAC), and ethyl phenylpropiolate (EPP) than did CD39+/+ mice in terms of both the magnitude
and time course. Late phase responses observed in CD39±/± mice were characterized histologically
by striking epidermal hyperplasia and marked leukocyte in®ltration. CD39+/± mice showed
intermediate responses between the two panels. Interestingly, in¯ammatory responses to the fourth
irritant chemical, phenol, were comparable between CD39±/± mice and CD39+/+ mice. Local
administration of soluble NTPDase reduced the extent of croton oil-induced ear swelling in
CD39±/± mice to the normal level, supporting the anti-in¯ammatory role for CD39. Upon
exposure to croton oil, BAC or EPP, but not to phenol, Pam 212 keratinocytes rapidly (< 10 min)
released biologically relevant amounts of ATP into culture media. Addition of CD39-expressing
XS52 cells in keratinocyte cultures signi®cantly reduced ATP levels in the media. Thus, we
conclude that LC-associated CD39 plays a protective role by hydrolyzing otherwise pro-
in¯ammatory ATP that is released by neighboring keratinocytes in response to selected forms of
environmental stimuli. Our results reveal two distinct (i.e. ATP-dependent and -independent)
pathogenic mechanisms of irritant contact dermatitis and form the basis to develop an in vitro
screening system that can be used to identify causative chemicals.
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SDZ ASM 981 Potently Inhibits the Induction of Coreceptors Involved in the Accessory
Cell-Dependent Activation of In¯ammation-Mediating T Cells
E. Kalthoff, J. Chung, M. Grassberger, and A. Stuetz
Novartis Research Institute, Vienna, Austria
Previously, we have reported that SDZ ASM 981 is a potent inhibitor of in¯ammatory cytokine
synthesis in both T cells and mast cells in vitro and inhibits the allergic contact hypersensitivity
(ACH) reaction in vivo. As the ACH reaction is dependent on ef®cient priming of responder T cells
by antigen-presenting cells, we studied whether SDZ ASM 981 would also interfere with the
activation-associated up-regulation of coreceptor molecules on helper T cells. Particularly, we
focussed on coreceptors recently proposed to be involved in the activation and expansion of
effector T cells in autoimmunity such as CD134 (OX-40), and CD137 (4±1BB) previously
suggested to mediate preferential activation of CD8+ T cells and Th1 cells producing
in¯ammatory cytokines. For comparison, we included the activation markers CD54 (ICAM-1)
and CD25 (high af®nity IL-2 receptor). To mimic the physiological situation as closely as possible,
we have used human monocyte-derived dendritic cells (MoDC) as potent stimulators of highly
puri®ed CD4+ T cells in the allogeneic mixed lymphocyte reaction (allo-MLR). The allo-MLR
was performed in the presence and absence of SDZ ASM 981 and Cyclosporin A (CyA) using a
50-fold excess of T cells over MoDC. After three days, the level of expression of the T cell
coreceptors was determined by ¯ow cytometry. SDZ ASM 981 dose-dependently inhibited the
up-regulation of CD25, CD54, CD134 and CD137 with 80% inhibition reached at about 10 nM.
In this respect, SDZ ASM 981 was at least 10-fold more potent than CyA. These differences in the
relative potency of the compounds were also revealed for the inhibition of T cell proliferation in
allo-MLR as determined by parallel thymidine incorporation assays. Taken together, SDZ ASM
981 not only inhibits T cell proliferation by blockade of cytokine synthesis but also prevents the
up-regulation of coreceptors thought to be critical for the development of in¯ammatory effector T
cells.
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Topical PPAR-a Activators Display Anti-In¯ammatory Activity in Irritant and Allergic
Contact Dermatitis Models
M. Sheu,* A. Fowler,* J. Kao, P. Elias, and K. Feingold
Dermatology, Veterans Administration Medical Center, San Francisco, California; *Medicine and
Dermatology, University of California at San Francisco School of Medicine, San Francisco, California
Activators of PPAR-a, a nuclear hormone receptor that heterodimerizes with RXR, stimulate
epidermal differentiation and inhibit proliferation. Here, we describe the anti-in¯ammatory effect
of PPAR-a activators in irritant and allergic contact dermatitis induced in mouse ears with TPA
and oxazalone, respectively. The PPAR-a activators were applied 45 min and 4 h after TPA or
oxazalone treatment. Ear thickness and weight were measured at 18 h, and assessed by histology
and immunohistochemistry for TNF-a and IL-1a. Clo®brate (0.02%) reduced the TPA-induced
increase in ear thickness and weight by ~50% (both p < 0.01), vs. vehicle- and stearic acid-(not a
PPAR-a activator)-treated controls. Two other PPAR-a activators, WY 14 643 (0.03%) and
linoleic acid (0.001%), produced similar results and all were comparable to clobetasol 0.05%.
Histology of clo®brate + TPA-treated ears revealed a marked reduction in TPA-induced
in¯ammation, and immunohistochemistry showed decreased TNF-a and IL-1a levels throughout
the epidermis. Since clo®brate did not signi®cantly reduce TPA-induced ear swelling in PPAR-a
knockout animals, the anti-in¯ammatory activity is receptor-mediated. Finally, PPAR-a activators
also reduced oxazolone-induced ear thickness and ear weight by 50%±55% (p < 0.05). These
studies demonstrate that topically applied PPAR-a activators possess receptor-mediated, anti-
in¯ammatory activity in both irritant and allergic contact dermatitis models. The anti-in¯ammatory
activity of these compounds, coupled with their antimitogenic and prodifferentiating effects,
suggest that they could prove bene®cial for the treatment of cutaneous in¯ammatory dermatoses.
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Oxysterol Ligands of LXR Display Anti-In¯ammatory Activities in Irritant and Allergic
Contact Dermatitis Models
A. Fowler,* M. Sheu,* J. Kao, P. Elias, and K. Feingold
Dermatology and Metabolism, Veterans Administration Medical Center, San Francisco, California;
*Dermatology and Medicine, UCSF, San Francisco, California
Recently, we have shown that oxysterols stimulate epidermal differentiation and development, and
inhibit keratinocyte proliferation by activating liver X receptors (LXR) that are present in
keratinocytes. LXR a and b are members of the nuclear hormone family that heterodimerize with
RXR to regulate gene expression. In the present study, the anti-in¯ammatory effect of two
oxysterols, 22(R)-hydroxycholesterol (22ROH) and 25-hydroxycholesterol (25OH), were
examined utilizing models of irritant and allergic contact dermatitis. Irritant dermatitis was
induced by applying TPA to the ears of CD1 mice followed by treatment with vehicle alone
(acetone), 22ROH, 25OH, cholesterol, or clobetasol 45 min and 4 h following TPA. Anti-
in¯ammatory effects were determined 18 h after TPA by measuring ear thickness and weight
(6 mm punch biopsy). Whereas TPA alone induced a ~2-fold increase in ear weight and thickness,
both 22ROH and 25OH treatment signi®cantly reversed this increase (50% decrease in thickness;
60±75% decrease in weight), comparable to anti-in¯ammatory effects observed with topical
clobetasol treatment. Histology also revealed a marked decrease in dermal in¯ammation in
oxysterol-, but not vehicle- or cholesterol-treated animals. Immunohistochemistry also
demonstrated a decline in the production of the proin¯ammatory cytokines, IL-1a and TNFa,
by oxysterol treatment. Since topical cholesterol did not affect TPA-induced in¯ammation, the
inhibition by oxysterols can not be attributed to a nonspeci®c sterol effect. Finally, both 22ROH
and 25OH also reduced ear thickness/weight by ~40% in the oxazolone allergic contact dermatitis
model. These studies demonstrate that naturally occurring oxysterol ligands of LXR display anti-
in¯ammatory activity in both irritant and allergic contact dermatitis models. Oxysterols could
provide a new class of therapeutic agents for the treatment of cutaneous in¯ammatory disorders.
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PTEN WAP±/± Mice, a Model of Spontaneous Cutaneous In¯ammation
B. Wang, S. Backman,* I. Freed, C. Mckerlie, W. Hanna, T. Mak, and D. Sauder
Dermatology, Coparative Research, and Pathology, Sunnybrook Health Science Centre, Toronto, Ontario,
Canada; *Immunolgy, Amgen, Toronto, Ontario, Canada
PTEN is a tumor suppressor with sequence homology to the protein tyrosine phosphatases and the
cytoskeletal protein tensin. The PTEN gene is the most highly mutated tumor suppressor gene in
post-p53 era. Somatic deletions or mutations of this gene have identi®ed in a wide range of tumors.
PTEN plays a signi®cant role not only in inducing programming apoptosis and cell cycle arrest, but
also in other aspects of cell physiology, including the regulation of cell adhesion, migration and
differentiation. In addition, in vitro studies suggest that PTEN may participate in the regulation of T
cell survival and T cell receptor signaling. Recently, we have developed tissue-speci®c PTEN
knockout mice (PTEN WAP±/±) with PTEN de®ciency in the skin. Intriguingly, PTEN
WAP±/± mice spontaneously developed chronic cutaneous in¯ammation. Clinically, the
dermatitis was characterized by thickened and reddened skin, and abnormal hair. The dermatitis
occurred on the trunk, head and ears. Histological examination of the skin sections revealed
marked hyperkeratosis, acanthosis, dermal thickening and mixed cellular in®ltrate composed of
mononuclear cells and neutrophils, hyperplasia of the pilosebaceous units and follicular plugging,
and neovascularization in PTEN WAP±/± mice, compared to the normal skin in PTEN WAP+/±
littermates. Microscopically, the hair of PTEN WAP±/± mice showed abnormality of the shape,
size and pigmentation pattern. The dermatitis observed in PTEN-de®cient mice had similarities
with T-cell-dependent chronic in¯ammatory skin diseases such as psoriasis. The spontaneous
occurrence of dermatitis in PTEN-de®cient mice suggests that PTEN may be involved in
cutaneous immune and in¯ammatory responses. PTEN WAP±/± mice provide for an
experimental model of cutaneous immune and in¯ammatory dermatoses.
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Attenuation of GAP-43 and NF-200 Innervation in Chronic Venous Ulceration
A. Rowe, M. Guest,* A. Davies,* and C. Bunker
Division of Medicine, Imperial College Medical School, London, UK; *Division of Surgery, Imperial College
Medical School, London, UK
Clinical and electrophysiological evidence of peripheral neuropathy and impairment of C-®bre
function have been found in venous ulcer patients. We have used immunohistochemistry and
image analysis quanti®cation of Growth-Associated Protein 43 (GAP-43) and Neuro®lament-200
(NF-200) immunoreactive (IR) nerve ®bres to examine the distribution of peptidergic and sensory
nerves in the skin adjacent to venous ulcers. Punch biopsies from patients with ulcers which healed
within 3 months (n = 14) and nonhealing ulcers (n = 15) were compared with age- and site-
matched control subjects (n = 12). Total GAP-43 IR ®bre length was signi®cantly decreased in the
dermis and epidermis in both patient groups (Mann±Whitney U test p < 0.001 in all cases).
Dermis controls, median 1795 mm (IQR 743 mm-3190 mm); healers, 198 (4±366); nonhealers, 197
(41±239); epidermis: controls 153 (65±304); healers, 0 (0±22); nonhealers, 0 (0±0). Total NF-200 IR
®bre length was decreased in the dermis in nonhealers only (Mann±Whitney U test p = 0.008):
controls, 2071 (1215±3177); nonhealers, 581 (327±1681). Total epidermal ®bre number, but not
length was slightly reduced in both patient groups (Mann±Whitney U tests p = 0.039 healers,
p = 0.028 nonhealers): controls, 4 (0±10); healers, 0 (0±2); nonhealers, 0 (0±1). Many GAP-43 ®bres
have been shown to contain peptidergic neurotransmitters such as calcitonin gene-related peptide
and substance P. Depletion of the cutaneous peptidergic innervation will affect a number of
structures and processes that may impact on tissue integrity and healing. Sensory nerve ®bres
(indicated by NF-200 IR) appear to be depleted to some extent in these patients. This could result
in decreased ability to respond to minor skin injury that may in turn lead to ulcer development.
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Neutral Endopeptidase Inhibition Improves Wound Repair in Diabetic Mice
M. Spenny, P. Muangman, J. Olerud, N. Bunnett,* J. Ansel,² and N. Gibran
Dermatology, University of Washington, Seattle, Washington; *Surgery, University of California, San
Francisco, California; ²Dermatology, Emory University, Atlanta, Georgia
In response to injury, C-®ber sensory nerves contribute to in¯ammation through release of
substance P (SP). Neutral endopeptidase (NEP) regulates SP effects through enzymatic
degradation. Skin and ulcers from patients with diabetes show increased NEP localization and
activity. We hypothesized that NEP activity would be increased in diabetic (db/db) mice and NEP
inhibition would improve in¯ammation and closure kinetics in excisional wounds. NEP activity of
skin from db/db mice and db/± littermates was determined ¯uorometrically. Using a 6-mm biopsy
punch, a dorsal excisional wound was created on the mice. Wounds were covered with a
semiocclusive dressing and treated for 7 days with normal saline (NS) or thiorphan. In one
experiment, mice were followed with weekly photographs until the wounds appeared closed. In
another experiment, wounds were harvested at 7 time points for H&E analysis. NEP activity in
unwounded db/db skin exceeded activity in db/± skin (20.6 vs. 7.9 pmol MNA per h per mg;
p = 0.02). In db/db mice, thiorphan-treated wounds healed faster (18d) than NS-treated (24d)
wounds (p < 0.05). There was no difference in the size of healed wounds suggesting that thiorphan
did not affect contraction. Analysis of wound histology using a semiquantitative scoring system
suggested that in¯ammation was increased at 6, 24, 48 and 72 h in wounds treated with thiorphan
compared to NS (p = ns). Increased NEP activity in skin from db/db mice correlates with NEP
activity in skin from patients with diabetes and corroborates use of db/db mice to study the role of
substance P after injury. NEP inhibition improved wound closure kinetics in db/db mice without
affecting contraction suggesting that epithelialization may be augmented. This improvement may
be due to increased availability of substance P and enhanced in¯ammation in the early stages of
wound healing.
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Selective COX-2 Inhibition Does Not Alter Healing of Incisional Sutured Skin Wounds
in SKH1 Mice
K. Chinn, E. Blomme, M. Hardy, J. Casler, W. Hall, D. Trajkovic, S. Kim, K. Khan, and C. Tripp
Skokie Discovery Biology, Pharmacia, Skokie, Illinois
Using an incisional wound model in SKH1 hairless mice, we evaluated the role of cyclooxygenase-
2 (COX-2) in the wound healing process by assessing the effects of therapeutic and supra-
therapeutic doses of nonselective COX inhibitors (naproxen and diclofenac), a selective COX-2
inhibitor (SC-791), and dexamethasone. Mice were administered vehicle or drugs 2±6 days prior to
wounding. A 1.5-cm incision was made on the dorsum of mice and closed with three equidistant
5±0 nylon sutures. Wound healing was monitored histologically, wound strength was evaluated
using a tensiometer and COX-2 protein expression was assessed by Western blot analysis and
immunohistochemistry up to 28 days postincision. Both the selective COX-2 and nonselective
COX inhibitors at therapeutic doses had no signi®cant effect on the macroscopic and microscopic
morphology of the wounds, whereas dexamethasone treatment resulted in epidermal and adnexal
atrophy. COX-2 expression was observed over the ®rst week postincision peaking at day 3 in the
presence and absence of both the selective and nonselective COX-2 inhibitors. In®ltrating
macrophages, as well as basal and migrating keratinocytes, expressed COX-2 and this pattern of
expression was not affected by therapeutic drug treatment. In addition, selective and nonselective
COX-2 inhibitors did not alter wound strength in contrast to dexamethasone, which reduced the
tensile strength of the healing wound by up to 38%. In conclusion, these data indicate that selective
COX-2 inhibition does not dramatically affect wound healing. These data suggest that COX-2
may not play a signi®cant biological role in skin wound healing or redundant pathways can
compensate for inhibition of COX-2.
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Increased E-Selectin, IL-8 and IL-10 Gene Expression in Human Skin After Minimal
Trauma: A Potential Explanation of Regional Distribution of Skin Lesions
F. Takeuchi, R. Streilein, and R. Hall
Dermatology, Duke University Medical Center, Durham, North Carolina
Although dermatitis herpetiformis (DH) is characterized by the distribution of skin lesions on
extensor surfaces such as elbows, knees and buttocks, the mechanism of this localization is not
known. We have demonstrated that neutrophils in patients with DH have an increased expression
of neutrophil CD11b, however, without appropriate expression of endothelial cell adhesion
molecules, neutrophil extravasation can not occur and skin lesions will not develop. We postulated
that minor trauma on extensor surfaces may lead to the expression of adhesion molecules, resulting
in the development of skin lesions in these areas of minimal trauma. In order to test this hypothesis
we gently rubbed normal inner arm skin of three subjects for 2 min with a pencil eraser. After 4 h
skin biopsies were obtained from the rubbed site and from adjacent normal, inner arm skin. Total
RNA was immediately isolated from the skin biopsies and cDNA produced by reverse
transcriptase. Real Time, Polymerase Chain Reactions (PCR) were performed using primers for
E-selectin and the cytokines IL-1a, ±1b, ±2, ±4, ±5, ±8, ±10, ±12p35, ±12p40, ±15, IFN-g and
TNF-a. Expression was normalized to the level of 18sRNA and gene expression was compared
between normal inner arm skin and rubbed arm skin for each subject. After 4 h a barely perceptible
erythema was seen with no other changes noted in the rubbed skin. Real Time-PCR analysis
revealed a marked increase in expression of E-selectin in the rubbed skin when compared to E-
selectin expression in normal, unrubbed inner arm skin (79.3; ratio mean rubbed skin expression/
normal skin expression). A similar increased expression of IL-8 (85.9) and IL-10 (38.1) was seen.
No signi®cant difference in the expression of the other cytokines was noted (0.69±3.3; ratio mean
rubbed skin expression/normal skin expression). These ®ndings suggest that minor trauma to skin
may induce speci®c expression of E-selectin, IL-8 and IL-10, which in the presence of partially
activated in¯ammatory cells would enhance extravasation of neutrophils and lead to localized
development of skin lesions. The localized increased expression of adhesion molecules and
cytokines in the skin after minor trauma may play an important role in regional expression of skin
lesions and clinical observations such as the Koebner phenomena.
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Mast Cells and TNFa Contribute to In¯ammatory Cell Recruitment to Sites of Early
Skin Granuloma Formation
E. von Stebut, J. Knop, and M. Maurer
Department of Dermatology, University of Mainz, Mainz, Germany
The induction of skin granuloma (SG)-formation, e.g. in foreign body granuloma or cutaneous
lesions of leishmaniasis, is characterized by the in¯ux of neutrophils (PMN) and macrophages.
However, little is known about how these cells are recruited to the sites of in¯ammation. Using a
murine model of polyacrylamide gel (PAG)-induced development of SG, we have characterized
the role of mast cells (MC) and TNFa in the early stages of SG-formation. Genetically MC-
de®cient KitW/KitW±v-mice and normal +/+ mice were injected subcutaneously with PAG
(Biogel P-100, 1 ml, back skin) and in®ltrating cells were recovered from the granulomas for FACS
analysis. PAG-induced granulomas in KitW/KitW±v-mice contained markedly less in®ltrating cells
as compared to +/+ mice at all time points studied: KitW/KitW±v-mice = 0.3, 2, and 17 vs. +/+
mice = 1, 19, and 34 3 106 cells/granuloma at 6 h, 12 h, and 24 h, respectively (p < 0.001). In both
genotypes, 90% of the cells recovered from the granulomas at all time points reported were
identi®ed as PMN by positive staining for antineutrophil mAb (7/4 and Gr-1). In +/+ mice,
numbers of degranulated MC at sites of SG-formation were signi®cantly increased 6 h after
injection of PAG as compared to vehicle-injected control skin (p < 0.05), indicating that PMN
recruitment to sites of SG-formation is mediated, at least in part, by activated skin MC. Since MC
produce, store, and release proin¯ammatory TNFa, a potent PMN chemoattractant, we have
assessed SG-formation in TNFa-de®cient (TNFa±/±)-mice and wild type (WT) mice. Notably,
50-fold more cells were recovered from granulomas in WT mice as compared to those in
TNFa±/± mice (57 vs. 1 3 106 cells/granuloma at 24 h, p < 0.001). These data suggest that MC
and TNFa play a key role in SG-formation in mice.
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Myeloperoxidase-De®cient Mice are Resistant to Experimental Bullous Pemphigoid
P. Hu, H. Xiao,* M. Lin, D. Rubenstein, E. O'Keefe, J. Jennette, L. Diaz, and Z. Liu
Dermatology, University of North Carolina, Chapel Hill, North Carolina; *Pathology, University of North
Carolina, Chapel Hill, North Carolina
Subepidermal blistering in experimental Bullous pemphigoid (BP) is triggered by anti-BP180
antibodies and depends on complement activation, mast cell degranulation, and neutrophil
in®ltration. We have recently shown that mice de®cient in gelatinase B (GB) and neutrophil
elastase (NE) are resistant to experimental BP. Our further studies reveal that gelatinase B
contributes to tissue damage indirectly by proteolytically inactivating a1-proteinase inhibitor (a1-
PI) to release neutrophil elastase, which directly causes tissue injury in experimental BP. Since
reactive oxygen species (ROS) generated through myeloperoxidase (MPO) pathway also can
inactivate a1-PI in vitro, in this study we investigated the role of ROS in experimental BP using
mice lacking MPO. Pathogenic anti-BP180 IgG induced subepidermal blisters in wild-type mice
but not MPO-de®cient mice. Further, intradermal injection of the MPO inhibitor or scavenger
abolished blistering in wild-type mice triggered by pathogenic IgG. Western blot assay reveals
signi®cantly higher levels of a1-PI in the skin of MPO-de®cient mice than wild-type controls at
the IgG-injected sites. These results suggest that ROS, in concert with gelatinase B, inactivate a1-
PI and the unchecked NE damages tissue at the dermal-epidermal junction in BP.
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BP180 (BPAG2) is a Neutrophil Chemoattractant In Vitro and In Vivo After Proteolysis
by Neutrophil Elastase
Z. Liu, T. Betsuyaku,* D. Rubenstein, L. Diaz, and R. Senior*
Dermatology, University of North Carolina, Chapel Hill, North Carolina; *Pulmonary and Critical Care
Medicine, Washington University Medical Center, St. Louis, Missouri
Bullous pemphigoid (BP) is an autoimmune disease characterized by subepidermal blisters and
autoantibodies against two hemidesmosomal proteins, BP230 (BPAG1) and BP180 (BPAG2).
Passive transfer of anti-BP180 IgG into neonatal mice induces BP-like lesions by complement
activation and neutrophil (PMN) in®ltration. We have recently shown that neutrophil elastase,
gelatinase B and a1-proteinase inhibitor (a1-PI) are key mediators involved in BP blister
formation. The purpose of this study was to search for additional PMN chemotactic factors that
may be relevant in modulating the lesions of BP. We tested whether NE-derived fragments of
BP180 recruit in¯ammatory cells. Recombinant murine BP180 (mBP180ABC) was digested by
NE and the proteolytic fragments (mBP180±18 kDa, mBP180±15 kDa, and mBP180±9 kDa) were
puri®ed and assayed for PMN chemotactic activity in vitro using a modi®ed-Boyden chamber and
murine PMN. Pro-in¯ammatory activity in vivo was tested by subcutaneous injection of these
BP180 fragments into mice. Biopsies of the injection site at different time points were evaluated.
PMN showed chemotaxis to mBP180±15 kDa at the peak response at 10(±7) M, which exceeded
the maximum response to the positive control, fMLP at 10(±4) M. Fragments mBP180±18 kDa
and mBP180±9 kDa showed no chemotactic activity. Likewise, injected mBP180±15 kDa induced
an early PMN in®ltrate and a late eosinophilic in®ltrate of the injected sites. Fragments mBP180±
18 kDa and mBP180±9 kDa did not elicit in¯ammation in vivo. These results indicate that cleavage
of BP-180 by NE releases BP180 peptides that are strongly chemotactic of PMNs and suggest that
in¯ammatory injury in BP may result in part, by release of proin¯ammatory factors derived from
hemidesmosomal proteins.
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Regulation of Tissue Factor in Dermal Endothelial Cells
F. O'reilly, K. Casper, S. Koo, and R. Swerlick
University, Dermatology, Emory Atlanta, Georgia
In¯ammation is accompanied by activation of the coagulation cascade, manifested by thrombosis
and ®brin generation. While endothelial cells normally provide a nonthrombogenic surface,
in¯ammatory mediators may induce the expression of tissue factor (TF), rendering their surface
thrombogenic. In order to de®ne the mechanisms regulating the expression of TF in the skin
microvasculature, we examined TF expression in human dermal microvascular endothelial cells
(HDMEC). Quiescent HDMEC did not constitutively express TF protein or mRNA, but could
be induced to express TF by treatment with TNF, IL-1, LPS, or PMA. Treatment with serum
induced modest expression of TF and augmented TNF-mediated TF induction. In order to de®ne
the pathways mediating TF induction, we examined the effects of MG-132, an inhibitor of NF-kB
activation, and SB203580 an inhibitor of p38/JNK activation. Despite an almost complete
inhibition of TNF-induced E-selectin expression, pretreatment with MG132 only partially
blocked TNF-induced TF induction. In contrast, SB203580 almost completely inhibited TNF-
induced TF expression but only partially inhibited TNF-mediated E-selectin induction. Neither
MG-132 nor SB203580 inhibited serum-induced TF expression. These data suggest mediators that
induce TF in HDMEC may utilize multiple pathways and that serum induction of TF occurs via
an NF-kB, p38/JNK independent pathway. In order to de®ne the potential mediators in serum,
we examined the effects of the platelet derived growth factors PDGF and basic FGF as well as the
lipid mediator sphingosine-1 phosphate (S1P). S1P-induced dose-dependent increases in TF
expression, while PDGF and bFGF had no effect, suggesting the serum effects on TF expression
may be mediated in part by this platelet-derived lipid. In conclusion, these data suggest that
interaction between pro-in¯ammatory cytokines and platelet-derived lipid mediators may play a
role in the expression of TF in the dermal vasculature.
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Fibrinogen Derivatives Control a Novel Pathway of Transendothelial Leukocyte Traf®c
Y. Miyazaki, K. Kunstfeld, K. Wolff, and P. Petzelbauer
Department of Dermatology, Division of General Dermatology, University of Vienna Medical School,
Vienna, Austria
The conversion of ®brinogen into its biologically active derivatives is tightly regulated and usually
limited to certain segments of the vascular bed. It occurs through proteolytic cleavage of
®brinopeptides by, e.g. thrombin or urokinase-type plasminogen activator (uPA), resulting in the
exposure of a neo N-terminus of the Aa- and/or Bb-chains of ®brinogen. To analyze a putative
role of these neo N-termini in in¯ammation, we used a truncated form of ®brinogen called N-
terminal disul®de knot of ®brinogen (NDSK), which is unable to polymerize and created by
cyanobromide digestion. To quantify in¯ammation, we employed two models, ®rst SCID mice
engrafted with human skin and human lymphocytes, second an in vitro transmigration assay. We
show that thrombin-treated NDSK (lacking ®brinopeptides A and B) caused vigorous
transmigration of monocytes and lymphocytes across endothelial barriers. Transmigration
depended on the interaction of the neo N-terminus of the Bb-chain of ®brinogen with
endothelial VE-cadherin and was blocked by peptide Bb15±42. Monocytes use CD11c to attach to
the neo N-terminus of the Aa-chain. In contrast to monocytes, lymphocyte transmigration was
independent from cleavage of ®brinopeptide A. It was thus not blocked by peptide Aa17±19 and
also functioned with uPA-treated NDSK (lacking ®brinopeptide B only). In conclusion, we
describe selective functions of two different proteolytic ®brinogen derivatives in monocyte and
lymphocyte transmigration. By bridging leukocytes with the junctional protein VE-cadherin, they
mimic PECAM-1-like functions.
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Different Interaction of Mast Cells with Human Endothelial Cells and Fibroblasts
T. Ohtsuka, A.Yamakage, and S.Yamazaki
Dermatology, Dokkyo University Sch. of Medicine, Mibu, Japan
In a number of chronic in¯ammatory conditions resulting into ®brosis, perivascular mononuclear
cell in®ltration including mast cells (MC) have been shown before the onset of vascular injury and
interstitial ®brosis. These observations suggest a role for MC to induce endothelial cell (EC) injury
and ®broblast (FB) proliferation and collagen synthesis. In view of these observations, the
interactions of MC to EC and FB were studied. MC adhesion to EC and FB showed time-
dependent increase reaching plateau at 1 and 3 h, respectively. Added MC, the proliferation of EC
showed dose dependent decrease, but that of FB dose dependent increase. MC, MC supernatant
and sonicated MC induced dose dependent cytotoxic activity to EC, which cytotoxicity was
inhibited by trypsin inhibitor. FB cocultured with MC showed 9.95 times collagen synthesis and
11.0 times protein synthesis compared with FB without MC. These results showed that (1) MC
attached to EC, inhibited the proliferation by cytotoxic activity to EC, which was due to a kind of
proteolytic enzyme involving trypsin, (2) MC had proliferative and collagen synthetic activity to
FB. These results suggest a possible role of MC to participate in a number of chronic in¯ammatory
diseases resulting into vascular injury and interstitial ®brosis.
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Activated Macrophages Express Scavenger Receptors in Skin of Mice with
Sclerodermatous Graft vs. Host Disease, a Model for Human Scleroderma
S. Desai, L. McCormick, Y. Zhang, and A. Gilliam
Department of Derm., University Hosp Research Institute and Case Western Reserve University, Cleveland,
Ohio
Murine sclerodermatous graft vs. host disease (Scl GVHD) is a model for human scleroderma in
which skin thickening, lung ®brosis, and cutaneous TGF-b1 and collagen mRNA up-regulation
occur by day 21 post bone marrow transplantation (BMT). Skin ®brosis, detectable by day 14 post-
BMT in Scl GVHD, may be monocyte/macrophage (Mo/Mph) driven as these are the
predominant and earliest cells in cutaneous in¯ammation. We characterized cutaneous immune
cells in murine Scl GVHD and examined their activation status. We produced Scl GVHD by
transplanting lethally irradiated female BALB/c mice (H-2d) with bone marrow and spleen cells
from male B10.D2 mice (H-2d). Syngeneic transplanted BALB/c mice do not develop disease. A
signi®cant decrease in the numbers of intact mast cells in sections of Scl GVHD skin from days 7±
21 re¯ects early activation and degranulation of mast cells, previously shown by others in GVHD
and scleroderma. By FACS analysis of dermal cell suspensions and by immunostaining, cutaneous
CD11b+ cell in®ltrates-primarily Mo/Mphs-predominate over T cells on days 14 and 21. PCR
analysis of Y chromosome sequences on DNA extracted from female Scl GVHD mice suggest that
in®ltrating cells are of male donor origin. Activation markers I-Ad (MHC class II alloantigen),
CD11b, and 2F8 and Marco macrophage scavenger receptors are up-regulated 3±6-fold in Scl
GVHD vs. controls, suggesting that in early ®brosing disease, macrophages in skin are activated and
may actively present antigens. Mice were given 2 doses of 150 mg of neutralizing antipan TGF-b
Abs or control rabbit IgG intravenously on days 1 and 6 post-BMT. Abs to TGF-b prevent
macrophage in¯ux as well as up-regulation of macrophage activation markers 2F8 and I-A, and
abrogate skin thickening. Therefore, activated macrophages may be a potential target for therapy of
scleroderma and other ®brosing disorders.
320
Cutaneous TGF-b and C-C Chemokines in Murine Sclerodermatous Graft vs. Host
Disease (Scl GVHD), a Model for Human Scleroderma
Y. Zhang, L. McCormick, S. Desai, C. Wu, and A. Gilliam
Department of Derm., University Hosp. Research Institute and Case Western Reserve University, Cleveland,
Ohio
Murine Scl GVHD is a model for human scleroderma, with skin thickening, lung ®brosis, and up-
regulation of cutaneous TGF-b1 and type I collagen mRNAs occurring by day 21 post bone
marrow transplantation (BMT). Fibrosis in Scl GVHD may be driven by in®ltrating TGF-b1-
producing monocyte/macrophages (Mo/Mph) and T cells, and their recruitment may be C-C
chemokine potentiated. We characterized the cutaneous chemokine environment, in®ltrating
immune cell types, and the ef®cacy of anti-TGF-b Ab in preventing skin thickening in the model.
We produced Scl GVHD by transplanting lethally irradiated BALB/c (H-2d) mice with B10.D2
(H-2d) bone marrow and spleen cells. Syngeneic transplanted BALB/c mice served as controls.
Mice were administered 2 doses of 150 mg of antipan TGF-b Abs or control rabbit IgG on days 1
and 6 post-BMT. Skin thickening is detectable by day 14, and skin is more than 40% thicker by
day 21 in Scl GVHD but not control animals. C-C chemokines MCP-1, MIP-1a, and RANTES
mRNAs are elevated in Scl GVHD vs. control mice by day 7 and remain elevated throughout the
early disease process. By FACS analysis, on day 14 cutaneous CD11b+ cell in®ltrates are primarily
Mo/Mphs that are increased 4-fold (15±30% of total skin cells). CD3+ T cells are increased more
than 4-fold (5±8% of total skin cells). By RT/PCR analysis, Mo/Mphs are the main cutaneous
cells producing increased TGF-b1 but not -b2 or -b3. Most importantly, we demonstrate that Abs
to TGF-b prevent Scl GVHD by effectively blocking the in¯ux of Mo/Mphs and T cells into skin,
and by abrogating up-regulation of TGF-b1, thereby preventing collagen synthesis. Therefore,
TGF-b1-producing mononuclear cells may be critical effector cells, and C-C chemokines may
play important roles in early Scl GVHD. The Scl GVHD model is useful for testing new
interventions in early ®brosing diseases, and chemokines may be new potential targets for
treatment of scleroderma.
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Nerve Growth Factor Receptor Inhibitor, K252a Improves Psoriasis: Role of NGF and
its Receptor System in Psoriasis
S. Raychaudhuri, S. Raychaudhuri, and E. Farber
Psoriasis Research Institute, Palo Alto, California
The peripheral nervous system, in addition to sensory and motor functions can regulate an
in¯ammatory response. The role of neurogenic in¯ammation in the pathogenesis of several
in¯ammatory diseases such as psoriasis, asthma, rheumatoid arthritis, ulcerative colitis, and atopic
dermatitis is currently an active ®eld of study. Nerve growth factor (NGF) and its receptor (NGF-
R) have been extensively studied in psoriasis. Increased levels of NGF in the keratinocytes and up-
regulation of NGF-R in the cutaneous nerves of psoriatic plaques have been documented by
several studies. Certain unique features of psoriasis substantiates an important role of NGF and its
receptor system in its pathogenesis: hyperproliferation of terminal cutaneous nerves, up-regulation
of neuropeptides, and resolution of active lesions of psoriasis at sites of anesthesia. In this double-
blinded, placebo controlled study, we addressed the role of NGF/NGF-R system in the
pathogenesis of psoriasis in an in vivo system using the severe combined immunode®cient (SCID)
mouse model of psoriasis. The 12 transplanted psoriatic plaques on the SCID mice were treated
with K252a, a high af®nity NGF receptor blocker. Complete resolution of psoriasis was observed
after completion of intralesional therapy with K252a at a dose of 100 microgram per kg per day for
two weeks. The length of the rete pegs changed from 308.57 6 138.72 mm to 164.64 6 64.78 mm
(p < 0.01, student t-test). In the eight controls (normal saline recipients) the rete peg lengths before
and after therapy were 269.37 6 57.78 and 209.37 6 74.00 (p > 0.1, student t test). HLA-DR
positive lymphocytic in®ltrates and intraepidermal CD8 positive lymphocytes were signi®cantly
reduced in the plaques treated with K252a. We also demonstrated that K252a inhibited NGF
induced mRNA and protein levels of RANTES, IFN-g and TNF-a involved in the pathogenesis
of psoriasis. This study yields direct evidence for the role of NGF/NGF-R system in the
pathogenesis of psoriasis and provides insights to develop novel therapies.
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CD80/86 Antisense Oligonucleotide Therapy Improves Psoriasis: Study in the SCID
Mouse Model
S. Raychaudhuri, S. Raychaudhuri, C. Bennett,* J. Karras,* R. Mehta,* A. Chatterjee, and E.
Farber
Psoriasis Research Institute, Psoriasis Research Institute, Palo Alto, California; *ISIS Pharmaceutical Inc.,
ISIS Pharmaceutical Inc., Carlsbad, United States
Co-stimulatory molecules are essential for the activation of the T cells to its full potential. Up-
regulation of B7-1 (CD80) and B7-2 (CD86) by the dendritic cells in psoriatic lesions suggests a
critical role for the CD28/B7 costimulatory system in the pathogenesis of psoriasis. Thus,
inhibition of the CD28/B7(CD-80,86) pathway may restrict the in¯ammatory processes of
psoriasis. In this study we used selective antisense oligonucleotides against human CD-80,86
mRNA. Transplanted psoriasis plaques on the SCID mice (n = 6) were treated with a cream
preparation consisting of 2.5% of each antisense oligonucleotide. Both oligos were 2¢-O-
methoxyethyl-modi®ed 20 mers with phosphorothioate backbones. The plaques from same
patients were transplanted on the control mice (n = 6) and treated only with the vehicle of the
active cream preparation. Both groups received the topical preparation twice a day for 4 weeks.
Signi®cant histological improvement marked by reduction of hyperkeratosis, acanthosis and
lymphomononuclear cellular in®ltrates was observed in the mice treated with CD80/CD86
antisense oligonucleotide cream. In the mice treated with the active agent the rete pegs changed
from 238.56 6 98.3 mm to 168.4 6 96.62 mm (p < 0.05); whereas in the control group the rete pegs
before and after treatment were 279.93 6 40.56 mm and 294.65 6 45.64 mm, respectively (p0.1).
HLA-DR positive lymphocytic in®ltrates and intraepidermal CD8 positive lymphocytes were
signi®cantly reduced in the transplanted plaques treated with the CD80/CD86 antisense cream.
Here we approached in a unique way to modulate the immune response by targeting the
costimulatory molecules. Results of this study indicate the therapeutic potential of topical antisense
oligonucleotide treatment in psoriasis and other in¯ammatory diseases.
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A K17 Peptide Induces Intracellular IFN-g in Lymphocytes from Psoriasis Vulgaris
Patients
Young, E. Shyong, H. Wei, M. Lebwohl, and L. Austin
Dermatology, Mount Sinai School of Medicine, New York, New York
Interferon-g (IFN-g) is one of several major regulatory cytokines implicated in lesion formation in
patients with psoriasis, an autoimmune skin disorder. Recently, short regions of keratins were
reported to induce IFN-g in circulating T cells in higher numbers from psoriatic patients than from
normal volunteers (Gudmundsdottir, Clin Exp Immunol 117:580±586, 1999). We are testing similar
pieces of synthesized keratin (K) peptides (19 AA each) of K17 and K18 on psoriatic patients'
lymphocytes in order to begin quantifying the Type 1 IFN-g vs. Type 2 Interleukin-4 (IL-4)
responses to these keratins. The circulating white blood cells of patients were pulsed for 5 h with
either peptide or ionomycin/12-O-tetradecanoyl-phorbol 13-acetate (PMA) or left unstimulated.
Induction of IFN-g, IL-4, and the early activation marker CD69 was then measured by
intracellular ¯ow cytometry. These measurements were considered positive when they were
greater than unstimulated controls. We found that the K17 peptide induced intracellular IFN-g and
low levels of IL-4 in contrast to an equal concentration of K18 peptide, which failed to induce
either cytokine. Despite the differences in cytokine responses, both keratin peptides could
stimulate CD69 in T cells, although the K17 response was greater than that of K18. These
preliminary experiments provide the basis for designing and evaluating cell-mediated antikeratin
responses in psoriatic patients.
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Tissue Distribution and Subcellular Localization of S100A7, S100A11 and S100A10 in
Normal and Psoriatic Epidermis
A. Broome and R. Eckert
Physiology and Biophysics, and Dermatology and Dermatology, Case Western Reserve Univeristy School of
Medicine, Cleveland, Ohio
S100 proteins are a family of small, acidic, calcium-binding proteins that regulate cell
differentiation, proliferation, and morphology. Calcium binding alters S100 protein structure
and they, in turn, bind to target proteins and regulate signal transduction processes. Eight of these
calcium-activated regulatory proteins are expressed in epidermis, and some may be involved in the
genesis of proliferation-associated skin disease. S100A7, for example, is highly overexpressed in
psoriasis. In addition, selected S100 proteins are known to be components of the keratinocyte
corni®ed envelop (Robinson and Eckert, JBC 273:2721, 1998). However, relatively little is known
about their subcellular distribution or speci®c function during differentiation. Our present studies
are designed to map the subcellular distribution of S100A10, S100A11 and S100A7 in
differentiating normal and psoriatic epidermis. Epidermal sections were paraformaldehyde-®xed
and processed for immunohistochemistry or immunoblot analysis. We show that S100A7 and
S100A11 localize in the basal and spinous layers in both normal and psoriatic epidermis. Moreover,
S100A7 and S100A11 relocate from the cytoplasm, in basal keratinocytes, to the plasma membrane
in differentiated spinous layer cells. S100A10 expression is also restricted to the basal and spinous
layers; however, it is both membrane-associated and cytoplasmic in these cell layers. Compared to
normal tissue, S100A7 expression is markedly elevated in psoriatic epidermis. S100A11 and
S100A10 expression, in contrast, are not changed. S100A10, however, it is less abundant than
S100A7 or S100A11. These ®ndings indicate that S100 proteins translocate to the plasma
membrane during keratinocyte differentiation, suggesting that their ultimate regulatory role is
likely to be accomplished at this location.
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Proteasome Inhibitor PS519 Reduces Superantigen-Mediated T-Cell Activation and
Severity of Psoriasis in a SCID-hu Model
T. Zollner, M. Podda, C. Pien,* P. Elliott,* R. Kaufmann, and W. Boehncke
Department of Dermatology, University of Frankfurt, Frankfurt, Germany; *Millennium Pharmaceutical,
Cambridge, Massachusetts
Psoriasis is a T-cell mediated skin disease characterized by the in®ltration of activated leukocytes
and the presence of a distinct in¯ammatory pattern. Superantigen activation of T-cells plays a
pivotal role in the induction of psoriasis. NFkB is a transcription factor which is involved in the
induction of many pro-in¯ammatory molecules known to be up-regulated in psoriasis. We
therefore addressed the question whether attenuation of NFkB activation by the proteasome
inhibitor PS519 may suppress T-cell mediated responses and may be effective in the treatment of
psoriasis. PBMC of 4 controls were stimulated with the superantigen TSST-1 in the presence of
nontoxic concentrations of PS519 (0±10 mg per ml). We found a dose-dependent inhibition of
lymphocyte proliferation of up to 95% compared to TSST-1 treated cells. Additionally, the
expression of T-cell activation markers such as CD69, CD25 and HLA-DR was markedly reduced
in PS519 treated, TSST-1 stimulated cultures. The effects of PS519 on the severity of psoriasis was
assessed in a xenogenic SCID-hu transplantation model. Lesional psoriatic skin obtained from
different donors was transplanted onto SCID mice. After 28 days, SCID mice were treated once
daily either with PS519 intraperitoneally (20 mg per mouse; n = 8) or with vehicle for 28 days
(n = 4). Thereafter, 20S proteasome activity was determined in the blood and the human
transplanted skin examined by immunohistochemistry. As expected, 20S proteasome activity was
markedly reduced in PS519 treated mice (0.22 6 0.01 [pmol AMC per s per mg protein])
compared to untreated mice (1.53 6 0.05; mean 6 SEM). In PS519 treated grafts, normalization of
epidermal architecture including loss of papillomatosis and marked reduction of akanthosis was
observed. We conclude that the PS519 reduces superantigen mediated T-cell activation in vitro and
shows antipsoriatic ef®cacy in the SCID-hu model.
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Human Dermal Migratory CD14+ Cells Differentiate into Langerhans Cells in the
Presence of GM-CSF, IL-4 and TGFb-1
A. Morelli, A. Larregina, L. Spencer, A. Logar, S. Watkins, A.Thomson, and L. Falo Jr
Departments of Dermatology, Surgery, Physiology, Thomas E. Starzl Transplantation Institute, University
of Pittsburgh Cancer Institute, and the Center for Biological Imaging, University of Pittsburgh School of
Medicine, Pittsburgh, Pennsylvania
Langerhans cells (LC) are skin migratory dendritic cells (DC) that, either constitutively or under
pathological conditions, traf®c to the epidermis where they function as sentinels of the immune
system. Although it has been postulated that LC precursors might represent a resident cell
population in the skin, there are no previous data con®rming this hypothesis. In the present study,
we have isolated and characterized a population of human dermal-resident CD14+ cells that
actively migrate from human epidermal/dermal explants (mCD14+). The morphological
characteristics of different skin migratory cells was determined in cytospins stained with May
GruÈnwald Giemsa and by scanning and transmission electron microscopy. The immune phenotype
of CD14+ and CD14± skin migratory cells was analyzed by ¯ow cytometry. The functional
characteristics of both cell populations were compared in antigen uptake assays and in the
allogeneic mixed leucocyte reactions. Skin migratory CD14+ cells did not adhere to plastic and
demonstrated combined morphologic and immunephenotype characteristics of monocytes and
myeloid DC markers (expression of CD14, CD68 and CD11b together with S-100, Class-I, Class-
II, CD40, CD80 and CD86 molecules, and they lack CD1a, E-cadherin and Birbeck granules
(BG)). Functionally mCD14+ cells showed receptor mediated endocytosis and macropinocytosis
activities, and they were a very weak stimulators of allogeneic naõÈve T cells. After short-term
culture in GM-CSF + IL-4 + TGFb-1, mCD14+ cells acquired ultrastructural features (BG and
multillamelar compartments) and immunophenotype of epidermal LC (E-cadherin+, CD1a+, and
lack of CD14) and they became potent stimulators of allogeneic T cells. Our results show for the
®rst time that skin migratory CD14+ cells constitute a reserve pool of LC precursors in the dermis
that are able to differentiate into epidermal LC in the appropriate cytokine environment.
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Cord Blood CD34+ Cells Differentiate into Dermal Dendritic Cells in Co-Culture with
Cutaneous Fibroblasts
Z. Mollah, H. Manome, Y.Yoshino, H. Tagami, and S. Aiba
Department of Dermatology, Tohoku University School of Medicine, Sendai, Japan
Skin is a unique organ that contains two different subsets of dendritic cells (DCs), i.e. Langerhans
cells (LCs) and dermal DCs. Our hypothesis is that cutaneous ®broblasts may affect the
development of these DCs. We cocultured cord blood CD34+ hematopoietic progenitor cells
(HPC) with several human cutaneous ®broblast cell lines (CFCL) without any exogenous
cytokines for three weeks. In this culture, HPC increased in number from 8.2 6 2.1 times, and
produced aggregates of cells with dendritic processes (n = 12). They were composed of
56.7 6 3.6% HLA-DR + CD14+ CD1a- cells and 12.2 6 3.5% HLA-DR + CD1a+ cells, which
also expressed CD11b and CD11c. Although some of them were Factor XIIIa+, there were no
Lag+ or E-cadherin+ cells. They were potent stimulators in allogeneic T cell activation. There was
a signi®cant difference in the ability to induce CD1a+ cells among different CFCL. TNF-a
induced the maturation of these DCs with augmented expression of CD86. The subsequent
experiment using a dividing chamber suggested a crucial role of direct contact between HPC and
CFCL in their growth and differentiation. The study using anti-GM-CSF antibody denied the role
of GM-CSF secreted from CFCL in this culture system. Finally, we found that, using the culture
system that preferentially stimulated the differentiation of HPC into LC, the coculture with CFCL
deviated their differentiation from CD1a + E-cad + Lag + LCs into CD1a + factor XIIIa + E-cad-
Lag- dermal DCs. These data suggest that cutaneous ®broblasts support the differentiation of
dermal DCs in addition to that of monocytes from HPC.
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Toll-Like Receptor is Differentially Expressed by Murine Langerhans Cells and Splenic
Dendritic Cells
H. Mitsui, H. Torii, A. Asahina, Y. Tada, K. Nakamura, and K. Tamaki
Dermatology, University of Tokyo, Tokyo, Japan
Toll like-receptors (TLRs) are recently discovered surface molecules through which the signaling
of bacterial components, such as lipopolysaccharide (LPS) is mediated. Among nine subtypes of
TLRs identi®ed so far, TLR2 and TLR4 seem to be of particular importance in LPS signaling.
C3H/HeN and C3H/HeJ mice are good and poor responder to LPS, respectively, and C3H/HeJ
has the point mutation in TLR4. Langerhans cells (LC) are immature dendritic cells (DC) residing
in the epidermis. The expression of TLR2 and TLR4 by murine LC and splenic DC was
investigated. The C3H/HeN LC were enriched by panning method using anti I-Ak antibody
(~95% purity assessed by ¯owcytometry). The splenic DC were obtained through the positive
selection by CD11c. The mRNA for TLR2 and TLR4 was detected in both LC and splenic DC
assessed by RT-PCR. However, the ¯owcytometry using the antisera to TLR4 revealed the
TLR4 expression was very weak in LC while it was highly positive in splenic DC. CD14 was
negative in LC and positive in splenic DC. The production of IL-6 from C3H/HeN DC was
highly increased (92.66 6 10.50 pg per ml vs. 271.12 6 79.40 pg per ml, p < 0.05) by 1 mg per ml
LPS. However, that from C3H/HeN LC was not increased (58.96 6 35.17 vs. 54.17 6 5.92, not
signi®cant) by LPS alone. But, by the combination of 20 mg per ml CD40 ligand, 100 ng per ml
IFN-g and 1 ng per ml TGF-b, the production of IL-6 from C3H/HeN LC was increased
(58.96 6 35.17 vs. 142.71 6 7.89, p < 0.05), and the simultaneous addition of 1 mg per ml LPS to
this combination further augmented IL-6 production (142.71 6 7.89 vs. 246.88 6 27.54, p
< 0.05). On the other hand, no signi®cant augmentation was found in C3H/HeJ LC
(87.63 6 22.01 vs. 75.538 6 22.12, NS) by the additional LPS, indicating this LPS signaling was
mediated through TLR4. The similar augmentative and unchanged tendency was found in C3H/
HeN and HeJ DC, respectively. Our results veri®ed the expression of TLR4 by murine LC and
splenic DC. The difference in the responsiveness to LPS between LC and splenic DC was
consistent to the deviated expression of TLR4, together with CD14, between these two DC
populations, suggesting the heterogeneity in the TLR expression among the murine DC.
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Increased Expression of Stat4 mRNA and Protein by Activated Murine Skin Dendritic
Cells
J. Lenczowski, M. Wilson, and M. Udey
Dermatology Branch, NCI, NIH, Bethesda, Maryland
Activation of immature dendritic cells (DC), like epidermal Langerhans cells (LC), by microbial
components transforms them from antigen acquiring cells into potent accessory cells that can
induce primary responses in naõÈve T cells and shape T cell mediated immunity. mRNA pro®ling
using arrays of known and/or incompletely characterized cDNAs may lead to insight into
regulation of DC activation. We puri®ed mRNA from murine fetal skin-derived DC (FSDDC),
cells that accurately model LC, before and 24 h after exposure to E. coli LPS (100 ng per ml), and
relative levels of approximately 9400 transcripts were determined by hybridization to a commercial
mouse cDNA array (Incyte Genomics). mRNA encoding Stat4 was one transcript that was
dramatically elevated in activated DC. To con®rm this, we used real-time quantitative RT-PCR
and measured up to 80-fold induction of Stat4 mRNA following LPS stimulation of FSDDC.
Western blotting revealed that up-regulation of Stat4 mRNA was accompanied by protein
expression. Stat4 mRNA was also detected in LC that matured in culture, as well as in epidermal
cells prepared from LPS (50 ng) injected murine ear skin. Concordant reduction of I-A alpha chain
and Stat4 mRNAs in suspensions depleted of MCH Class II + cells using magnetic beads indicated
that LPS induced Stat4 mRNA expression in LC. Stat4 is essential for IL-12-dependent IFNg
production by T cells, and murine splenic DC have been reported to produce this important T cell
regulatory cytokine. However, using identical stimuli and RT-PCR or ELISA, we failed to detect
IFNg mRNA or protein production by murine skin DC (FSDDC and LC). In addition, initial
experiments have not revealed surface phenotypic differences between LC from wild type and
STAT4 knockout mice, and STAT4 knockout and wild type LC induce allogeneic T cell
proliferative responses of comparable magnitudes. Thus, although it is intriguing that Stat4 is
induced in activated skin DC, the functional relevance of this observation remains to be
determined.
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Study of MHC Class II±Autoantigen Interactions by Confocal Microscopy
K. Paley, C. Willis, A. Moesta, and A. Sinha
Dermatology, Weill Medical College of Cornell University, New York, New York
The characterization of the route and location of autoantigen interactions with disease
susceptibility class II molecules at the molecular level will help to de®ne the nature of genetic
susceptibility and elucidate the early mechanisms of autoimmune induction in diseases such as
pemphigus vulgaris (PV). Confocal microscopy allows three-dimensional, real-time imaging of
dynamic cell processes. We have transfected the human melanoma cell line Mel JuSo (which
express DRA1*0101 constitutively) with the PV associated MHC class II DRB1*0402 that has
been coupled to enhanced green ¯uorescent protein (EGFP). We have used ¯uorescent techniques
to visualize DRB1*0402 intracellularly and at the cell surface in Mel JuSo cells. We have also
shown Mel JuSo cells to have active endocytic uptake, utilizing a cyanine 3-transferrin conjugate to
visualize the endocytic pathway. Furthermore, we have coupled tetramethylrhodamine to the
amino terminus of desmoglein 3 (Dsg3) 190±204 peptide (Dsg3190±204 has been previously
reported as a putative autoantigenic epitope in PV). We are coculturing DRB1*0402-EGFP
expressing Mel JuSo cells with the tetramethylrhodamine-Dsg3190±204 conjugate to track the
intracellular interactions of class II molecules with autoantigens by 2 color confocal analysis. The
intracellular location of MHC class II±peptide interaction is being studied by three color analysis
using a panel of cyanine 5-conjugated antibodies directed against markers for speci®c subcellular
compartments. Confocal microscopy offers an innovative platform to systematically study the
interaction of a speci®c autoantigen with known class II susceptibility molecules at the intracellular
level. By investigating the intracellular locations and biochemical parameters required for
autoantigen interaction with disease susceptibility class II molecules, we seek to strengthen our
understanding of MHC-peptide±T cell interactions in autoimmunity and further our goal of
developing viable immunotherapeutic strategies.
332
Expression and Function of Adenosine-Receptors in Human Dendritic Cells
E. Panther, M. Idzko, D. Purlis, and J. Norgauer
Experimentelle Dermatologie, UniversitaÈts Hautklink, Freiburg, Germany
Dendritic cells (DCs) are specialized antigen presenting cells characterized by their ability to
migrate into target sites, process antigens and activate naive T cells. Here, the biological activity
and intracellular signaling of adenosine was analyzed. Using RT-PCR analyses, mRNA-expression
of the adenosine-receptors A1, A2a and A3 in immature human DCs was revealed. Functional
experiments after adenosine-stimulation showed chemotaxis, intracellular calcium transients and
actin polymerization, but no activation of adenylyl-cyclase in immature DCs. Studies with selective
receptor agonists indicated that chemotaxis, calcium transients and actin polymerization were
mediated via A1- and A3-receptors. Maturation of the DCs induced by LPS resulted in down-
regulation of the A1- and A3- receptor mRNA, while the A2a-receptor mRNA was still
expressed. Yet, in LPS-differentiated DCs adenosine and the A2a-receptor agonist stimulated
adenylyl-cyclase activity, enhanced intracellular cAMP levels and inhibited IL-12 production. In
contrast, adenosine and the selective A1- and A3-agonist failed to induce chemotaxis, actin
polymerization and calcium transients in LPS-differentiated DCs. This ®ndings indicate that
adenosine has important biological effects in DCs activity as chemotaxin towards immature DCs
and modulating IL-12 production in mature DCs.
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Particulate Antigen Delivery Reveals Functional Differences Between In Vivo Generated
Myeloid and Lymphoid Dendritic Cells
Y. He, J. Nayak, M. Robb, J. Plowey, and L. Falo Jr
Department of Dermatology, University of Pittsburgh Cancer Institute, University of Pittsburgh School of
Medicine, Pittsburgh, Pennsylvania
CD8+ lymphoid (LDC) and CD8-myeloid (MDC) splenic DC populations are hypothesized to
have distinct roles in eliciting tolerogenic and stimulatory effects, respectively, on the immune
response, although direct in vitro or in vivo functional evidence for these effects has not been clearly
established. In this study, we systematically compared the uptake, processing, and presentation of
particulate antigens between LDC and MDC in vitro and in vivo. Signi®cant differences between
LDCs and MDCs are observed both in vitro and in vivo when examining phagocytosis of particulate
latex microsphere antigens using a quantitative cyto¯uorometric approach. While LDCs were
found to be de®cient in the capacity to capture particulates irrespective of their maturation status,
we were surprised to discover that both phenotypically immature and mature MDCs could
internalize particulate antigens in an inhibitable fashion. Class I-restricted OT-I T cell proliferation
and class II-restricted DO.11 cell stimulation assays demonstrated that intracellular proteolytic
processing and presentation of antigen-loaded particles is found only in MDCs. Finally, we
demonstrated that difference in particulate antigen uptake and presentation of LDCs and MDCs
was retained in unperturbed splenic DC populations in vivo. Our data suggest that the speci®c role
of bystander LDCs in immunologic priming or tolerance induction remains in question, while
MDCs may directly participate the initiation of antigen-speci®c immunity by internalizing and
processing blood-borne antigens, speci®cally particulates, in vivo.
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The Langerhans/Dendritic Cell-Associated Protein, 3C5, Structurally Resembles
Subunit d of the Vacuolar-ATPase Complex, but is Functionally Distinct
K. Ariizumi, S. Shikano, A. Das, P. Perlman, and P. Cruz
The Departments of Dermatology and Molecular Biology, The University of Texas South-western Medical
Center, Dallas, Texas
For ef®cient presentation to T cells, protein antigens (Ag) have to be processed by Ag presenting
cells (APC) within acidic vacuolar compartments fueled by the proton pump activity of vacuolar
(V)-ATPase complexes that are, in turn, made up of multiple subunits including subunit d. By
subtractive cloning, we recently identi®ed a novel protein (3C5) expressed selectively by mouse
Langerhans cells (LC) and dendritic cells (DC). 3C5 shares 67% sequence homology with mouse
subunit d (msd). In addition, 3C5 transfected into COS cells augments the activity of V-ATPase
complexes. To better characterize 3C5 function, we took advantage of a yeast strain (Vma6D) that
lacks the VMA6 gene, rendering Vma6D unable to grow in media with neutral pH or with
glycerol. We asked whether 3C5 or msd can substitute functionally for the VMA6 gene, allowing
Vma6D cells to grow in media of neutral pH or containing glycerol. msd-transformed Vma6D cells
grew as vigorously as the wild type, whereas 3C5-transformed Vma6D cells failed to grow (just like
Vma6D alone). To account for this failure, we measured 3C5 protein expression and assembly of
V-ATPase complexes in these transformed cells. 3C5-transformants exhibited high levels of C35
protein. However, they produced very low levels of assembled V-ATPase complex proteins,
whereas msd-transformants and wild type cells displayed high levels. Thus, although 3C5 resembles
msd structurally, it is functionally distinct. Finally, we hypothesize that 3C5 in LC and DC is a
regulator of V-ATPase complex activity (rather than a subunit of the V-ATPase complex) in these
cells, thus contributing to their potent APC capacity.
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Histamine Receptor on Human Dendritic Cells: Identi®cation and Coupling to
Chemotaxis and Cytokine Release
J. Norgauer, M. Idzko, A. La Sala,* D. Ferrari,² E. Panther, G. Girolomoni,* F. Di Virgilio, and S.
Dichmann
Experimentelle Dermatologie, UniversitaÈts Hautklink, Freiburg, Germany; *Laboratory of Immunology,
Instituto Dermopatico dell'Immacolata, Roma, Italy; ²Experimental and Diagnostic Medicine, University of
Ferrara, Ferrara, Italy
Histamine, is a well-known in¯ammotry mediator, which has been implicated in varoius
immunoregulatory effects that are poorly understood. Thus, we investigated the biological activity
and intracellular signaling of the histamine on Dendritic cells (DCs), which are specialized antigen
presenting cells characterized by their ability to migrate into target sites, process antigens and
activate naive T cells. Here we could show by using RT-PCR that immature and matured human
DCs express the spezi®c mRNA of the H1-, H2- and H3- histamine-receptors. Functional
experiments after histamine-stimulation showed chemotaxis, intracellular calcium transients and
actin polymerization, but no activation of adenylyl-cyclase and cytocine production in immature
DCs. Studies with receptor selective agonists indicated that activation of all 3 receptor subtypes
induced calcium transients. In contrast actin polymerization and chemotaxis were mediated via
H1- and H3-receptors, while the activation of the H2-receptor with Dimaprit even resultes in a
inhibition of migration of immatured DCs. Maturation of the DCs induced by LPS resultes in the
loss of histamine induced cell responses chemotaxis, actin polymerization and calcium transients.
Whereas now histamine dose-dependently enhanced intracellular cAMP levels and IL-10-
production while it inhibited IL-12 and TNFa secretion. Stimulation with the different receptor-
agonists showed, that the modulation of IL-12 and IL-10 production by histmaine were mediated
through the H2- and H3-receptor. In contrast all three receptor subtypes seemed to be invovled in
the inhibition of TNFa production. This ®ndings indicate that histamine has important biological
effects in DCs activity as chemotaxin towards immature DCs and modulating IL-10, IL-12 and
TNFa production in mature DCs.
336
A Mouse Model of Allergic Asthma Induced by Adoptive Transfer of Antigen-Pulsed
Dendritic Cells
S. Graf®, G. Stingl, and M. Epstein
Vienna International Research Cooperation Center/DIAID, Department of Dermatology, Vienna University
Medical School, Vienna, Austria
Though allergen-speci®c Th2 cells play a central role in the pathogenesis of allergic asthma, the
mechanism leading to Th2 cell priming remains unknown. While dendritic cells (DC) are the most
potent type of antigen presenting cells capable of inducing Th1 immune responses, it is not clear
whether they play a role in the generation of Th2 responses. To determine whether DC can
induce dominant Th2 cell responses, we chose to study the role of DC in the initiation of mouse
allergic asthma. We injected naive C57Bl/6 syngeneic mice ip. with OVA-pulsed wild type DC,
MHC class II±/± DC or irradiated RMA tumor cells on day 0, followed by aerosolized OVA 7 and
14 days later. The DC-enriched spleen cell populations consisted of 60±90% CD11c+ cells with
high expression of costimulatory and adhesion molecules. Only 5% of this population was CD8a+
suggesting cells of predominantly myeloid origin. Functional analysis of these DC in vitro revealed
that puri®ed OVA-pulsed wild type DC stimulated OVA-speci®c CD4+ BO-97.11 T hybridoma
cells to produce IL-2 compared with unpulsed DC. Upon adoptive transfer of OVA-pulsed wild
type DC, we observed lung eosinophilia (60%) 48 h after the last aerosol challenge. In addition,
OVA-speci®c serum IgE and IgG1 levels were elevated in these mice. No response was induced by
unpulsed cells or OVA-pulsed RMA tumor cells. Sensitizing with OVA-pulsed MHC class II±/±
DC led to increased numbers of lung in®ltrating lymphocytes similar to wild type DC but without
induction of eosinophilia and lower levels of IgE and IgG1. These results suggest that dendritic
cells are involved in the induction of Th2-mediated immune responses and may be an interesting
target for therapeutic strategies aiming at interfering with atopic tissue in¯ammation.
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Restraint-Induced Modi®cation of Langerhans Cell Morphology and Migration in
BALB/c Mice is Dependent Upon Timing of Restraint
M. Flint, B. Abrigo, and S. Tinkle
TMBB, NIOSH-CDC, Morgantown, West Virginia
The timing of a stressful event with respect to antigen exposure affects the development of the
immune response. We have reported that restraint applied to a naive mouse prior to sensitization
(day 1) decreased chemical-induced changes in ear swelling and lymphocytosis and restraint applied
during sensitization (days 1 and 2) or prior to challenge (day 6), increased ear swelling. We
hypothesized that these dichotomous effects of restraint would be re¯ected in changes in
Langerhans cell (LC) migration and morphology. To compare the effects of restraint on LC in
naive and DNFB-treated mice, we sensitized mice onto the back with 0.5% DNFB on days 1 and 2
and challenged onto the ears with 0.25% DNFB on day 6. Mice were restrained for 2 h
immediately prior to chemical application on day 1 or on day 6 prior to challenge. LC morphology
and migration were examined in epidermal sheets by counting the number of FITC-conjugated Ia
stained cells per mm2 at 24 h after DNFB-challenge. To assess the effect of restraint on T cell
proliferation in vivo, 24 h following challenge, T lymphocyte proliferation was examined using the
local lymph node assay. We determined that DNFB induced a signi®cant reduction in the number
of epidermal LC at 24 h. Restraint on day 1 resulted in the retention of LC in the epidermis and
the LC had longer dendritic processes than nonrestrained mice. However, LC from mice restrained
on day 6 demonstrated a dendritic cell like-morphology similar to nonrestrained mice but showed
a signi®cant reduction in epidermal LC numbers 24 h after DNFB challenge. Furthermore, we
demonstrated a signi®cant two-fold decrease in T cell proliferation in mice restrained on day 1 and
an elevation of T cell proliferation in mice restrained on day 6. These data suggest that acute
restraint stress applied prior to sensitization modulates epidermal LC morphology and migration
and T cell proliferation differently than restraint applied prior to challenge.
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Intact Lymphoid Structure and Germinal Center Formation are Not Crucial for
Mounting an Antigen Speci®c Humoral Response in CD18 Null Mice
K. Scharffetter-Kochanek, T. Peters, W. Bloch,* C. Wickenhauser,² C. Leuker,³ S. Tawadros, D.
Kess, R. Hinrichs, T. Krieg, and W. Muller
Dermatology and Venerology, University of Cologne, Cologne, Germany; *Anatomy, University of Cologne,
Cologne, Germany; ²Pathology, University of Cologne, Cologne, Germany; ³Genetics, University of
Cologne, Cologne, Germany
b-2 integrins play a central role in host defence and if speci®cally mutated lead to a disorder known
as leukocyte adhesion de®ciency 1 (LAD1) in humans. Mice with a CD18 null mutation suffer
from recurrent bacterial infections, impaired wound healing and skin ulcers closely resembling
human LAD1. We here report on the impact of CD18 de®ciency on the organization of lymphoid
tissue, B cell differentiation, germinal center formation and T-dependent B cell response. CD18
de®cient and wildtype (wt) control mice were immunized with the T-dependent antigen
nitrophenylacetate (NP) chicken gammaglobulin to analyze NP hapten-speci®c antibody
production. All animals were re-injected with the soluble antigen at day 34 to further study the
secondary immune response. The detection of serum NP-speci®c antibodies showed only a slightly
retarded and decreased primary response in in CD18 null mice, whereas class switch and af®nity
maturation occurred as in wt mice. In the secondary immune response virtually no difference to wt
controls existed indicating a normal memory B cell generation and function. These results were
completely unexpected, as conventional histology and immunohistochemistry with stainings for
proliferation (Ki-67), germinal center B cells (peanut agglutinin), T-cell and dendritic cell markers
of all major lymphoid tissues which were performed at three time points after primary
immunization had revealed a completely resolved architecture of the lymphoid tissues without any
initiation of classical germinal center reactions. In ultrastructural analysis the tight membrane
adhesions (< 5 nm) between lymphocytes and dendritic cells observed in wt mice (n=6) were
missing in CD18 null mutants (n=6) in all lymphoid tissue sections analyzed (lymph nodes, spleen,
Peyer's patches, tonsils). However, rudimentary bridges of membrane contacts existed. We here
provide evidence that formerly described lymphoid structures and germinal center formation are
not necessarily required to mount an antigen speci®c immune response in CD18 null mice, but
that residual structures can compensate. (BMBF 01 KS 9502)
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Rho GTPases are Key Regulators of Dendritic Cell Morphology and Function
D. Maurer, S. Jaksits, E. Kriehuber, and G. Stingl
DIAID, Department of Dermatology, University Vienna Medical School, Vienna, Austria
Dendritic cells (DCs) are characterized by their irregular, dendrite (i.e. lamellipodium and
®lopodium)-bearing plasma membrane and by their unique ability to activate naõÈve T
lymphocytes. The latter function is linked to their high migratory capacity and their abundant
display of MHC and costimulatory molecules. Interestingly, cell shape, migration, and export of
MHC products to the cell surface of DCs require actin assembly. Molecules that mediate actin
polymerization, and, thus, may control DC phenotype and function are small Rho GTPases. To
study the importance of individual GTPases in DCs, stem cell-derived Langerhans cell-type DCs
were transfected with constructs encoding myc-tagged dominant negative mutants of Cdc42
(N17-Cdc42), Rac1 (N17-Rac1) or RhoA (N14-RhoA). CD40 ligand-stimulated DC
transfectants showed stable expression of the myc-tagged transgenes over several days and survived
at similar rates as empty vector transfected control cells. By confocal microscopy, we observed
dramatic alterations of the cellular cytoskeleton imposed by the various constructs. N17-
Cdc42+ DCs were essentially round without ®lopodia or lamellipodia and displayed an only poorly
developed actin cytoskeleton. N17-Rac1+ and N14-RhoA+ DCs displayed collapsed lamellipodia
and thinned surface-associated actin, respectively. In contrast, constitutively active GTPase mutants
induced lamellipodia formation (L61-Rac1), short membrane protrusions (L63-RhoA) and, most
strikingly, long, actin-bearing dendrites/®lopodia (L61-Cdc42) in monocytes. Thus, by
phenotype, these monocytes were hardly discernable from DCs. Furthermore, DCs transfected
with dominant negative mutants of Rho-GTPases showed reduced migration to chemokine
stimuli and were also impaired in their ability to stimulate T cells. Surprisingly, DCs require
functional Cdc42 for the stimulation of CD8+, but less so, for CD4+ T cells. Apparently, this
effect is mediated by reduced MHC class I surface export of this molecule from (post)Golgi
compartments but is not due to destabilization of surface MHC class I. In contrast, MHC class II
surface expression and IL-12 secretion were hardly affected. In summary, DC morphology and DC
function are co-ordinately controlled by similar, if not identical, signaling modules, i.e. Rho
GTPases. Moreover, Cdc42 seems to be of particular importance for DC-T cell communication
and, thus, for T-cell-dependent immunity.
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IL-10-Treated Human Dendritic Cells Induce Anergic CD4+and CD8+ T Cells with
Antigen-Speci®c Suppressor Activity
K. Steinbrink, S. Kubsch, E. Graulich, T. Tueting, J. Knop, and A. Enk
Department of Dermatology, University of Mainz, Mainz, Germany
Recently, we demonstrated that IL-10-treated dendritic cells (DC) induce an alloantigen- or
peptide-speci®c anergy in various CD4+ and CD8+ T cell populations. In this study we wanted to
analyse whether these anergic T cells have immunoregulatory functions. Coculture experiments
revealed that alloantigen-speci®c anergic CD4/8 + T cells suppress the proliferation of naive
syngeneic T cells in a dose dependent fashion. The same effect was observed if tyrosinase-speci®c
cytotoxic CD8+ T cells or the haemagglutinin-speci®c CD4+ T cell clone HA1.7 were
cocultured with anergic T cells of the same speci®city. In contrast, anergic T cells did not mediate
an antigen-independent bystander inhibition. Functional analysis revealed that previously activated
tyrosinase-speci®c CD8+ T cells cocultured with anergic tyrosinase-speci®c CD8+ T cells failed to
lyse a tyrosinase-expressing melanoma cell line. Suppression was dependent on cell to cell contact
between anergic and responder T cells and required activation by antigen-loaded DC. Supernatants
of anergic T cells did not mediate T cell suppression. Inhibition could be overcome by addition of
IL-2 or anti-CD3-/CD28-mAb and was blocked by CTLA-4-Ig or anti-CD86-mAb.
Furthermore, anergic T cells displaying increased expression of CTLA-4 surface molecules were
involved in the suppressor activity. Taken together, our experiments demonstrate that anergic T
cells induced by coculture with IL-10-treated DC mediate antigen-speci®c suppression of T cells.
Induction of anergic T cells might be exploited therapeutically for suppression of cellular immune
responses in allergic or autoimmune diseases with identi®ed (auto-) antigen.
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Adhesion of CD34+-Derived Dendritic Cells to Human Dermal Microvascular
Endothelial Cells is Down-Regulated upon Maturation and Depends on CD11a,
CD11b, CD36
V. Nguyen, S. Ebner, C. Furhapter, N. Romani, D. Kolle,* P. Fritsch, and N. Sepp
Dermatology, University of Innsbruck, Innsbruck, Austria; *Obstetrics, University of Innsbruck, Innsbruck,
Austria
Dendritic cells (DC) function as sentinels of the immune system. When bone marrow-derived DC
precursors reach their target tissue, they need to bind and migrate out of microvascular endothelial
cells, in particular. To determine the adhesive properties of DC at various differentiation stages to
human dermal microvascular endothelial cells (HDMEC), DC were generated from human cord
blood-derived CD34+ hematopoietic progenitors by culture in the presence of GM-CSF, TNF-a
and hSCF. To enhance DC maturation, cells were additionally exposed to a de®ned cocktail of IL-
1b (2 ng per ml)/IL-6 (1000 U per ml)/TNF-a (10 ng per ml)/PGE2 (1 mg per ml) (``cocktail
DC''). Adhesion was assessed and quanti®ed by phase contrast microscopy and by means of a
¯uorimetric adhesion assay. Signi®cantly more immature (37.8 6 9.7%) than mature DC
(13.8 6 6.3% for conventionally matured DC and 2.5 6 0.87% for ``cocktail DC'') bound to
unstimulated HDMEC. HDMEC pretreatment with TNF-a and IFN-g resulted in an enhanced
attachment of both immature and mature DC by 50±160%. Flow cytometric analysis revealed that
mature DC are characterized by the lack of CD31, CD36, CD45RA and CLA expression and by
the low expression of CD11a, CD11b and CD49d. Blocking mAb's against CD11a, CD11b, and
CD36 markedly inhibited DC binding (mean inhibition 65±70%), whereas anti-CD49d Ab's did
not. Simultaneous application of these mAb's did not potentiate inhibition. Our data support the
hypothesis of immunosurveillance with selective recruitment of immature blood DC at sites of
cutaneous in¯ammation. They might have potential relevance in the development of
immunotherapy strategies for cancer indicating the inef®cacy of intravenous DC application.
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Differential Effects of LPS and TGF-b on the Production of IL-12 p40 and IL-6 of Mouse
Langerhans Cells, Spleen-Derived Dendritic Cells and Macrophages
Y. Tada, A. Asahina, K. Nakamura, H. Mitsui, H. Torii, and K. Tamaki
Dermatology, Faculty of Medicine, University of Tokyo, Tokyo, Japan
The response of Langerhans cells (LC)/Dendritic cells (DC) to bacterial lipopolysaccaride (LPS) is
the best example of innate recognition. However, contradictory results have been reported on the
ability of LC/DC to respond to LPS. Here, we examined modulatory effects of LPS on IL-12 p40
and IL-6 production of highly puri®ed LC (95%), spleen-derived CD11c+ DC and peritoneal
exudate macrophages (Mj) by ELISA. Low dose LPS (1 ng per ml) up-regulated IL-12 p40
production of anti-CD40/IFN-g-stimulated Mj, and it also up-regulated IL-6 production of anti-
CD40/IFN-g-stimulated DC and Mj. In contrast, low dose LPS up-regulated neither IL-12 p40
nor IL-6 production of stimulated LC. Since LC did not express CD14 and spleen-derived
CD11c+ DC expressed low density of CD14, it is likely that LC, DC and Mj respond differently
to low dose LPS depending on the density of cell surface CD14 expression, which is at least known
to be involved in LPS-induced Mj activation. However, high dose LPS (1 mg per ml) up-regulated
IL-6 production of LC, suggesting the ability of LC to respond to LPS. We also explored the
immunomodulatory effects of transforming growth factor (TGF)-b on stimulated LC and Mj,
since TGF-b is known to inhibit signalling of LPS-induced in¯ammatory responses, especially in
Mj. As has been expected, TGF-b1 down-regulated IL-12 p40 and IL-6 production of anti-
CD40/IFN-g/LPS-stimulated Mj. TGF-b1 up-regulated IL-12 p40 production of anti-CD40/
IFN-g-stimulated Mj, but did not modify IL-6 production of anti-CD40/IFN-g-stimulated Mj.
In contrast to Mj, TGF-b1 up-regulated IL-6 production of anti-CD40/IFN-g/LPS (1 mg
per ml)-stimulated LC, and also up-regulated IL-6 and IL-12 p40 production of anti-CD40/IFN-
g-stimulated LC. These results suggest that TGF-b is the key cytokine in the skin innate immunity
by up-regulating LC secretion of IL-12 and IL-6, which are essential for activating cell-mediated
and humoral immunity.
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The Negative Effects on Human Dendritic Cells: Roles of Endothelial Interleukin-8
Y. Lu, W. Zhu, and X. Zhang*
Department of Dermatology, The 1st Af®liated Hospital,Nanjing Medical University, NANJING, China;
*Institute of Immunology, Suzhou Medical College, SUZHOU, China
Since high levels of interleukin-8 (IL-8) had been detected both in serum and in situ of melanoma
patients in our study,it was of interest to further explore its impacts on dendritic cells (DC),which
are the most important antigen presenting cells in the body. Human endothelial cells and
monocytes can produce and secrete two forms of IL-8, respectively, with different compositions
and distinct biological characteristics by stimulation of TNF-|AÂ . These two types of IL-8 of
different origins were added to the routine DC cultures at an early stage (Day 3) or at a late stage
(Day 7) maintaining till supernants were collected on day 9. Here we reported for the ®rst time the
negative effects of endothelial IL-8 on human DCs. Endothelial IL-8, which if added at an early
stage to the DC cultures, could inhibit DC maturation with signi®cantly decreased expressions of
CD40, CD80, CD83 and HLA-DR; while CD14, a marker for macrophage, expression was
obviously up-regulated with corresponding morphologic changes. Such effects were also
demonstrated by greatly reduced stimulating indexes of allogeneic mixed lymphocyte reactions
and interleukin-12 secretions by DCs. Moreover,they could be selectively blockaded by anti-IL-8
monoclonal antibodies. But monocytic IL-8 did not show any inhibitory impacts on DCs. In
conclusion, DCs couldn't undergo terminal maturation in response to endothelial IL-8 that had
®ve extra N-terminal amino acids lacking in monocyte-derived IL-8. This was a novel function of
endothelial cells involving melanoma formation and development of tumors by escape from
immune surveillance.
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Fractalkine Induces Chemotaxis and Actin Polymerization in Human Dendritic Cells
U. Luther, S. Dichmann, Y. Herouy, D. Purlis, P. Gebicke-HaÈrter,* H. Rheinen, and J. Norgauer
Dermatology, University of Freiburg, Freiburg, Germany; *Psychiatry, University of Freiburg, Freiburg,
Germany
Dendritic cells (DCs) are considered as principle initiators of immune responses. They are able to
migrate into target sites, process antigens and activate naive T cells. Here, the chemotactic activity
and intracellular signaling of fractalkine was analyzed and compared to well known chemotaxins.
The mRNA-expression of G protein-coupled CX3CR-1 was analyzed by RT-PCR. Chemotaxis
was measured in 48 well Boyden chambers and actin polymerization by ¯ow cytometry. The
mRNA-expression of CX3CR-1 in immature and mature DCs has been analyzed. Fractalkine
elicited actin polymerization and chemotaxis in a dose-dependent manner in DCs independent
from their state of maturation. These results show that immature and mature DCs express mRNA
for the CX3CR-1 and that fractalkine induces chemotaxis and migration associated actin
polymerization in immature as well as in mature DCs, contrasting the action of other chemokines
such as RANTES or MIP3-b which act only on distinct maturation states of DCs. These ®ndings
suggest a role of this novel chemokine and CX3CR-1 in the recruitment of DCs.
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Functional Leptin Receptor is Expressed on Human Blood-Derived Dendritic Cells
(BDC) and Leptin Promotes Maturation of BDC
S. Nakagawa, H. Tagami, and S. Aiba
Dermatology, Tohoku University School of Medicine, Sendai, Japan
Leptin is a 16-kDa peptide hormone synthesized mainly in adipose tissue to regulate body weight.
Although leptin receptor (ObR) is widely distributed including hematopoietic cells, its functional
isoform (ObRb) is restricted to certain cells such as T cells. Leptin enhances alloproliferative
response by T-cells, especially of its memory subset, and biases T-cell response towards a Th1 type.
In this study, we investigated the expression of ObRb on BDC and the effect of leptin on their
maturation. BDC was generated from CD14-selected human peripheral blood mononuclear cells
(PBMC) by culturing with GM-CSF (100 ng per ml) and IL-4 (100 ng per ml) for 6 days.
Expression of ObRb mRNA as well as ObR mRNA was detected by RT-PCR with appropriate
primers. Maturation was determined by measuring the levels of cell surface molecules on BDC by
¯ow cytometry after 18 h culture with 0, 3, 10, 30, or 100 nM of leptin in the culture medium, and
by the expression of mRNA for proin¯ammatory cytokines after 4 h-stimulation by leptin. ObRb
mRNA could be detected on BDC but the expression level was lower than that of PBMC. In
contrast, ObR mRNA level was comparable between BDC and PBMC. High doses of leptin up-
regulated the expression of CD54, CD83 and CD86 on BDC and leptin enhanced their expression
of IL-1beta, IL-6 and IL-8 mRNA in a dose-dependent manner. These results suggest a possible
role played by leptin in the regulation of cutaneous immune response by stimulating dendritic cell
maturation in vivo.
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R848 Activates Immature Dendritic Cells In Vitro and Modulates the Sensitization and
Effector Phase of Murine Contact Hypersensitivity (CHS) Responses
S. Grabbe, M. Gunzer, and H. Riemann
Dermatology, University of MuÈnster, MuÈnster, Germany
R848 is a 1003 stronger derivative of the topical immunomodulator Imiquimod, the active
substance of ALDARA(tm). To further explore its mechanism of action, we tested the effects of
R848 on the development of antigen presenting dendritic cells (DC) in vitro and in different CHS
models in vivo. Non-adherent bone marrow cells from Balb/c mice were cultured with GM-CSF/
IL-4+/± graded doses of R848 for 6 days (development). On day 6 ¯oating cells were harvested,
assayed for phenotype/function and replated for additional 24±48 h in GM-CSF/IL-4+/± R848
(maturation). During the development of DC from bone marrow precursors, R848 was an
inhibitor of DC proliferation and strongly reduced cell yield after 6 d of culture. Nevertheless, cells
recovered from the cultures were almost indistinguishable from untreated controls by surface
molecule expression, in their ability to stimulate proliferation of allogeneic T cells in mixed
lymphocyte responses (MLR), or in their endocytotic capacity, but produced much larger amounts
of TNFa, IL-6 and IL-12. DC which had been incubated with R848 during the maturation phase
only were more effective inducers of T cell proliferation as compared to untreated DC or cells
permanently in contact with R848. In both cases, R848 incubation drastically increased the
capacity of DC to stimulate IFNg production by allogeneic T cells in MLR. In vivo, R848 was
given i.p. at the time of sensitization or elicitation of CHS, and ear swelling responses were
measured 24 h later. R848 strongly enhanced sensitization, but intriguingly, the elicitation phase of
CHS to the allergen FITC was potently inhibited. Thus, while R848 disturbs the development of
DC from their precursors, it strongly enhances their capacity to induce Th1 responses in vitro and
differentially modulates the induction and elicitation phases of murine CHS.
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Internalization and Presentation of Particulate Antigens by Activated Bone Marrow-
Derived Dendritic Cells
J. Nayak, A. Larregina, Y. He, L. Wang, G. Erdos, J. Plowey, K. Thompson, R. Salter, S. Watkins,
and L. Falo
Departments of Dermatology and Cell Biology, University of Pittsburgh Cancer Institute and Center for
Biologic Imaging, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
Antigen delivery to mature myeloid DC populations has received little attention but may
constitute an effective strategy for inducing antigen-speci®c immunity. We exposed BMDCs
differentiated in GM-CSF/IL-4 to potent maturation signals including activating CD40-IgM to
examine the capacity of dendritic cell populations to functionally internalize, process, and present
distinct soluble and particulate antigen formulations. Our ®ndings support conclusions from
previous studies that soluble ligand uptake and proteolysis is greatly diminished in activated DCs.
However, when examining for phagocytosis of 1 mm particulates using a sensitive, quantitative
cyto¯uorometric assay, we ®nd that particle uptake is retained within both immature, and enriched
populations of mature BMDC. Approximately 12±33% of activated BMDCs are associated with
the phagocytic activity observed. Confocal microscopy of mature DC ¯uorescently stained to
identify lysosomes demonstrates that particulate internalization by DCs results in cytoskeletal
remodeling and lysosome cluster disruption in a time-dependent manner. Live dendritic cell
®lming of particle phagocytosis by DC labeled with Lysotracker reagent supports these ®ndings.
Importantly, we observe that activated, mature DCs process and presented particulate OVA
through both MHC class I and class II restricted pathways to antigen-speci®c T-cell hybridomas.
Taken together, these data argue strongly that phagocytosis is a constitutive and tightly regulated
process in both immature and now mature BMDCs, but that ultimate presentation of internalized
particulate antigens in activated myeloid DCs is in¯uenced by local microenvironmental cues.
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Cross Priming is an Important Mechanism for T-cell Priming in Cutaneous Genetic
Immunization
L. Spencer, G. Erdos, J. Plowey, A. Pimenov, and L. Falo, Jr
Department of Dermatology, University of Pittsburgh Cancer Institute, University of Pittsburgh School of
Medicine, Pittsburgh, Pennsylvania
To evaluate the role of cross-priming in immune induction following gene gun immunization of
mouse skin, the keratin K14 promoter was used to drive expression of a model antigen, cytosolic
chicken egg ovalbumin (OVA489), speci®cally in keratinocytes. The K14 promoter has been
previously characterized for its speci®city for strati®ed basal layer keratinocytes. Here we use RT-
PCR to show that this promoter does not drive expression in skin dendritic cells (DCs), verifying
that antigen-encoding genes driven by this promoter are appropriate tools to study the
contribution of cross-priming to immunity in our cutaneous vaccination model. We make use of
an in vivo assay for antigen-speci®c proliferation, using adoptive transfer of CFSE ¯uorescent dye-
labeled OVA-speci®c OT-1 CD8+ T-cells from TCR transgenic mice into naõÈve syngeneic
recipients. Sequential halving of CFSE ¯uorescence in vivo upon cell division can be used to assess
the CD8+ proliferative response generated in immunized animals through cross-priming. To our
knowledge, we are the ®rst to describe the use of this system for a functional quantitative
comparison of T-cell proliferation between treatment groups. We demonstrate that cross-priming
through genetic immunization results in a robust proliferative response of antigen-speci®c OT-1
T-cells. In agreement with these results, standard CTL assays demonstrated that immunization with
pcK14-OVA489, encoding cytoplasmic OVA driven by the K14 promoter, resulted in antigen-
speci®c lysis of syngeneic target cells. Time-course experiments suggest that cross-priming requires
more time for immune induction, which may be attributable to the time required for repopulation
of skin DCs following the initial wave of migration. These results demonstrate that DCs in skin can
ef®ciently take up antigen from transfected keratinocytes for presentation through the MHC-I
pathway, resulting in CD8+ effector T-cell proliferative and cytolytic responses. Collectively,
these data imply that while direct transfection of dendritic cells may be an important goal for the
development of immunotherapeutic strategies, cross-priming is a major mechanism for T-cell
priming after biolistic cutaneous genetic immunization. They suggest that the immunogenicity of
foreign proteins expressed in keratinocytes may be problematic for the ongoing development of
gene therapy strategies.
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Langerhans Cells are Susceptible to Fas-Mediated and Antigen-Speci®c T Cell-Mediated
Apoptosis
L. Timares, J. Douglas,* and H. Hirofumi²
Dermatology, University of Alabama at Birmingham, Birmingham, Alabama; *Gene Therapy Center,
University of Alabama at Birmingham, Birmingham, Alabama; ²Molecular Medicine, Sapporo Medical
University, Sapporo, Japan
We examined the response of Langerhans cells (LC) to stimuli of apoptosis pathways of activation
induced cell death (AICD) and passive cell death (PCD). Fas cross-linking with Jo2 mAb or
antigen±speci®c interaction with a CD4+ T cell hybridoma, 3A9 were used as AICD stimuli,
while staurosporine was used as a PCD stimulus. The murine LC line XS106 and LC obtained
from A/J mouse skin organ cultures were examined. Flow cytometric analysis revealed that both
XS106 cells and LC expressed Fas, which was further inducible by LPS. Fas expression levels
correlated with susceptibility to apoptosis by crosslinking with Jo2 mAb, resulting in 80% cell death
of LC and LPS-treated XS106 in 20- h cultures, as indicated by Annexin V and 7AAD staining.
When XS106 cells were cultured for 20 h in the presence of the antigen hen egg lysozyme (HEL),
or with the HEL-speci®c CD4+ T cell hybridoma, XS106 cell death was not detected. However,
when both HEL and 3A9 T cells were cocultured, 50% of the XS106 cells were apoptotic.
Similarly, 65% of LC underwent apoptosis after only 12 h of antigen±speci®c interaction with 3A9
T cells. Overexpression of the human Bcl-xl gene by adenovirus infection of XS106 cells did not
confer resistance to T cell-mediated apoptosis, but staurosporine-induced apoptosis was effectively
inhibited. These results support a role for immune-mediated apoptosis in regulating LC function.
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Subcutaneously (SC)-Injected, CXCR5-Transduced Bone Marrow-Derived Dendritic
Cells (BMDC) Traf®c to B Cells Zones of Lymph Nodes (LN) and Modify Antigen-
Speci®c Immune Responses
M. Wu, H. Saeki,* and S. Hwang
Dermatology Branch, National Cancer Institute, Bethesda, Maryland; *Dermatology Department, Tokyo
University, Tokyo, Japan
Speci®c chemokine expression in the B and T cell zones (TCZ) of the LN contribute to the
development of these distinct anatomical regions. The formation of B cell zones (BCZ), for
example, depends on B lymphocyte chemoattractant (BLC) expression in the BCZ of LN and the
expression of CXCR5 by B cells. Our previous data showed that skin-derived migratory DC
express CXCR5, respond to BLC in vitro, and migrate to BCZ in addition to TCZ in LN in vivo.
Murine BMDC, by contrast, express 10-fold less CXCR5, do not migrate in response to BLC, and
migrate exclusively to TCZ in LN in vivo. To address whether functional expression of CXCR5 by
BMDC alters their traf®cking dynamics and in¯uences immune responses, we transduced BMDC
with CXCR5 and GFP using a bicistronic retroviral vector (transduction ef®ciency ~60%).
CXCR5-BMDC were responsive to BLC in vitro in chemotaxis assays (3-fold over nontransduced
BMDC, p < 0.01). When injected into the footpads of mice, CXCR5-BMDC migrated not only
to TCZ, but also to BCZ, in the draining LN as detected by confocal microscopy. CXCR5-
BMDC or BMDC transduced with vector alone were pulsed with keyhole limpet hemocyanin
(KLH) and injected SC into Balb/C mice to induce speci®c cellular and humoral immune
responses manifested by footpad swelling in response to KLH injection and KLH-speci®c Ig
production, respectively. In response to KLH challenge, mice injected with CXCR5-BMDC
(n = 5) demonstrated 23% less footpad swelling (p < 0.05). CXCR5-BMDC produced 50% more
KLH-speci®c IgG (p < 0.05) and 143% more KLH-speci®c IgM (p < 0.01) than vector-transduced
BMDC (n = 5). Thus, expression of CXCR5 alone is suf®cient to direct BMDC to BCZ of LN in
vivo and modi®es antigen-speci®c immune responses induced by BMDC vaccination. Therefore,
expression of CXCR5 in skin migratory DC in vivo may in¯uence immune responses generated
against cutaneous antigens.
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UV-B Irradiated Dendritic Cells Cannot Tolerize Hapten-Speci®c or TCR-Transgenic
Murine CD8+ T Cells
J. Simon, J. Dudda, S. Martin, R. Denfeld, and C. Leicht
Dermatology, University of Freiburg, Freiburg, Germany
The recognition of CD8+ T cells as the main effector cells in contact allergy to a number of
chemicals and drugs necessitates the development of strategies for tolerance induction in
CD8+ Tc1 cells. UV-B irradiation of the skin and ex vivo Langerhans cells before antigen-
application was shown to tolerize mice for contact allergens. We have used UV-B irradiated bone
marrow derived dendritic cells (UV-B DC) to induce tolerance in CD8+ T cells specifc for the
contact allergen TNP and others in the mouse. In contrast to the successful tolerization of naive
CD4+ Th1 cells in some transgene systems, naive CD8+ T cells as well as established Tc1 effector
cells could not be tolerized by TNP-modi®ed UV-B DC in vitro. In addition, i.d. injection of
TNP-modi®ed UV-B DC in a contact hypersensitivity model in vivo also failed to induce allergen-
speci®c tolerance in CD8 T cells. To con®rm this is a general phenomenon for murine CD8+ T
cells we made use of two transgenic TCR-systems: H-2Db/LCMV GP p33-speci®c P14 mice and
additionally the H-2Kb/Ova-speci®c OT-1 mice. In vitro priming experiments showed a reduction
of priming capacity by a factor of 10±100 by UV-B DC, but no tolerance induction in rechallenge
experiments. UV-DC also failed to tolerize an established CD8+ TC clone. To preliminary results
in vivo, UV-B DC were not successful in tolerising naive p33-speci®c CD8+ TC in an adoptive
transfer system. Although immunization of the adoptive host with UV-B DC elicited no
signi®cant primary proliferative response of the transgenic donor T cells, these T cells proliferated
upon rechallenge after 5 weeks. Taken together, bone marrow derived UV-B DC do not induce
tolerance in CD8 T cells at least in the investigated systems. We have to think about alternative
strategies. This work was supported by the Klinische Forschergruppe ``Pathomechanismen der
allergischen EntzuÈndung'' BMBF FKZ: 01GC9701/7.
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Up-Regulation of Ia+B220± Lymph Node Cell Costimulatory Molecules Induced by
UVB is Not Further Enhanced by DNFB
E. Toichi, T. McCormick, and K. Cooper*
Department of Derm., University Hosp. Research Institute and Case Western Reserve University, Cleveland,
Ohio; *Department of Derm., University Hosp. Research Institute and Case Western Reserve University
and VA Medical Center, Cleveland, Ohio
Low-dose in vivo UVB exposure results in the suppression of contact hypersensitivity (CHS) and
tolerance to an antigen sensitized through the UV-irradiated site. Because costimulatory molecules
on antigen-presenting cells (APC) and IL-12 play important roles in inducing Th1 cells, we
analyzed CD40, CD80 and CD86 on APC by ¯ow cytometry and IL-12 p40 by RT-PCR in
lymph nodes (LN) where sensitization occurs. C3H/HeN mice were painted with 0.5% DNFB, as
a sensitizing agent, on back skin without UV irradiation or 48 h after a tolerogenic UVB irradiation
(72 mJ per cm2). Draining LN were prepared for three-color ¯ow cytometry and RNA extraction.
Since Ia+ cells include a large number of B cells and B cells express CD40, CD80 and CD86, we
used B220 (B cell marker) to select a B220 negative population (B220±). The percentage of
Ia+B220± cells was slightly up-regulated 18 h after sensitization (0.35 6 0.05 vs. 0.44 6 0.07). The
percentage of Ia+B220± cells 66 h after UV irradiation in nonsensitized mice was signi®cantly up-
regulated (0.35 6 0.05 vs. 0.48 6 0.03, n = 4, p < 0.05). At 66 h post-UV, IL-12 p40 mRNA was
also detected by RT-PCR. However, sensitization on UV skin did not result in a signi®cantly
increased percentage of Ia+B220± cells (0.46 6 0.08) compared to either sensitized or UV treated
alone. Increased expression of costimulatory molecules was also observed upon sensitization and
UV treatment. No additive increase in CD40 expression on Ia+B220± LN cells from UV/sensitized
mice was observed (11% increase) compared to sensitized or UV treated alone (16 and 4%,
respectively). This was also true of CD80 and CD86, where the combined UV/sensitized percent
increase (34 and 118%, respectively) did not exceed UV treated alone (21 and 125%, respectively)
plus sensitized alone (19 and 118%, respectively). An expected additive effect for the combined
UV/sensitized condition was not seen either with the costimulatory molecules nor IL-12. Thus,
low-dose UVB irradiation alone does not down-regulate, but rather up-regulates costimulatory
molecule expression associated with IL-12 p40 in DLN. However, UV skin has a suppressed up-
regulation of expression of costimulatory molecules on APC and IL-12 p40 in response to antigen.
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In Vivo Evidence that Epidermal Langerhans Cells are Targeted Selectively for Gene
Expression by a Dectin-2 Promoter
M. Bonkobora, S. Shikano, P. Zukas, A. Das, P. Cruz, and K. Ariizumi
The Department of Dermatology, The University of Texas South-western Medical Center, Dallas, Texas
Despite their unsurpassed antigen presenting capacity especially for naive T cells, Langerhans cells
(LC) and dendritic cells (DC) have been rarely used as targets of gene-based techniques because
well-de®ned regulatory elements controlling speci®c expression in these cells have not been
identi®ed. Previously we reported that a 5¢-¯anking region in the mouse dectin-2 gene (Dec2FR)
directs gene expression in LC/DC (but not other cell) lines. To evaluate LC/DC speci®city in vivo,
we generated transgenic mice bearing a luciferase (Luc) reporter gene controlled by Dec2FR. In
these mice, Luc activity was highest in skin, much less in lymphoid organs, and close to
background level in other organs. Epidermal cells expressed markedly high activity, and depletion
of Ia+ cells (LC) almost completely abrogated such activity. By contrast, Luc activity in spleen cells
was 200-fold lower than in epidermal cells, and depletion of CD11c+ DC led to 30% reduction of
total spleen Luc activity. Among FACS- or magnetic bead-puri®ed cells, Ia+ epidermal LC
expressed the highest activity (12 RLU/cell); CD11c+ spleen DC and Mac-1+ peritoneal
macrophages (MF) showed detectable but markedly low activity (0.08 and 0.07 RLU/cell,
respectively), whereas B220+ B cells and CD3+ T cells exhibited background levels. Even when
activated, B cells failed to express Luc activity, whereas T cells and MF showed inducible Luc
activities that were still 10-fold lower than resting epidermal LC. We conclude that epidermal LC
are targeted selectively for high-level constitutive gene expression by Dec2FR in Luc transgenic
mice. These ®ndings have encouraged us to use Dec2FR in developing additional mouse models
of LC-targeted gene expression that will lead ultimately to an improved understanding of LC
biology and cutaneous immunology, with potential applications for immunotherapy.
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Catecholamines Inhibit Epidermal Immune Reactions by Directly Affecting Langerhans
Cells
K. Seiffert, J. Hosoi, H. Torii, H. Ozawa, and R. Granstein
Department of Dermatology, Weill Medical College of Cornell University, New York, New York
Adrenergic factors are present in the skin and a role in cutaneous immune function has been
proposed. Epidermal LC are found in close vicinity to nerve endings and may thus be affected by
nerve-derived catecholamines. We have previously shown that the murine skin derived dendritic
cell line XS52 (H-2d) and LC enriched to 98% homogeneity from CAF1 mice (H-2
a/d) express
mRNA for a1a, b1 and b2-adrenergic receptors. Furthermore we showed that epinephrine (EPI)
and norepinephrine (NE) inhibit antigen presentation in three different functional assays: (a) in vitro
EPI and NE inhibited presentation of a speci®c antigen by BALB/c (H-2d) epidermal cells (EC) to
a reactive Th1-clone in a dose-dependent manner; (b) both catecholamines also signi®cantly
inhibited EC (enriched to ~12% LC-content by antibody- and complement mediated lysis of Thy
1.2-bearing cells) presentation of tumor associated antigens for elicitation of delayed-type
hypersensitivity (DTH) in previously immunized CAF1 mice. This inhibitory action was blocked
by a b-, but not an a-adrenergic antagonist and thus appears to be a b-adrenoceptor mediated
process; (c) intradermal injection of EPI prior to sensitization by topical application of 2,4-dinitro-
1-¯uorobenzene signi®cantly reduced the contact hypersensitivity reaction elicited 7 days later
upon rechallenge with the hapten. To determine whether catecholamines affect LC antigen
presenting capability directly or indirectly through an effect on other cells (e.g. cytokine release by
keratinocytes), we enriched murine EC preparations by antibody- and complement-treatment
followed by cell separation utilizing I-Ad targeted magnetic beads. This process yielded a LC
population of 98% purity. These LC were cultured for 3 h in graded concentrations of EPI and NE
(10±7 M±10±9 M), pulsed with keyhole limpet hemocyanin (KLH) overnight and subsequently
cocultured with the KLH-responsive T cell clone HDK1. Both EPI and NE inhibited presentation
of KLH by murine enriched LC to this T cell clone in a dose dependent manner, as assessed by
IFN-c production at 72 h. These ®ndings support the hypothesis that adrenergic agents are
involved in regulation of skin immune function by directly affecting LC-antigen presenting
capability.
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The Interactions of Staphylococcus aureuswith Murine Langerhans Cells
N. Meduri, D. Yao, and G. Murakawa
Dermatology, Wayne State School of Medicine, Detroit, Michigan
Staphylococcus aureus is the most common cause of cutaneous infections and is present on lesions of
chronic in¯ammatory skin diseases such as atopic dermatitis; yet, the interactions between bacteria
and host are poorly understood. We investigated the ability of S. aureus to adhere to, invade into,
and grow on Langerhans cells in vitro. Adherence was determined at speci®c time points by
washing away nonadherent bacteria, disrupting cell monolayers, and performing quantitative plate
assays. Intracellular bacteria were similarly quantitated after killing extracellular bacteria with
lysostaphin prior to monolayer disruption (lysostaphin is cytotoxic to S. aureus but does not enter
host cells, thus, intracellularly located bacteria are protected from its effects). S. aureus adhere to and
invade into Langerhans cells quickly and ef®ciently; adherence approached 100% immediately and
50±80% of the bacteria were located intracellularly within 30 min After a stationary phase, the
bacteria within the Langerhans cells replicated intracellularly. The results of this present study show
that S. aureus adhere to, invade into, and grow on Langerhans cells at rates comparable to other
macrophage cell lines while, the invasion rate is signi®cantly higher than nonprofessional
phagocytes (i.e. keratinocytes, ®broblasts, melanocytes). The skin is the ®rst level of host defense
against many pathogens. As the primary antigen presenting cells of the skin, Langerhans cells have
an important role in either directly or indirectly shaping the antigen-speci®c host immune response
to cutaneous pathogens. These studies characterize the initial interactions between Langerhans cells
and bacteria, which is an important step in studying both the host immune response and the
mechanisms employed by S. aureus during skin infections.
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The Cellular and Functional Properties of Isolated Human Langerhans Cells are Affected
by Keratinocyte Coculturing
M. Peiser, M. Artuc, A. Gruetzkau, and G. Kolde
Dermatology, Charite, Berlin, Germany
We have recently shown that human epidermal Langerhans cells (LCs) obtained by magnetic-
activated cell sorting (MACS) with optimized anti-CD1a concentrations, resemble immature
intraepidermal cells and undergo only slight spontaneous maturation upon culture. This in vitro
system thus represents an excellent tool to analyze in detail the effects of bacterial antigens and
cytokines on the phenotypical and functional properties of immature LCs. Freshly MACS-isolated
ultrapure LCs with high levels (95%) of HLA-DR and CD1a expression were incubated with LPS,
CD40L, TNF-a, Flt3-L, TGF-b, IFN-g and INF-w for 24 h. Triple color ¯ow cytometry revealed
up-regulation of the CD83 expression after stimulation with LPS and TNF-a, increased CD80
expression after TGF-b, and up-regulation of CD95 ligand after IFN-g incubation. A signi®cant
increase in the MLR with CD4-positive T cells was only observed after incubating the cells with
LPS. However, none of these incubations were able to inhibit the loss of viability and decreased
expression of CD1a and HLA-DR occuring upon spontaneous culturing of the cells. When
coculturing freshly MACS-isolated LCs with the human keratinocyte cell line HaCaT, there were
a rather constant viability, and CD1a and HLA-DR expression. This coculture system was
additionally found to strengthen the effects of in¯ammatory stimulation. In conclusion, our
®ndings demonstrate that (i) proin¯ammatory cytokines and bacterial antigens induce distinct
phenotypical and functional changes of immature human LCs, and (ii) keratinocytes play a crucial
role in regulating not only the viability, but also the differentiation and maturation of isolated LCs.
This regulation obviously requires direct interactions of the cells, because the incubation with
keratinocyte supernatants failed to affect the behavior of cultured human LCs.
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Effects of the Topical Application of Cholera Toxin on the Migration of Human
Langerhans Cells
A. Lau, L. Spencer, A. Larregina, and L. Falo, Jr.
Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
Dendritic cells, including epidermal Langerhans cells, are potent professional antigen presenting
cells (APC). The development of immunization strategies which target antigen delivery to
Langerhans cells, which are readily accessible in the skin, is an attractive approach to vaccine
design. In addition to antigen delivery, effective cutaneous vaccination strategies will likely induce
the activation and migration of resident dendritic cells, typically through the use of adjuvants.
Applying cholera toxin (CT), which has been shown to have potent adjuvant effects, onto intact
skin has been proposed to induce migration, traf®cking, and/or activation of Langerhans cells.
Here, we investigate the migration of Langerhans cells out of human epidermis in response to the
topical application of CT. We compared migration of Langerhans cells from human foreskins after
topical application of CT, a model protein antigen alone (¯uorescent-OVA (DQ-OVA)), the
combination of CT and antigen, or vehicle alone as a control. Migration of Langerhans cells was
determined by the quanti®cation of HLA-DR positive cells remaining in epidermal sheets at
various time points. Our results indicate a signi®cant increase in migration of Langerhans cells out
of skin exposed to either CT or DQ-OVA at 3 h, compared to vehicle control. In comparison
studies, the difference between migration induced by CT alone, simultaneous application of CT
and DQ-OVA, or DQ-OVA alone was not signi®cant. Furthermore, the majority of LC migration
occurred within the ®rst 3 h, and increasing contact time between the adjuvant/antigen and the
skin (3 h vs. 28 h exposure) did not appear to signi®cantly enhance LC migration. These results
indicate that while CT induced LC migration, the migration observed was not signi®cantly greater
than administration of the antigen DQ-OVA alone, and that only a brief exposure of either of
these agents is suf®cient to induce LC migration from human skin.
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Enhanced Internalization and Presentation of Transport Peptide Conjugated Antigens
by Dendritic Cells
L. Wang, J. Nayak, J. Plowey, S. Watkins, P. Robbins, G. Erdos, and L. Falo Jr
Departments of Dermatology, Cell Biology and Physiology, and Molecular Genetics and Biochemistry, Center
for Biologic Imaging, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine,
Pittsburgh, Pennsylvania
We have examined the effectiveness of an antigen delivery strategy that utilizes a transport peptide
(PTD-5) to deliver antigen to dendritic cells. First, we compared the internalization of FITC-OVA
conjugated to PTD-5, to the control antigens FITC-OVA and FITC-OVA conjugated to Avidin,
by bone marrow-derived dendritic cells grown for 5 days in the presence of GM-IL4. Compared
to controls, accumulation of FITC-OVA-PTD-5 was dramatically increased in the DCs after as
little as 15 min of incubation. A large proportion of the intracellular FITC-OVA-PTD-5 appeared
to be concentrated in many large compartments colocalizing with the lysosomal marker, Lamp-1.
Inhibition studies suggest that the internalization process involves not only an endocytic pathway,
but also a possible direct translocation through the membrane. In contrast, FITC-OVA or FITC-
OVA-Avidin was taken up by cells with less ef®ciency, and only through the endocytic pathway.
To evaluate the ef®ciency of presentation of PTD-5 conjugated antigens, the capacity of DCs to
present conjugated or control antigens to OVA-speci®c MHC class I and class II restricted
hybridomas was determined in vitro, and the capacity of antigen pulsed BMDCs to present antigen
to MHC class I-restricted, ovalbumin-speci®c, CD8+ T cells (OT-I cells) was evaluated in vivo.
These experiments demonstrated that presentation of OVA-PTD-5 was signi®cantly more ef®cient
through both MHC class I and II processing pathways both in vitro and in vivo. Our data clearly
indicate that PTD±5 association with antigen facilitates active and passive antigen entry into
BMDCs, and enhances MHC class I and II antigen presentation by BMDCs in vitro and in vivo.
This approach for delivering antigen to dendritic cells may be an important strategy for the
development of vaccines and immunotherapies.
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Dendritic-Cell Based Immunotherapies: Route of Administration Effects Dendritic Cell
Traf®ciking and Regional Immune Responses
L. Geskin, S. Watkins, L. Spencer, J. Plowey, C. Celluzzi, and L. Falo, Jr.
Department of Dermatology and the University of Pittsburgh Cancer Institute, University of Pittsburgh School
of Medicine, Pittsburgh, Pennsylvania
Dendritic cells (DCs) are the most potent antigen presenting cells (APCs). DC vaccines, based on
the adoptive-transfer of antigen-loaded DCs, are currently being evaluated as a strategy to induce
antitumor immunity in cancer patients. The effects of different routes of administration of DCs on
DC traf®cking, in vivo localization, and immunogenicity has not been conclusively determined,
and remains a critical issue for the development of DC-based therapies. To address this issue, the
effect of different routes of administration on subsequent localization of DCs in lymphoid organs,
and the correlation between DC localization and immunogenicity was determined. Identical
numbers of BmDCs were ¯uorescently labeled and injected into C57BL/6 mice either s.c. or i.v.
Lymphatic organs were harvested at varying time points after immunization and the presence of
labeled DCs in the lymph nodes and spleen was determined by ¯ow cytometery and quantitative
morphometric analysis. After s.c. injection, labeled DCs were detected in the regional but not
distant lymph nodes or spleen. Labeled cells were present in the regional lymph nodes for at least 5
days, reaching a peak by day 2. After i.v. injection labeled DCs were found in spleens, but not in
lymph nodes during the ®rst 3 days. To evaluate regional immunogenicity, we made use of an assay
based on the adoptive transfer of CFSE ¯uorescent dye-labeled OT-1 CD8+ T-cells into naõÈve
syngeneic recipients to measure antigen-speci®c T-cell proliferation in vivo. After 3 days,
considerable antigen-speci®c proliferative responses were observed in the draining lymph nodes,
but not the spleens, of SC injected animals. Conversely, IV injection of DCs led to brisk antigen-
speci®c proliferative responses in the spleens, but not in the lymp nodes, of injected animals. Taken
together, these results demonstrate that the route of administration effects subsequent traf®cking
and localization of adoptively transferred DCs, and in¯uences the development of regional
immune responses.
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Dendritic Cells (DC) Treated with TAT Protein Transduction Domain (PTD)-
Containing Recombinant Tumor Antigens Ef®ciently Induce Cytotoxic Lymphocytes
(CTL) and Tumor Immunity
N. Shibagaki and M. Udey
Dermatology Branch, National Cancer Institute, Bethesda, Maryland
There is considerable interest in harnessing the antigen presenting power of DC to elicit CTL in
cancer patients. CD8+ CTL recognize peptides that preferentially derive from endogenous
proteins and bind to MHC class I. We hypothesized that protein transduction could be used as an
alternative to cDNA transfection or viral infection to introduce proteins into DC and to load
MHC class I with peptide epitopes of interest. Plasmids encoding full length chicken ovalbumin
(Ova) with His6 and HA tags were engineered with and without an 11 amino acid HIV TAT
PTD, and bacterial recombinant proteins were puri®ed. TAT-HA-Ova rapidly entered EL-4
lymphoma cells, while PTD-de®cient HA-Ova did not. TAT-HA-Ova, but not HA-Ova, also
sensitized EL-4 thymoma cells to lysis by CTL speci®c for the Ova SIINFEKL peptide epitope.
SIINFEKL:H-2Kb complexes were detected on TAT-HA-Ova transduced EL-4 cells and
transduced bone marrow DC (BMDC) with a mab (25.d1.16). Subq injection of TAT-HA-Ova
pulsed BMDC led to generation of Ova-speci®c CTL in both normal and CD4+ T cell-de®cient
mhc class ii knockout mice. Bmdc pulsed with HA-Ova or the control protein TAT-HA-b-Gal
did not induce CTL. Vaccination with TAT-HA-Ova pulsed bmdc prevented growth of Ova
CDNA EL-4 stable transfectants into tumors in 24 of 26 recipients. Twenty of 30 mice that
received SIINFEKL peptide pulsed DC were also protected, while recipients of untreated or TAT-
HA-b-Gal pulsed BMDC were not. Recombinant TAT PTD-containing protein antigens can be
easily prepared, readily enter DC and are processed for MHC class I presentation as if they were
synthesized endogenously. DC transduced with ptd-containing tumor antigens are also potent
inducers of ctl that can ef®ciently eradicate tumors in mice. This vaccination strategy has
advantages over those that are in current use, and may promote development of ef®cacious dc-
based immunotherapies for use in patients.
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Induction of Tumor-Speci®c Protective Immunity by In Situ Langerhans Cell Vaccine
T. Kumamoto, E. Huang,* R. Valentini,* and A. Takashima
UT South-westerm, Dallas, Texas; *Brown University, Providence, Rhode Island
Many dendritic cell (DC)-based vaccine protocols have been recently developed for the treatment
of cancer patients. However, time- and cost-consuming ``customizing'' processes that are required
in the current format for isolation, expansion, and antigen-pulsing of autologous DC remain a
major hurdle for preventing broader clinical applications of this new vaccine concept. Here we
report a novel format that requires no ex vivo DC manipulation. Upon exposure to haptens,
Langerhans cells (LC) migrate to draining lymph nodes (DLN) and begin to exhibit features of
mature DC. We sought to entrap these migratory LC by creating an arti®cial chemokine gradient
in their homing path. Among several chemokines tested in the transwell system, MIP-3b promoted
optimal migration of mature DC. Based on these observations, we formulated ethylene-vinyl-
acetate (EVA) polymer rods that released biologically intact MIP-3b in a controlled fashion (300 ng
per ml release in the ®rst 48 h). When these rods were implanted subcutaneously into mouse
abdomen and DNFB was applied over the implantation sites, marked LC accumulation was
observed around the implanted MIP-3b rods, but not control BSA rods, and only after DNFB
painting. FITC-triggered LC homing to DLN (assessed by counting IA+/FITC+ LN cells) was
markedly (80%) inhibited by MIP-3b rod implantation at 24 h. Recovery of IA+/FITC+ LN cells
increased thereafter to the normal level at 72 h, indicating that LC can be entrapped transiently
without affecting their homing potential. As an attempt to load migratory LC with tumor-
associated antigens (TAA) at the entrapment sites, we coimplanted MIP-3b rods together with the
second EVA polymer rods releasing ovalbumin (OVA to serve as a model TAA) and applied
DNFB 24 h later. These mice developed potent CTL activities to lyse the OVA-transduced E.G7-
OVA tumor target, but not the parental EL4 tumor target, and exhibited almost full protection
against subsequent challenge with E.G7-OVA tumor cells (p < 0.01, 10 mice/panel). Only
marginal, if any, CTL activities or protection were observed in control panels receiving MIP-3b
rod alone, OVA rod alone, or both rods but in separate locations. Thus, tumor-speci®c protective
immunity is readily inducible by combining MIP-3b-mediated LC entrapment and EVA polymer-
based LC loading with relevant TAA. Our in situ LC vaccine strategy represents a major
breakthrough moving the DC-based vaccine concept toward practical medicine.
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Suppression of Allogeneic Immune Responses by CD95L-Transduced Killer Hybrids
Created by Fusing Donor- and Recipient-Derived Dendritic Cells
H. Matsue, K. Matsue, M. Kusuhara, T. Kumamoto, and A. Takashima
UT South-western, Dallas, Texas
Allogeneic immune responses, which are initiated by dendritic cells (DC) of both donor and host
origins, remain a major obstacle in organ transplantation. Allo-antigens are presented by dual
mechanisms: (a) direct presentation, in which T cells recognize intact allo-MHC molecules
expressed on allogeneic DC; and (b) indirect presentation, in which T cells recognize allogeneic
peptides presented by syngeneic DC. Here we report a novel strategy designed to suppress both
pathways. The stable DC line XS106 (A/J mouse origin) was transfected with CD95L cDNA and
fused with splenic DC puri®ed from allogeneic BALB/c mice. The resulting ``killer'' DC-DC
hybrid clones expressed CD95L and MHC class I and class II molecules of both A/J and BALB/c
origins and otherwise maintained phenotypic features of mature DC. In primary allo-MLR, killer
DC-DC hybrids completely abrogated proliferative responses of both CD8+ and CD4+ T cells
from A/J mice to BALB/c-derived DC, as well as T cell responses in the reversed direction
(BALB/c®A/J). In the 3H-thymidine release assay, killer DC-DC hybrids ef®ciently induced
apoptosis of allo-reactive T cells of both A/J and BALB/c origins. On the other hand, CD95L-
transduced XS106 DC (i.e. killer DC expressing A/J-derived MHC molecules alone) suppressed
the allo-responses between the two strains only partially, corroborating our previous report (Nature
Med 5:930, 1999). Vector-transfected control DC-DC hybrids delivered potent activation signals,
instead of apoptotic signals, to allo-reactive T cells from either strain. These results document the
unique ability of killer DC-DC hybrids to suppress complex allo-responses that occur bi-
directionally and via direct and indirect presentation mechanisms. When i.v. injected into BALB/c
mice, killer DC-DC hybrids inhibited almost completely their delayed-type hypersensitivity
(DTH) responses to A/J-associated allo-antigens, but not to irrelevant allo-antigens of C57/BL6
origin. Killer DC-DC hybrids also suppressed DTH responses of A/J mice to BALB/c-associated
allo-antigens, again, indicating bi-directionality. Moreover, the onset of GVHD in (BALB/c 3 A/
J) F1 hosts receiving A/J-derived hematopoietic cell transplantation was suppressed signi®cantly
(p < 0.001) by killer DC-DC hybrid treatment. These results establish a new concept that
allogeneic immune responses can be prevented by CD95L-transduced hybrids created by fusing
donor- and host-derived DC.
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BAFF, a TNF Family Member Expressed by Dendritic Cells, is Involved in T Cell
Activation
B. Huard, P. Schneider,* D. Mauri,² J. Tschopp,* and L. French
Dermatology, Medical University Center, Geneva, Switzerland; *Institute of Biochemistry, University of
Lausanne, Epalinges, Switzerland; ²R & D, Apotech Biochemicals Inc., Epalinges, Switzerland
BAFF is a recently described TNF family member with a potent stimulatory activity on B cells.
BAFF is expressed in dendritic cells and we will present data on the T cell costimulatory activity
mediated by BAFF. BAFF induces T cell proliferation and IFNg secretion in the presence of
suboptimal concentrations of antibodies to the TCR/CD3 complex. Interestingly, this
costimulation pathway is additive to the CD28 pathway. Resting T cells (CD4+ and CD8+) as
well as primed T cells were found to be responsive to this costimulation pathway. This indicates
that BAFF may not only regulate humoral but also cellular immune responses.
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Papillomavirus-Like Particles Cause Dendritic Cell Maturation and Induce a Potent In
Vitro Primary Immune Response
P. Lenz, P. Day, Y. Pang, D. Lowy, and J. Schiller
Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland
High risk human papillomaviruses (HPV) are present in virtually all cases of cervical carcinomas
worldwide providing an opportunity to prevent a major cause of cancer deaths in women through
vaccination. Papillomavirus-like particles (VLPs), composed of L1 major capsid proteins, are potent
inducers of humoral and cellular immune responses, making them attractive vaccine candidates and
early phase clinical trials are currently under way. However, the mechanisms of immune activation
by VLPs remain to be elucidated. Here we focused on the role of dendritic cells (DCs) in VLP-
induced immunity, given their essential role in initiating and modulating T cell responses. We
found that murine bone marrow derived dendritic cells (BMDCs) effectively bound and rapidly
internalized bovine papillomavirus (BPV) VLPs. Exposure to fully assembled VLPs of BPV, human
papillomavirus (HPV)16 or HPV18, but not to predominately disordered HPV16 capsomers
induced acute phenotypic maturation of BMDCs. Interestingly, structurally similar polyomavirus
VLPs bound to the DC surface and were internalized, but failed to induce maturation. DCs that
had incorporated HPV16 VLPs produced proin¯ammatory cytokines IL-1b, IL-6 and TNFa.
Production of IL-12p70 by VLP-exposed DCs required the addition of syngeneic T cells or
recombinant IFNg. Finally, BMDCs pulsed with HPV16 VLPs induced Th1-dominated primary T
cell responses in vitro. Our data provide evidence for the ability of DCs to respond to virion
structural patterns thereby causing a rapid transition from innate to speci®c immunity. They
furthermore offer a mechanistic explanation for the striking ability of papillomavirus VLP-based
vaccines to induce potent T cell responses in the absence of adjuvant.
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Mouse Bone Marrow-Derived Dendritic Cells Do Not Effectively Cross-Present
Haptens and Soluble Proteins on MHC Class II Molecules
E. Olasz and S. Katz
Dermatology Branch, NCI, Bethesda, Maryland
The phenomenon of ``cross-presentation'' results when antigen presenting cells (APC) take up
exogenous antigens and present them to CD8+ cells in the context of APC MHC class I
molecules. Cross-presentation is thought to play a role in the maintenance of tolerance, in the
rejection of transplants or tumor cells and in dendritic cell (DC)-based vaccines. Although cross-
presentation of MHC class I-restricted antigens is well documented, much less is known about
cross-presentation of antigens on MHC class II molecules. Our purpose was to determine whether
there is cross-presentation on MHC class II molecules during protein and hapten sensitization.
Thus, we functionally characterized mouse bone marrow-derived DC (BMDC) in vitro (in
protein-antigen and hapten-speci®c assays) and in vivo (injecting soluble protein- and hapten-
pulsed DC). For immunization purposes, 3±5 3 105 mature BMDC pulsed with 1 mg per ml hen
egg lysozyme (HEL) or with 1 mM TNBS were injected subcutaneously. Using an in vitro T cell
proliferation assay and in vivo delayed-type hypersensitivity (DTH) and contact sensitivity (CS)
assays we found that protein- and hapten-pulsed BMDC were able to sensitize syngeneic but not
allogeneic recipients. We also found that even large numbers of heat-killed allogeneic protein-
pulsed or hapten-coupled BMDC (up to 107 cells) did not induce CS or DTH. Furthermore, if we
injected BALB/c and C57BL/6-derived HEL-pulsed BMDC into F1 mice, speci®c secondary
proliferation of primed T cells occurred only when antigen-pulsed stimulator cells syngeneic to the
injected BMDC were used. These results demonstrate that, although immature DC take up and
cross present particulate antigen in the context of MHC class I molecules, BMDC do not
effectively cross present haptens and soluble proteins on MHC class II molecules. These ®ndings
increase our understanding about the potential in vivo immunogenic effects of BMDC when they
are used in vaccination and immunotherapy protocols.
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Transfection of Human Skin Dendritic Cells by Biolistic Delivery of Naked DNA
A. Larregina, G. Erdos, S. Watkins, L. Spencer, D. Beer Stolz, W. Storkus, and L. Falo, Jr
Departments of Dermatology, Surgery and the University of Pittsburgh Cancer Institute, University of
Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
Gene therapy techniques can be important tools for the induction and control of immune
responses. Antigen delivery is a critical challenge in vaccine design, and DNA based immunization
offers an attractive method to deliver encoded transgenic protein antigens. In the present study, we
used a gene gun to transfect human skin organ cultures with a particular goal of expressing
transgenic antigens in resident cutaneous dendritic cells with plasmid DNA encoding for different
reporter proteins (EGFP or ®re¯y luciferase) or for the human melanoma antigen MART-1.
Particle delivery to DC was determined in the epidermis by confocal microscopy and in migratory
DC (miDC) by transmission electron microscopy. The expression of reporter proteins was
determined by confocal microscopy and luciferase assays in epidermal or dermal sheets as well as in
puri®ed epidermal LC or in miDC. Activation and migration of LC was analyzed at different time
points after gene delivery. The possibility of direct transfection of cutaneous DCs was analysed by
RT-PCR. The ability of transfected LC to present transgenic peptides and to stimulate a CTL
response was analysed in cocultures of LC transfected with a pCDNA encoding for the human
melanoma antigen MART-1 with speci®c CTL clone HLA-A2 restricted. Our studies
demonstrate that delivered gold particles are observed primarily in the epidermis, even when
high helium delivery pressures are used. We demonstrate that Langerhans cells resident in the basal
epidermis can be transfected, and that biolistic gene delivery is suf®cient to stimulate the activation
and migration of skin dendritic cells. RT-PCR analysis of dendritic cells, which have migrated
from transfected skin, demonstrates the presence of transgenic mRNA, indicating direct
transfection of cutaneous dendritic cells. Importantly, transfected epidermal Langerhans cells can
ef®ciently present a peptide derived from the transgenic melanoma antigen MART-1 to a MART-
1 speci®c CTL.
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Comparative Analysis of Strategies Designed to Deliver Tumor-Derived Proteins to
Dendritic Cells
D. Hokey, L. Geskin, and L. Falo Jr
Department of Dermatology, University of Pittsburgh Cancer Institute, University of Pittsburgh School of
Medicine, Pittsburgh, Pennsylvania
Dendritic cells (DCs) are potent professional antigen presenting cells capable of inducing effective
antigen-speci®c CTL-mediated antitumor immunity. The development of effective strategies for
delivering tumor antigen to DCs in vitro and in vivo is critical for the development of antitumor
immunotherapies. In addition to the challenge of Ag delivery, most current tumor immunization
strategies depend on the identi®cation and production of appropriate tumor Ags. The development
of strategies to deliver tumor-derived proteins into the appropriate antigen presentation pathways
of dendritic cells could potentially overcome this limitation, resulting in polyvalent immunization
to multiple tumor-speci®c epitopes, while obviating the need to identify speci®c tumor Ags. Our
laboratory and others have investigated the use of whole tumor cells or tumor cell lysates as a
source of tumor antigens for DCs. While both methods result in the presentation of tumor antigens
by DCs, little has been done to compare their relative ef®cacy. Here, we use ¯uorescence
microscopy and ¯ow cytometry to compare the transfer of tumor-derived proteins to DCs
following coculture with either intact tumor cells or tumor cell lysates. Our results demonstrate
that culture with either whole tumor cells, or tumor cell lysates, results in the transfer of tumor-
derived proteins to DCs. Quantitatively, feeding tumor cell lysates derived from ¯ourescently
labeled tumor cells results in a signi®cantly greater increase in mean ¯uorescence intensity of DCs
when compared to the ¯uorescence intensity of DCs cocultured with intact, identically labeled
tumor cells. These results indicate that these distinct methods of tumor antigen delivery to DCs
result in signi®cant differences in the ef®ciency of antigen delivery, which may impact the
functional immunogenicity of tumor-antigen loaded DCs.
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The Skin Receiving Gene Therapy Induces Immune Response through Cross-priming
H. Kosaka, H. Azukizawa, I. Takahashi,* X. Gao,² J. Takeda,³ S. Itami, and K.Yoshikawa
Dermatology, Osaka University, Suita, Japan; *Internal Medicine and Molecular Science, Osaka University,
Suita, Japan; ²Dermatology, China Medical University, Shenyuang, China; ³Social and Environmental
Medicine, Osaka University, Suita, Japan
Although a current theme of gene therapy is mostly focused on how to transfer the gene into target
tissues, another important subject is to control immunologic reaction to newly introduced
molecule. Here we study the immune response of the host after gene transfer into the epidermis,
by means of establishing K5-mOVA, a transgenic mouse expressing a membrane-bound form of
ovalbumin (OVA) under keratin5 promoter as a model. To represent the situation that patients
receive autologous skins having been manipulated with the gene, the skin expressing OVA is
transplanted on nonexpressing syngeneic mice. The skin graft is, however, rejected, implying that
the immune system of the host recognizes the newly synthesized protein coded in the gene. To
analyze the recognition mechanism of CD8+ T cells that play a crucial role in the rejection of
endogenously expressed antigen, OVA-speci®c CD8+ T cells are transferred into K5-mOVA mice.
OVA speci®c CD8+ T cells home to the skin draining lymph node, followed by being activated
and proliferating. This response that is restricted with MHC class I antigen of bone marrow derived
cells is referred to cross-priming. From these results, we propose that the gene should be modi®ed
to lessen the immunogenecity of the product otherwise the immune response of the host might
bring the gene therapy to no vail.
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Modulating Speci®c Immune Responses by Varying the Route of Vaccine
Administration
P. LuÈhrs, R. Kutil, M. Buschle,* W. Schmidt,* G. Stingl, and A. Schneeberger
Department of Dermatology, DIAID, University of Vienna Medical School, Vienna, Austria; *InterCell,
Vienna, Austria
We have previously shown that the subcutaneous (s.c.) injection of a vaccine consisting of b-
galactosidase and poly L-arginine induces an antigen-speci®c T cell response able to protect animals
against a challenge with tumor cells expressing this model antigen. In this study, we asked whether
the route of administration would in¯uence quality and quantity of this response. To this end, mice
received the protein vaccine either via the s.c. or intradermal (i.d.) route and were then analyzed
for the occurrence of antitumor immunity. We found that, while the s.c. administration of the
protein vaccine prevented the growth of b-gal-expressing tumor cells (RENCAlacZ) in only 50%
of the animals, the i.d. application of the antigenic complex resulted in protection rates of 80±
100%. Depletion experiments revealed that CD8+ T lymphocytes are crucial in this regard. b-gal-
speci®c antibodies present in these animals did probably not contribute to the antitumor effect
observed as they failed to bind intact RENCAlacZ cells. To test whether the protection rates of the
two routes of protein vaccine administration would correlate with the strength of the T cell
response, we quanti®ed the number of cytokine-producing CD8+ T lymphocytes recognizing the
immunodominant epitope of b-gal. While both modes of vaccine application activated similar
numbers of IL-4-producing T cells, the i.d. vaccine administration was superior in its capacity to
elicit IFNg-expressing T lymphocytes. These results demonstrate that the i.d. administration of
surrogate tumor antigens induces a more effective state of antitumor immunity than the
vaccination via the s.c. route. Our ®ndings also lend further support to the hypothesis that the
Th1/Tc1 rather than the Th2/Tc2 component of the immune response is of decisive importance
for the prevention of tumor growth.
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CpG Motifs Act as Ef®cient Adjuvants for pDNA-Based Vaccines to Induce Protective
Antitumor T Cell Responses only when Directly Introduced into Vector Sequences
S. Wagner, T.Weimann, C. Wagner, P. LuÈhrs,* M. Goos, G. Sting, and A. Schneeberger
Department of Dermatology, University of Essen, Essen, Germany; *Department of Dermatology, University
of Vienna, Vienna, Austria
DNA sequences containing a consensus immunostimulatory motif, so called CpG motifs, have
been shown to stimulate induction of cellular and humoral immune responses. In this study we
asked whether CpG motifs are a useful adjuvant for genetic cancer vaccines to induce antigen-
speci®c T cell responses in vivo. We therefore analyzed the induction of protective T cell responses
against the melanoma self-antigen Pmel17/gp100 in the experimental Cloudman M3/DBA/2
mouse melanoma model. When given simultaneously as oligodeoxynucleotides, CpG motifs
abrogated any protective effect induced otherwise by mPmel17-encoding pDNA against a tumor
cell challenge with Pmel17 6 M3 melanoma cells. To analyze the adjuvant activity of CpG motifs
present in vector sequences, we cloned 16 CpG motifs into the backbone sequences of pDNA
vector pUK21-A2 thereby generating its CpG-enriched derivative pMCG16. Mice immunized
with mPmel17/pMCG16 pDNA showed a signi®cantly increased protection against subsequent
melanoma challenge with Pmel17+-M3 melanoma cells as compared to mice immunized with the
parental vector. Induction of an antigen-speci®c T cell imune response by mPmel17/pMCG16
pDNA could be demonstrated by (i) induction of protection against Pmel17+- but not Pmel17±-
M3 melanoma sublines (ii) complete loss of protection by in vivo CD4+/CD8+ T cell but not NK
cell depletion and (iii) the detection of a Pmel17/gp100-speci®c T cell response in CTL assays at
levels consistently higher than in splenocytes immunized with the parental vector construct. These
results demonstrate for the ®rst time that CpG motifs can improve the induction of protective,
antigen-speci®c T cell IR by pDNA vaccines when introduced into vector sequences but not
when coadministered as oligodeoxynucleotides.
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DNA-Based Vaccines: Mechanisms of Immune Activation
A. Schneeberger, P. LuÈhrs, C. Wagner,* T. Weimann,* M. Goos,* G. Stingl, and S. Wagner
Department of Dermatology, DIAID, University of Vienna Medical School, Vienna, Austria; *Department
of Dermatology, University of Essen Medical School, Essen, Germany
We have recently shown that the direct intradermal (i.d.) injection of plasmid DNA coding the
autologous form of Pmel17 induces a T cell response to this antigen that is able to protect DBA/2
mice against a challenge with an otherwise lethal dose of syngeneic Pmel17-expressing melanoma
cells. In the present study, we attempted to explore the mechanism(s) of this protective response.
To this end, we used b-galactosidase (b-gal) as a surrogate antigen. A single i.d. injection of a
VR1012 vector engineered to express the lacz gene led to the activation of b-gal-speci®c CTLs
and antibodies (IgG2aIgG1). Mice depleted of CD4+ T cells failed to mount a speci®c CTL as well
as antibody response. To learn more about the fate of the vector at the injection site (i-site), we
injected BALB/c mice with VR1012 lacz, excised the i-sites at de®ned time points thereafter (days
1, 4, 6, 8, 11, 13) and evaluated the animals for the presence of b-gal-speci®c T and B cells on day
14. Results obtained showed that the removal of the i-site until d 6 prevented the activation of
peptide epitope-speci®c T cells (as assessed by Elispot) and of a speci®c antibody response (as
assessed by ELISA). We began to detect b-gal-speci®c immunity when the i-site stayed in situ for 8
days (number of Elispots 20% of those seen in nonexcised control mice). By day 11, the immune
reaction was approximately half as strong as that seen in nonexcised controls and comparable to it
by day 13. Our data suggest that for the formation of the sensitizing antigenic moiety, the
intradermally injected vector must interact with skin cells rather than being immediately
transported to the regional lymph node. The experimental system presented in this study should
not only be useful to identify the critical sensitizing cell population of the skin but also to devise
and test strategies to improve the transfection ef®cacy and thereby the immunologic potency of
DNA-based vaccines.
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Comparison of Genetic with Conventional Protein Vaccines: Induction of Protective
Antitumor T Cell Responses Against Tumor Antigen Expressed by pDNA-Based
Vaccine but not Against Recombinant Protein
S. Wagner, T. Weimann, C. Wagner, P. LuÈhrs,* A. Zemann, M. Goos, G. Stingl, and A.
Schneeberger
Department of Dermatology, University of Essen, Essen, Germany; *Department of Dermatology, University
of Vienna, Viennna, Austria
The recent development of genetic vaccines raises the question whether these genetic vaccines are
superior to conventional immunization strategies employing the respective protein for the
induction of protective T cell responses. We therefore cloned the 1.9 kb full length cDNA murine
homologue of human MAA Pmel17/gp100, generated a recombinant baculovirus containing the
respective cDNA sequence by ligation independent cloning, expressed the recombinant protein in
Sf9 insect cells, and con®rmed its identity by SDS-PAGE and Western blot analysis. This
recombinant full-length protein was compared with a pDNA vaccine for the induction of
protective antigen-speci®c T cell responses in the experimental Cloudman M3/DBA/2 mouse
melanoma model. Mice genetically immunized with mPmel17-encoding pDNA showed
signi®cant protection against subsequent tumor challenge with Pmel17+-M3 melanoma cells in
contrast to mice immunized with the recombinant protein (p < 0.001 at day 15). Whereas
induction of an antigen-speci®c T cell response by mPmel17-encoding pDNA could be
demonstrated by (i) induction of protection against Pmel17+- but not Pmel17±-M3 melanoma
sublines (ii) complete loss of protection by in vivo CD4+/CD8+ T cell depletion and (iii)) the
detection of a Pmel17/gp100-speci®c T cell response in CTL assays, antigen-speci®c T cell
responses could not be detected in mice immunized with the respective recombinant protein.
These results demonstrate for the ®rst time that genetic immunization with antigen-encoding
pDNA is superior to immunization with the respective recombinant protein for the induction of
antigen-speci®c, protective antitumor T cell responses in vivo.
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Suppression of the Induction of Delayed-Type Hypersensitivity (DTH) to Tumor-
Associated Antigens by Intravenous Administration of Tumor RNA can be Transferred
with Spleen Cells
D. Faulhaber, W. Ding, and R. Granstein
Department of Dermatology, Weill Medical College of Cornell University, New York, New York
Intravenous (i.v.) administration of protein antigens can induce relative tolerance to subsequent
immunization with that antigen. We have previously reported that i.v. injection of total cellular
RNA from the S1509a spindle cell tumor line also reduces immunity to tumor associated antigens
derived from this tumor cell line. In this study we examined whether the suppression of immunity
can be transferred by spleen cells. A group of CAF1 mice (n = 10) was primed i.v. with 100 mg of
total cellular RNA from the S1509a spindle cell tumor line, control groups were primed i.v. with
saline alone or with unrelated RNA from the NS cell line. One week after i.v. injection the spleen
cells of the mice were harvested and subsequently transferred i.v. into naõÈve CAF1 mice. All mice
were then immunized by subcutaneous injection of disrupted S1509a cells 3 times at weekly
intervals. One week after the last immunization, syngenic epidermal cells enriched for Langerhans
cell content (eEC) by antibody- and complement-mediated deletion of Thy-1-bearing cells were
pulsed with a soluble extract of the S1509a cells as a source of tumor-associated antigens (TAA).
TAA-pulsed eEC were then injected into a footpad of each mouse. Twenty-four hour footpad
swelling was assessed as a measure of DTH with a spring-loaded micrometer. Mice given spleen
cells from S1509a RNA-primed mice demonstrated a signi®cantly (p < 0.001) smaller DTH
response (31 3 0.01 mm 6 1.9 [SEM]) compared to mice given spleen cells from mice primed i.v.
with saline (49 3 0.01 mm 6 2.4 [SEM]) or unrelated NS-RNA (43.3 3 0.01 mm 6 1.9 [SEM]).
These results demonstrate that the suppression of the DTH response to S1509a derived TAA
induced by i.v. administration of total cellular RNA from the S1509a spindle cell tumor line can be
transferred with spleen cells.
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Epicutaneous Application of Peptide Allows Priming of Cognate Cytotoxic T Cells in
the Presence of IL-12 and in the Absence of Barrier Disruption
J. Dutz and Y. Hu
Medicine, University of British Columbia, Vanvcouver, BC, Canada
It has recently been shown that epicutaneous application of peptide to tape stripped skin can allow
priming of cognate cytotoxic T cells (CTL). Barrier disruption results in increased permeability to
exogenous peptides and in the activation of resident dendritic cells. IL-12 is a cytokine that is
known to facilitate the priming of CTL and can be produced by keratinocytes. The purpose of this
study was to determine whether the epicutaneous administration of peptide results in the priming
of cognate CTL in the absence of barrier disruption. Using a patch protocol, we immunized mice
with a peptide (SIYRYYGL) recognized by the 2C T cell receptor on Kb. NaõÈve T cells transgenic
for the 2C T cell receptor were adoptively transferred to these animals prior to immunization. The
presence of systemically administered IL-12 (1 mg IP daily, on days 0±2) allowed the proliferation
of cognate CTL as determined by FACS analysis. Further, these cells were functional as determined
by a standard chromium release killing assay. Thus epicutaneous administration of peptide to intact
skin can result in the priming of CTL in the presence of IL-12. Strategies that enhance local IL-12
release may potentiate CTL priming to epicutaneous antigen.
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Delayed Type Hypersensitivity Skin Reactions to HIV-1 Epitopes Induced with
Engineered Plasmids in the Guinea Pig
H. Maguire Jr, M. Chattergoon, T. Robinson, J. Boyer, and D. Weiner
Pathology, University of Pennsylvania, Philadelphia
We have found that delayed type hypersensitivity (DTH) to protein can readily be induced in the
guinea pig with a plasmid expressing that protein. In a typical experiment three guinea pigs were
sensitized by the intradermal injection of 100 micrograms of a plasmid expressing gp160 of the
HIVmn envelope protein, in PBS. Ten days later they and three naive guinea pigs were challenged
intradermally with gp120 protein. The perpendicular diameters in mm. of the induration of the
skin tests at 24 h of the plasmid sensitized guinea pigs was 13 3 15, 12 3 12 and 10 3 13, and that
of the controls was 0 3 0, 0 3 0 and 0 3 0. The histology of the skin reactions showed a round cell
in®ltrate and edema characteristic of DTH. Other experiments with plasmids expressing unrelated
proteins demonstrated the speci®city of the sensitization. In further studies, we sensitized guinea
pigs to HIV-1 envelope with plasmids, or with protein in complete Freund's adjuvant. Epitope
analysis by skin testing ®rst with pools and then with individual peptides from a group of
overlapping peptides encompassing gp120 revealed common epitopes as well as epitopes unique to
each method of sensitization. The model provides a useful technique for rapidly comparing
different vaccine strategies and for optimizing immunization programs as relates to cell mediated
immunity.
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Treatment of Human Cells with HSP70-Rich Yeast Extract Enhances Cell
Thermotolerance and Resistance to Stress
J. Botto, K. Cucumel, C. Dal Farra, and N. Domloge
Biochemistry and Dermatology, Seporga Research Laboratories, Sophia Antipolis, France
Heat Shock Proteins (Hsp) represent a family of widely expressed chaperon proteins implicated in
maintaining cell integrity after an exposure to a stress stimulus. Hsp expression is regulated at the
transcriptional level by Heat Shock Factors (HSF) and an overexpression is observed a few hours
after stress exposure. Based on the great sequence homology of 70% to 85% with human Hsp, and
in order to provide the cell with Hsp molecules without stress, yeast heat-induced Hsp70 and HSF
extract were prepared by Biotechnology from an ascomycota fungus strain and administered to the
cells in these studies. Dose studies were conducted on human ®broblasts incubated with or without
the yeast extract during various points over time. Total protein extract as well as total RNA were
subsequently prepared. Proteins were submitted to SDS-PAGE and immunoblotting and the
expression of Hsp70 was examined. In parallel, Hsp70 mRNA level was studied using a
digoxigenin-labeled probe in Northern blot experiments. Immunoblotting studies demonstrated
that ®broblasts treated with the yeast extract show a very rapid increase (within 30 min) in their
Hsp70 content (over their HSC level). The Northern blot experiments revealed a transient and
reproducible Hsp70 mRNA expression increase 3±5 h after the incubation with the yeast extract.
This suggests that the early increase in Hsp is due to yeast Hsp. Additional studies show that cells
treated with yeast Hsp demonstrate no sign of cell stress and a signi®cant increase in their thermal
and UV tolerance. The cells exhibited an immediate superior resistance, with no time needed for
Hsp synthesis. Studies on the ex vivo model con®rmed this bene®cial effect. These interesting
results provide the ®rst evidence that Hsp70 extract stress-free administration to the cells enhances
their protection and defense from stress.
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Hyperproliferative Activity of Mast Cells Derived from Atopic Dermatitis Model Mice
NC/Nga through Enhanced Tyrosine Phosphorylation of JAK/STAT Pathways
K. Mitsuishi, K. Kawamoto,* H. Suto, K. Hira, C.Ra,* and H. Ogawa
Dermatology, Juntendo University, Tokyo, Japan; *Atopy(Allergy) Research Center, Juntendo University,
Tokyo, Japan
NC/Nga (NC) mice, a model mouse for human atopic dermatitis (AD), kept in air-uncontrolled
conventional circumstances spontaneously suffer from AD-like eczema and pruritus. The skin
lesions of NC mice with dermatitis show hyperkeratosis, lymphocyte and eosinophil in®ltration,
and marked increase of mast cells, and the severity of dermatitis well correlated with the number of
dermal mast cells. In this sutdy, we investigated the mechanism of mast cell hyperplasia in NC mice
by using bone marrow-derived cultured mast cells (BMMC). The BMMC of NC mice showed
higher uptake of [3H]thymidine by stimulation of mast cell growth factors including IL-3 and stem
cell factor (SCF) than those of BALB/c mice. There was no signi®cant difference in the expression
of the speci®c receptors for IL-3 and SCF on mast cells between these two mice, however, tyrosine
phosphorylation of Janus kinases (JAK) 2 and signal transducer and activator of transcription
(STAT) proteins in postreceptor signaling of IL-3 and SCF stimulation was markedly enhanced in
NC BMMC. Thus, it is suggested that the hyperactivation of JAK/STAT pathways of mast cells in
response to IL-3 and SCF may be attributable to marked increase of mast cell number of the skin
lesions in NC mice.
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The Secretory Mediator Release of NC/Nga Mice Mast Cells
K. Hira, K. Mitsuishi, K. Kawamoto,* V. Supajatura, H. Suto, C. Ra, and H. Ogawa
Dermatology, Juntendo University, Tokyo, Japan; *Atopy (Allergy) Research Center, Juntendo University,
Tokyo, Japan
NC/Nga Mice, an animal model for human atopic dermatitis (AD) spontaneously suffer from AD-
like eczema and pruritus associated with high serum IgE when raised in a nonsterile environment.
Skin lesions of NC/Nga mice show hyperkeratosis, lymphocyte and eosinophil in®ltration and
marked increase of mast cells, and the severity of dermatits well correlate with the number of
dermal mast cells. In this study, we investigated the degranulation response of NC/Nga mice mast
cells when stimulated through the IgE receptor. First, we observed the IgE-mediated degranulation
of bone marrow-derived mast cells and of peritoneal mast cells in NC/Nga, using BALB/c mice as
a control, by b-hexosaminidase release assay. Although there were no signi®cant differences in the
percent release of b-hexosaminidase, the amount released and the cell content was greater in NC/
Nga mice. Next, the percutaneous anaphylaxis (PCA) reaction was observed. PCA reaction was
greater in NC/Nga mice compared to BALB/c mice. These results suggest that the amount of
secretory granules such as b-hexosaminidase, released, may be a factor which cause its strong PCA
reaction, and may contribute to the skin in¯ammations characteristic of NC/Nga mice.
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Fetal Skin-Derived Cultured Mast Cells (FSMC); a Novel Model to Study Cutaneous
Mast Cells
N. Yamada, Y. Tagaya,* S. Shimada,² and S. Katz
Dermatology, National Cancer Institute, Bethesda, Maryland; *Metabolism, National Cancer Institute,
Bethesda, Maryland; ²Dermatology, Yamanashi Medical University, Yamanashi, Japan
We describe a novel culture system for generating large numbers of murine skin-associated mast
cells and distinguish their characteristics from bone marrow-derived cultured mast cells (BMMC).
Addition of IL-3 and SCF to day 16 fetal skin single cell suspensions allowed expansion and
maturation of mast cells in the presence of stromal cells. The average yield of mast cells after two
weeks was 7.3 million cells per fetus at a purity of 96%. These fetal skin-derived cultured mast cells
(FSMC) increased their histamine content in a time-dependent manner to 3.6 pg per cell after two
weeks and 6.7 pg per cell after four weeks. Phenotypic analyses revealed much greater expression of
DX5 and CD81 and lesser expression of CD77 and CD102 on FSMC as compared with BMMC.
These ®ndings suggest a close similarity between FSMC and freshly isolated cutaneous mast cells.
Connective tissue mast cell characteristics of FSMC were evidenced by (1) their greater histamine
content (2) the presence of heparin, and (3) their degranulation in response to compound 48/80
and substance P. Importantly, we also identi®ed functional differences between FSMC and
BMMC including (1) different dose±response curves (of IgE and antigen) after FceRI crosslinking,
and (2) altered cytokine secretion (more IL-13 but much less MIP-1b and IL-6 by FSMC). Thus
FSMC have many characteristics distinct from BMMC and can be used as a model of cutaneous
mast cells to discern their functions and to potentially serve for screening of skin mast cell-
modifying drugs.
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CD4+T-Cells Augment DMBA Skin Carcinogenesis
C. Elmets, B. Bjarnason, N. Iranikhah, E. Arnold, and H. Xu
Department of Dermatology, University of Alabama at Birmingham, Birmingham, Alabama
Polyaromatic hydrocarbons (PAHs) are ubiquitous environmental agents, which, when applied
topically, produce cutaneous malignancies in animal models and in humans. Studies from our
laboratory have shown that topical application to mice of several different PAHs also results in the
development of antigen speci®c cell-mediated immunity. The objective of this study was to
characterize the T-cells that are responsible for PAH contact hypersensitivity and to determine
whether they participate in PAH-induced skin tumorigenesis. Topical application of the
carcinogenic PAH, 7,12-dimethylbenz(a)anthracene (DMBA) to C3H/HeN mice, as expected,
resulted in the development of contact hypersensitivity. In vivo administration of anti-CD8
antibodies prior to sensitization abrogated the response. In contrast, in vivo depletion of CD4+ T-
cells with anti-CD4 antibodies augmented DMBA contact hypersensitivity and treatment of
CD4+ knockout mice on a C3H background with DMBA also was found to increase DMBA
contact hypersensitivity. When ELISAs were performed on T-cells from DMBA contact sensitized
mice to determine the cytokine pro®le of T-cells, CD8+ T-cells were found to produce interferon
g and little or no IL-4, whereas CD4+ T-cells were found to elaborate both IL-4 and interferon g.
To determine if CD4+ T-cells augmented PAH skin tumorigenesis, CD4+ knockout and wild
type mice were compared when subjected to a DMBA skin tumorigenesis protocol. CD4+
knockout mice developed 80% fewer tumors than wild type mice. The percent of mice with
tumors and the number of tumors/tumor bearing mice were also decreased in CD4+ knockout
mice. These ®ndings are consistent with the hypothesis that, in addition to immune responses
against PAH-induced tumors, there are immune responses to the PAHs themselves and that the
CD4+ T-cell subpopulation suppresses those host defense mechanisms. Immunopreventive
strategies in which the action of CD4+ T-cells is inhibited in individuals predisposed to the
development of chemically induced skin tumors may be successful in reducing PAH cancer
development.
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Treatment of Murine BMDC with a-MSH Results in the Generation of T-Suppressor
Cells
T. Brzoska, A. Schwarz, M. Moeller, B. Altmann, H. Kalden, T. Scholzen, T. Schwarz, S. Grabbe,
and T. Luger
Department of Dermatol. and Ludwig Boltzmann Institute for Cell- and Immunobiology of the Skin,
University of MuÈnster, MuÈnster, Germany
Intravenous injection of the immunomodulating peptide a-MSH induces hapten-speci®c
tolerance. To investigate the underlying mechanisms, bone marrow derived dendritic cells
(BMDC) were generated from Balb/C mice with GMCSF and IL-4. On day 6, cells were treated
3 h with a-MSH (10±11 M) and/or DNBS (1 mM) for 2 h. After washing BMDC (5 3 105) were
injected i.v. into naive mice. 5 d later, mice were challenged with DNFB and the ear swelling
response was measured. To evaluate tolerance induction, mice were resensitized after 2 weeks and
rechallenged 5 d later. Mice treated with DNBS pulsed BMDC developed a signi®cant ear swelling
response upon challenge with DNFB which was even enhanced after resensitization. In contrast,
mice injected with a-MSH exposed BMDC revealed a signi®cantly reduced ear swelling response.
In addition, ear swelling was still suppressed following resensitization, indicating that tolerance had
developed. Tolerance was hapten speci®c, since the same animals could be normally sensitized with
the unrelated hapten oxazolone. In order to test whether a-MSH treated BMDC induce tolerance
via the generation of T-suppressor cells, BMDC were treated with DNBS and/or a-MSH and
coincubated with T-lymphocytes derived from lymphnodes of DNFB sensitized mice. Treatment
(i.v.) of naive mice with these T-lymphocytes resulted in signi®cant inhibition of chs and induced
tolerance against DNFB. Since it was recently shown that the T-suppressor mediating suppression
in the model of UV-induced tolerance express CTLA-4, T-lymphocytes in this study were tested
for CTLA-4 expression. A-MSH-treated bmdc induced the generation of a subpopulation of
CTLA-4+ (= 5%), CD4+ and CD8+ lymphocytes. These data suggest that a-MSH pulsed dc may
cause immunosuppression and tolerance induction through the generation of CTLA-4+ T-
suppressor lymphocytes.
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IL-13 is Required Independently of IL-4 for Epicutaneously Induced Th2 Responses to
Soluble Protein
C. Herrick, R. Tigelaar, and K. Bottomly
Dermatology and Immunobiology, Yale School of Medicine, New Haven, Conneticut
Unlike contact-induced responses to low molecular weight haptens (e.g. contact dermatitis),
epicutaneous (e.c.) exposure to protein antigens can lead to vigorous Th2 type immune responses
(e.g. contact urticaria or latex hypersensitivity). We have shown that e.c. sensitization of mice to
ovalbumin (OVA) leads to systemic Th2 activation, as evidenced by: (1) OVA-speci®c IgG1 and
IgE responses; (2) lung in¯ammatory responses following airway challenge with high numbers of
eosinophils; and (3) Th2 cytokine production by in¯ammatory cells (IL-5, IL-13). Furthermore,
these Th2 responses are still generated in IL-4 de®cient (±/±) mice, but not when IL-4±/± mice are
also depleted of IL-13. It was not clear, however, whether IL-13 was simply able to replace IL-4,
consistent with previously described redundant roles for these cytokines, or if IL-13 had an
independent role in Th2 activation. To address this, IL-13±/± mice were exposed to e.c. OVA
(100 mg) on day 0 and then challenged with inhaled OVA (25 mg) from day 14±19. Th2 responses
were markedly impaired in IL-13±/± mice, compared to wildtype (WT), in that: (1) OVA-speci®c
IgG1 levels were decreased (53 6 16 vs. 186 6 52 mg per ml; p = 0.02); (2) serum IgE levels were
decreased (130 6 30 vs. 1603 6 673 ng per ml; p = 0.03); and (3) both the total number of cells
recovered by bronchoalveolar lavage (BAL) (2.1 6 0.2 vs. 15.7 6 4.7 3 105; p = 0.005), as well as
the number of eosinophils in BAL (0.7 6 0.2 vs. 132 6 43 3 104; p = 0.003) were decreased. In
addition, skin-draining lymph node (LN) cells from IL-13±/± mice, isolated 4 days after e.c. OVA
exposure and restimulated in vitro with OVA, produced reduced amounts of the Th2 cytokine IL-5
(124 6 29 vs. 591 6 299 pg per ml), but equivalent amounts of the Th1 type cytokine IFN-g
(9.0 6 3.8 vs. 10.3 6 2.9 ng per ml) as compared to LN cells from WT mice. In contrast, induction
of contact hypersensitivity to the hapten DNFB, a response mediated by Th1 CD4 and CD8 T
cells, was not impaired in IL-13±/± mice. Thus, IL-13 plays a critical role in generation of Th2
responses speci®cally to epicutaneously encountered antigens.
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Potential Mechanism of CD8 Effector T Cell Dominance in Murine Contact
Hypersensitivity to Trinitrophenol (TNP)
J. Simon, S. Martin, and J. Dudda
Dermatology, University of Freiburg, Freiburg, Germany
For a variety of allergic reactions to haptens it has recently been shown that CD8+ T cells rather
than CD4+ T cells are the crucial effector cells. We have used the murine model of contact
hypersensitivity (CHS) to the hapten trinitrophenol (TNP) to analyse the mechanisms underlying
the predominance of CD8+ T cells as effectors in this type IV allergic reaction. When mice were
immunized by i.d. injection of TNP-modi®ed DC an ef®cient ear swelling response was detected
after ear challenge. The effector cells isolated from regional draining lymph nodes turned out to be
cytotoxic, IFN-g producing Tc1 type CD8+ T cells. Functional as well as phenotypic analysis of
the activated effector cells revealed a lack of CD4+ T cell priming despite the presence of
immunogenic TNP-epitopes for CD4+ T cells on the antigen presenting cells (APC). In an in vitro
T cell priming system using DC as APC and T cells and APC from Perforin-de®cient and Fas/
FasL-de®cient mice, we could show that soluble factors do not play a role in the preferential CD8+
T cell priming but that the CD8+ Tc1 effectors lyse the CD4+ T cells in a Fas dependent manner.
These ®ndings suggest that bystander cytolysis of CD4+ T cells could be the mechanism
underlying the preferential CD8+ T cell activation observed for a number of allergic responses to
haptens. This work was supported by the Klinische Forschergruppe ``Pathomechanismen der
allergischen EntzuÈndung'' BMBF FKZ: 01GC9701/7.
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Migratory Properties of Naive, Effector, and Central Memory CD8+ T Cells
W. Weninger, M. Crowley, N. Manjunath, and U. von Andrian
The Center for Blood Research, Harvard Medical School, Boston, Massachusetts
It was recently proposed that different subsets of antigen-experienced T cells may exist that are
distinguishable by their preferential ability to home to lymphoid tissues (central memory cells) and
nonlymphoid sites (effector cells and effector memory cells). We have shown that antigen primed
CD8+ T cells, when cultured in IL-15, resemble central memory cells by phenotype and function
(CD8cm); CD8cm cells are CD44hi, L-selectinhi, express CCR7, and mount rapid antigen speci®c
recall resposes in vivo. In contrast, antigen primed CD8+ T cells cultured in IL-2 (CD8eff) are
CD44hi, L-selectinlo, CCR7-, and display effector functions, such as lysis of antigen presenting
cells. Here we report the in vivo traf®cking behavior of CD8cm and CD8eff cells. Both CD8cm and,
to a lesser degree, CD8eff cells localized to the T cell area in the spleen, but only CD8cm and not
CD8eff cells homed ef®ciently to peripheral (PLN) and mesenteric lymph nodes (MLN) or Peyer's
patches. Intravital microscopy of PLN revealed that CD8cm cells, but not CD8eff cells, rolled and
arrested in high endothelial venules. Migration of CD8cm cells to lymph nodes depended on L-
selectin and required chemokines that act on CCR7 (i.e. SLC and/or ELC); CD8cm homing to
PLN and MLN of plt/plt mice, which do not express CCR7 agonists in lymphoid organs, was
reduced by 80% and 87%, respectively. Both antigen experienced subsets, but not naive cells
responded to in¯ammatory chemokines (RANTES, MCP-1, and IP-10) and accumulated at sites
of in¯ammation. CD8eff cells homed ~12-fold more ef®ciently to the in¯amed peritoneal cavity
than CD8cm cells, whereas naive T cells were incapable of entering this site of in¯ammation. In
summary, IL-2 treated antigen primed CD8+ effector T cells cells home ef®ciently to in¯amed
tissues, but are excluded from entry into most lymphoid organs. Differentiation of antigen primed
CD8+ T cells with IL-15 generates central memory-like cells that enter lymphoid organs via HEV
and can also migrate to sites of in¯ammation.
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Epidermis-In®ltrating Lymphocytes Possess a Repertoire of Homing Molecules and
Chemokine Receptors Unique Among Tissue-In®ltrating Lymphocytes
J. Campbell,* E. Butcher, and E. Kunkel
Department of Pathology, Stanford University School of Medicine, Palo Alto, California; *Department of
Pathology, Harvard Medical School, Boston, Massachusetts
The hypothesis that peripheral blood memory lymphocytes are subdivided into discrete subsets
with distinct tissue tropisms has received much experimental support in the past few years. Speci®c
expression of adhesion molecules and (more recently) chemokine receptors has been linked to
these subsets. Within the memory CD4 T cell population, the adhesion molecule CLA and the
chemokine receptor CCR4 are associated with the skin-homing subset, while integrin a4b7 and
chemokine receptor CCR9 are associated with the small-intestine-homing subset. Here, to shed
light on the mechanisms by which cells enter tissues speci®cally, we have undertaken to
characterize CD4 lymphocytes isolated directly from a wide variety of normal and in¯amed tissues.
We have developed nonenzymatic methods to isolate cells directly from normal and in¯amed
epidermis. Using the same methods, we have isolated CD4 lymphocytes from lung, synovial ¯uid,
liver, jejunum, ileum, colon (nonlymphoid tissues) and tonsil (a representative secondary lymphoid
tissue); for comparison with those from skin. We have found that cells isolated from skin are
dramatically enriched in CLA expression, but depleted in a4b7 expression. Cells isolated from
intestinal sites display a reciprocal pattern: depletion of CLA but enrichment of CCR9. Cells
isolated from blood and lymphoid tissues consisted of both naõÈve and memory phenotypes, whereas
nonlymphoid tissues contained only memory cells. Activated cells (as assessed by the activation
marker CD69) were found in both lymphoid and nonlymphoid tissues, but not in the blood.
Expression of both CXCR3 and CCR5 was found on nearly all lymphocytes from nonlymphoid
tissues, suggesting that these chemokine receptors do not play a role in tissue-speci®c homing.
CCR4 was expressed at high levels only by lymphocytes derived from skin. CCR4 (but not CLA)
was expressed at low levels within lung and in¯amed synovial ¯uid, but never within intestinal
sites. CCR4 responses on cells sorted by CCR4 expression levels (assessed by MAbs) demonstrated
that only those cells with the highest levels of CCR4 could respond to CCR4 ligands. Thus,
functional CCR4 expression may be more tightly associated with skin homing than originally
believed.
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Screening of Th2-Speci®c Anti-In¯ammatory Agents and their Inhibitory Effects on
Th2-Dominant Allergic Reaction
M. Nonomura, Y. Ichikawa, K. Hori, I. Ichimura, H. Nojiri, Y. Takema, and G. Imokawa
Biological Science Laboratories, Kao Corporation, Tochigi, Japan
In an attempt to topically normalize Th1/Th2 imbalance involved in several in¯ammatory
cutaneous disorders including atopic dermatitis, it is intriguing to seek Th2-speci®c anti-
in¯ammatory agents instead of potent but nonspeci®c anti-in¯ammatory drugs such as
corticosteroids. In this study, inhibitory potential against IL-4 and IL-2 production was assessed
in culture following incubation with various samples during in vitro elicitation of lymph node cells
isolated from Keyhole Limpet Hemocyanin (KLH)-sensitized Balb/c mice. The amounts of the
cytokines released into the culture medium were measured by ELISA to evaluate the potential for
the Th2-speci®c inhibition. In the long course of seeking such speci®c agents, we have recently
discovered that Eucalyptus extract has a characteristic as a Th2-speci®c anti-in¯ammatory agent
with IC50 for IL-4 and IL-2 at a concentration of 0.1% and 0.5%, respectively (5 fold Th2-
speci®c), in contrast to a low Th2-speci®city for hydrocortisone with IC50 for both IL-4 and IL-2
at a concentration of 0.03 mg per ml. Topical application of the Eucalyptus extract to mouse ear lobe
at a concentration of 10% during the elicitation with house dust mite antigen (MA) (Th2-
dominant allergic reaction) showed an anti-in¯ammatory effect as revealed by 40% inhibition of
the ear swelling. In an organ culture of the elicited ear lobe, the Eucalyptus extract applied
signi®cantly suppressed the release of IL-4 into the medium without affecting the release of IFN-?.
On subsequent fractionation analysis, the most active component has been identi®ed as an aromatic
sesquiterpen alcohol, globulol, although the degree of the Th2-speci®city was slightly diminished
with IC50 for IL-4 and IL-2 at 1 mg per ml and 3 mg per ml, respectively (3 fold Th2-speci®c),
compared with the original extract. Topical application of globulol exerted a similar anti-
in¯ammatory effect on the MA-sensitized DTH model at a much lower concentration (0.1%) than
the Eucalyptus extract did. Our results indicate that topically applied Th2-speci®c anti-
in¯ammatory agents may be useful in ameliorating Th2-type in¯ammatory disorders.
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Hsp70 Induction by Artemia Extract Exhibits an Anti-In¯ammatory Effect and Down
Regulates IL-1 and IL-8 Synthesis in Human HaCaT Cells
E. Bauza, C. Dal Farra, and N. Domloge
Dermatology & Biochemistry, Seporga Research Laboratories, Sophia Antipolis, France
Heat Shock Proteins 70 (Hsp70) play an important role in cell protection against different forms of
stress such as thermal shock and UV irradiation. It has been shown that induction of Hsp70 inhibits
IL-1 and other cytokines biosynthesis in human cells and, thereby, serves a protective role by
suppressing the proin¯ammatory response. As our prior studies have demonstrated that human cell
treatment with Artemia extract 3% induces Hsp70 in a stress-free manner, we investigated the anti-
in¯ammatory effect of Artemia-induced Hsp70 on IL-1a and IL-8 synthesis in irradiated HaCat
cells. ELISA assays were performed in order to determine total IL-1a and IL-8 synthesis after UVB
exposure. UVB dose course studies (0, 10, 20, 30, 40 mJ per cm2), and time course experiments (0,
6, 8, 18, 24 h) were performed. The results showed that the dose of choice of UVB to study IL-1a
and IL-8 synthesis was 30 mJ per cm2, and that maximum synthesis occurred 6±8 h after UVB
radiation for IL-1a, 18±24 h for IL-8. Moreover, our studies demonstrated that, depending on
UVB doses, IL-1a and IL-8 level of synthesis decreases considerably in the Hsp70-induced cells,
by 20±30% and 25±40%, respectively, compared to the control cells. Interestingly, maximum
decrease in IL-1a in these cells was observed 18±24 h after UV. Statistical treatment of these results
by the Student's T-test (p < 0.05) showed that the decrease of synthesis level of these two related
cytokines is signi®cant. Our studies con®rm the anti-in¯ammatory effect of Hsp70 and propose a
very interesting and new approach to inhibiting the in¯ammatory response via stress-free Hsp70
induction in the cells.
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Artemia Extract Induces Hsp70 in Human Cells and Enhances Cell Protection from
Stress
K. Cucumel, J. Botto, E. Bauza, C. Dal Farra, R. Roetto,* and N. Domloge
Dermatology, Seporga, Sophia Antipolis, France; *Biology, University of Colorado, Boulder, Colorado
Heat shock proteins (Hsps) or molecular chaperons, play an important role in protecting cells from
different types of stress (in particular Hsp70). In mammalian cells, under nonstressful conditions,
Hsps are signi®cant for cell development, differentiation and for protein folding and assembly. As
we previously studied the multiple cell-protective effects of Artemia extract, we investigated
whether the induction of Hsp70 was one of these protective mechanisms. Different time and dose
course studies showed that Artemia extract 3% signi®cantly induced Hsp70 synthesis in cultured
human ®broblasts, HaCat and A431 cells. In ®broblasts, Northern blot studies revealed Hsp70
mRNA expression within 3 h of Artemia extract application. The protein pro®le of Hsp70 shows a
moderate increase in the ®rst hour, probably due to the translation of some pre-existent Hsp70
mRNA in the cell, followed by a stronger and consistent increase 3, 6, and 24 h later. Other studies
strongly suggest that this induction of Hsp70 is stress-free. As stress is the condition that usually
triggers Hsps synthesis, we have the ®rst evidence of a stress-free Hsp induction mechanism. In
order to investigate the ability of stress-free Hsp70 induction in enhancing cell physiological
protection from stress, we exposed the cells to a thermal shock (47°C for 1 h). Cells treated with
Artemia were less affected and more resistant to the heat insult than the untreated cells. Moreover,
studies on an ex vivo model con®rmed these results and showed that Artemia extract 3% application
in a cream formula into the skin signi®cantly induced Hsp70 protein in the skin's keratinocytes and
®broblasts, compared to the placebo-treated control. Moreover, Artemia-induced Hsp70 skin
samples exposed to heat stress presented a well-preserved structure and minimal heat-injury signs
compared to placebo-treated skin. These studies demonstrate that Artemia extract induces Hsp70
in human cells and skin. This induction is stress-free and increases skin defense and resistance to
stress.
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Tumor Necrosis Factor Receptor-I Pathway Involved in Arsenic Induced Human T-
Helper Cells Apoptosis
H. Yu, W. Liao, and K. Chang
Dermatology and Biochemistry, Kaohsiung Medical University, Kaohsiung, Taiwan
Epidemiological studies demonstrated that long-term exposure to arsenic induces arsenical skin
cancers, including Bowen's disease. Patients with Bowen's disease showed a defective
immunological function and a decreased T-helper subpopulation in peripheral mononuclear cells
(MNC). The purpose of this study was to investigate the effects of arsenic on T cell survival and
functions in MNC. The cytotoxicity of arsenic was detected by XTT assay. Cell cycle analysis and
TUNEL staining of apoptotic cells were measured by ¯ow cytometry. We also detected the
apoptosis associated TNF receptor-I (TNF-RI) expression on T cells using double stained ¯ow
cytometric analysis. The apoptosis related protein expression in TNF-RI pathway were detected
by Western blotting. Arsenic concentrations higher than 1 mM induced cytotoxic effect on T cells.
When exposed to arsenic, MNC cell cycle was arrested at G0/G1 phase, at the same time,
apoptotic cell death was induced. CD4+ T-helper cells were the major apoptoic population in
MNC. TNF-RI expression on CD4+ cells was signi®cantly enhanced by arsenic treatment when
compared to other cells in MNC. This ®nding may provide a reasonable explanation that T-helper
cells are sensitive to arsenic stimulated apoptotic induction. Increased expressions of TNF-RI
related proteins, i.e. TNF-RI associated death domain protein, Fas-associating protein with death
domain and activated caspases were observed. TNF-RI plays an important role in apoptotic
signaling in various physiological and pathological conditions, especially in immunological
reactions. Our results indicate that TNF-RI signaling is involved in arsenic induced apoptosis in T-
helper cells.
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The Regulatory Roles of Adenylate Cyclase and Cyclic Nucleotide Phosphodiesterases 1
and 4 in Interleukin-13 Secretion by Activated Human T Cells
N. Kanda and S. Watanabe
Dermatology, Teikyo University School of Medicine, Tokyo, Japan
We studied the activities of cAMP-synthesizing adenylate cyclase (AC) and cAMP-hydrolyzing
cyclic nucleotide phosphodiesterase (PDE) in PHA- or anti-CD3 plus anti-CD28-stimulated
human T cells, and examined their roles in IL-13 secretion. PHA- or anti-CD3/CD28-induced
IL-13 secretion was blocked by AC inhibitor MDL 12 330 A, PDE 1 inhibitor 8-methoxymethyl-
3-isobutyl-1-methylxanthine, or PDE4 inhibitor rolipram. AC in T cells was transiently activated
5 min after stimuli, followed by the transient activation of PDE4 at 30 min PDE1 activity,
undetectable in resting T cells, was detected 3 h after stimuli, then gradually increased. Anti-CD3/
CD28, but not PHA, increased PDE1, 2, 3, and 4-independent PDE activity, and the increase was
blocked by PDE7 antisense oligonucleotide. PHA or anti-CD3/CD28 newly induced PDE1B
mRNA expression. Neither stimulus altered PDE4 mRNA level. Anti-CD3/CD28, but not PHA,
increased PDE7 mRNA level. The cAMP level of T cells increased 5 min after stimuli, returned to
the basal level at 2 h, then continued to decrease. These results suggest that PHA or anti-CD3/
CD28 initially (= 5 min) increases cAMP in T cells via AC, then reverses the increase via PDE4
(= 2 h), and in the later phase (2 h) further decreases cAMP via PDE1. Both the time-dependent
increase and decrease of cAMP may be required for IL-13 secretion.
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Identi®cation and Functional Characterization of Human CD4+CD25+ T-Cells with
Regulatory Properties Isolated from Peripheral Blood
A. Enk, H. Jonuleit, E. Schmitt,* M. Stassen,* A. Tuettenberg, and J. Knop
Department of Dermatology, University of Mainz, Mainz, Germany; *Institute of Immunol, University of
Mainz, Mainz, Germany
CD4+ CD25+ T-cells represent a unique population of regulatory T-cells that suppress the
activation of conventional T-cells. So far these cells have only been identi®ed in rodents. This
study shows that comparable ``professional'' suppressor T-cells are also present in human blood.
Human CD4+ CD25+ or CD4+ CD25- T-cells were sequentially enriched by immunomagnetic
beads from peripheral blood. A subpopulation of human CD4+ CD25+ T-cells (but not CD25-
T-cells) express CD45RO, HLA-DR and intracellular CTLA-4, do not expand following
stimulation with mature allogeneic DC, PHA, or anti-CD3/CD28. Furthermore,
CD4+ CD25+ T-cells markedly suppress the expansion and cytokine production of conventional
CD4+ CD25- or CD8+ T-cells in a cell contact and activation dependent manner.
CD4+ CD25+ T-cells express CTLA-4 on the membrane after activation, which is detectable
for several weeks thereafter. The anergic state of CD4+ CD25+ T-cells was not reversed by
addition of anti-CTLA-4 or anti-TGF-b or anti-IL-10 antibodies. Transwell experiments
demonstrated that the suppressive properties of human CD4+ CD25+ T-cells are dependent on
direct cell contacts between regulatory and conventional T-cells. Moreover, regulatory T-cells
showed a cell cycle arrest in the G1/G0 phase and no detectable production of IL-2, IL-4, or IFN-
g either on the protein or mRNA level. The anergic state of CD4+ CD25+ T-cells was partially
reversible by addition of IL-2 or IL-4. These data demonstrate that human blood contains a
resident T cell population with potent regulatory properties.
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IL-4 Reverts DNA-Induced Th1-Development In Vitro and In Vivo
M. RoÈcken, O. Egeter, S. Zimmermann,* I. SeegmuÈller,* H. Wagner,* and K. Heeg*
Dermatology and Allergology, Ludwig-Maximilians-University, Munich, Germany; *Microbiology,
Technical University, Munich, Germany
Bacterial DNA has been shown to induce IFN-gamma producing CD4+ T cells (Th1) in vitro and
in vivo. This effect can be mimicked by single stranded oligodeoxynucleotides containing
unmethylated CpG motifs (CpG-ODN). Most strikingly, CpG-ODN are capable of redirecting
established IL-4 mediated Th2 immune responses into protective Th1 responses in murine models
of leishmaniasis and asthma. In order to study the interaction of CpG-ODN and IL-4 during T cell
differentiation, we stimulated naive transgenic CD4+ T cells from DO11.10 mice in vitro with the
speci®c peptide (OVA) and antigen presenting cells (APC) in the presence of either CpG-ODN or
CpG-ODN + IL-4. Priming of Th cells in the presence of CpG-ODN induced Th1-
differentiation as T cells secreted high amounts of IFN-gamma but no IL-4 upon restimulation.
In contrast to data obtained with L. major infection or asthma, addition of IL-4 during T cell
priming completely inhibited CpG-ODN mediated Th1-induction. Instead, T cells developed a
Th2 phenotype marked by strong antigen-speci®c IL-4- and suppressed IFN-gamma-production.
In order to evaluate the signi®cance of our ®ndings for the in vivo situation, we transferred OVA-
speci®c CD4+ T cells into BALB/c mice and immunized the mice with ovalbumin in the presence
of either CpG-ODN or CpG-ODN + IL-4. CD4+ T cells isolated from mice immunized in the
presence of CpG-ODN developed a Th1 phenotype and, again, IL-4 inhibited CpG-ODN
induced Th1-induction as Th cells isolated from mice immunized in the presence of CpG-
ODN + IL-4 showed an IL4+/IFN-g- Th2-phenotype. Since IL-4 is capable of suppressing CpG-
ODN induced IL-1, IL-12(p35) and IL-12(p40) mRNA-expression of SEB-stimulated spleen
cells, IL-4 may inhibit CpG-ODN induced Th1-differentation through a direct effect on freshly
activated APC.
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In Vitro Generation of ``Central Memory'' T Cells
K. Ferenczi,* S. King, R. Fuhlbrigge,² and T. Kupper³
Harvard Skin Disease Reaserch Center, Brigham and Women's Hospital, Boston, Maryland; *Harvard Skin
Disease Reaserch Center, Brigham and Women's Hospital, Boston, Maryland; ²Harvard Skin Disease
Reaserch Center, Brigham and Women's Hospital, Boston, Maryland; ³Harvard Skin Disease Reaserch
Center, Brigham and Women's Hospital, Boston, Massachusetts
Administration of in vitro activated antigen-speci®c autologous T cells is becoming an important
approach in cancer immunotherapy. By virtue of their having been exposed to antigen, these T
cells bear memory T cell markers, such as CD45RO. Very recently memory T cells have been
subclassi®ed into two groups based upon their homing properties. (1) ``Effector memory'' T cells
bear tissue-speci®c homing markers (CLA, a4b7) and cannot enter lymph nodes from blood due
to their lack of expression of CCR7 and L-selectin. (2) In contrast, ``central memory'' T cells are
de®ned by their expression of L-selectin, CCR7 and LFA-1, molecules absolutely required to
enter lymph nodes from blood. ``Central memory'' T cells are thought to confer long-term
memory. We reasoned that effective, lasting immunotherapy would require the transfer of central
memory T cells. As a ®rst step to approach this problem, we cultured T cells under conventional
activating conditions with anti-CD3 and IL-2. T cells cultured under these conditions expressed
low levels of L-selectin or CCR7 but virtually no cells expressed both markers. Thus, T cells
cultured under conventional conditions were almost exclusively effector memory T cells. In
contrast, memory T cells cultured in the presence of IL-7 coexpressed high levels of the molecules
that de®ne central memory T cells: L-selectin and CCR7. It may be that the ef®cacy of autologous
T cell therapy can be enhanced by optimizing conditions that favor central memory cell generation
in vitro.
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Differential Regulation of CTLA-4 in Human Memory and Naive CD4+ T Cells
H. Wong, V. Warke,* K. Sandeep,* E. Enyedy, M. Nambier, D. Farber,* and G. Tsokos
Cellular Injury, Walter Reed Army Institute of Research, Silver Spring, Maryland; *Cell Biology and
Molecular Genetics, University of Maryland, College Park, Maryland; ²Dermatology, Henry Ford Health
System, Detroit, Michigan
Immunologic memory is a cardinal aspect of the immune response and is acquired upon exposure
to antigen. Proper development of memory is essential for elimination of antigen. Abnormalities in
memory T cell function can lead to diverse cutaneous and systemic in¯ammatory diseases. At the
molecular level, the basis of T cell memory remains poorly characterized, particularly in the CD4+
subset. It is believed that memory cells undergo biochemical and genetic changes that permit these
cells to respond qualitatively and quantitatively more robustly to an antigenic stimulus. One surface
marker, CD45RO, has been used to separate memory CD4+ T cells from naõÈve T cells. To study
the molecular differences between these two subpopulations, we isolated genes that were expressed
preferentially in CD45RO+,CD4+ T cells by a PCR based, suppressive-subtraction approach.
Numerous genes were identi®ed that were expressed at a greater level in memory T cells. One
gene identi®ed by this method and is important in immune function is CTLA-4 (CD152). CTLA-
4 shares homology to CD28 and binds costimulatory molecules B7-1 and B7-2 to regulate T cell
activation. By RT-PCR, the level of CTLA-4 expression was greater in CD45RO + T cells by 7
fold. In addition, the protein level for CTLA-4 as measured by immunoblots was higher in the
CD45RO+ population. Upon activation of memory T cells, CTLA-4 was induced with a more
rapid kinetics in comparison to naõÈve T cells at the message level and the protein level. These
®ndings indicate that the mechanism regulating CTLA-4 expression differs in naõÈve and memory T
cells, both in the resting and activated state. These ®ndings suggest that studying the regulation of
CTLA-4 expression in naõÈve and memory T cells may lead to an understanding of memory T cell
development and insight into mechanisms of memory T cell-mediated diseases.
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A Critical Role for CCR6 in the Arrest of CLA+ Memory T Cells on Microvascular
Endothelia Under Physiologic Flow Conditions In Vitro
W. Maki, D. Fitzhugh, S. Caughman,* S. Naik,* and S. Hwang
Dermatology Branch, NCI, Bethesda, Maryland; *Department Dermatology, Emory University School of
Medical, Atlanta, Georgia
CC chemokine receptors 4 and 6 (CCR4 and CCR6) are expressed by skin-homing memory T
cells (mTC) in psoriasis and may be involved in T cell recruitment to skin. We asked whether one
or the other was required for ®rm arrest of mTC on activated human dermal microvascular
endothelial cells (HDMEC) in vitro. By real-time quantitative RT-PCR, LARC (a CCR6 ligand)
mRNA was up-regulated 170-fold in TNF-a-stimulated HDMEC whereas TARC (a CCR4
ligand) was minimally expressed. CD45RA± human mTC (15±40% CLA+) enriched from
peripheral blood were injected into a parallel plate ¯ow chamber at 1.5 dynes per cm2 using either
an activated HDMEC monolayer or recombinant chemokines and adhesion molecules coated onto
plastic as substrates for rolling and arrest. T cell arrest after 5 min of ¯ow was quanti®ed with
motion analysis software. LARC (vs. no chemokine) increased arrest of CLA+ mTC as well as of
CCR6-transduced Jurkat T cells by 6-fold in ¯ow assays with recombinant E-selectin/ICAM-1.
Rolling and arrest of mTC on activated HDMEC was E-selectin- and CLA-dependent. Exposure
of mTC to receptor desensitizing levels (1 mg per ml) of LARC caused a 50±75% decrease (n = 8, p
< 0.001) in arrest of mTC that was indistinguishable from the decrease observed when mTC were
treated with pertussis toxin (n = 8, p > 0.5), which inactivates Gi-protein-coupled chemokine
receptors. By contrast, exposure of mTC to TARC and SLC (a CCR7 ligand) had no effect on
arrest. Furthermore, mTC depleted of CCR6+ cells by magnetic beads arrested poorly on
HDMEC. By confocal microscopy, CCR6 redistributed to the leading edge of polarized mTC
after arrest on HDMEC. Our results clearly demonstrate that CCR6 expression by skin-homing
mTC is a critical component in chemokine receptor-mediated arrest of mTC in vitro and is likely
to contribute to the recruitment of mTC to in¯amed skin in vivo.
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Very Late Antigen (VLA)-5 Costimulation of CD4+ T Cells: Relevance to UV-Induced
Immunotolerance
S. Stevens, T. Bon®eld, A. Levine,² and T. McCormick
Department of Derm., University Hosp. Research Institute and Case Western Reserve University, Cleveland,
Ohio; *Dermatology, Cleveland VA Medical Center, Cleveland, Ohio; ²Medicine, Case Western Reserve
University, Cleveland, Ohio
Macrophages that in®ltrate UV-exposed skin (UV-Mph) are associated with the induction of
antigen-speci®c tolerance. We previously showed, in humans, that the activation of CD4+ T cells
(TC) by UV-Mph differs from that by Langerhans cells (LC); including de®cient expression of IL-
2 receptora-chain (CD25), induction of type 2 cytokines, and distinct costimulatory molecule and
growth factor use by UV Mph-, relative to LC-activated TC. We now explore whether integrin
signaling directs distinct TC activation by UV-Mph. Blocking TC VLA-5 a-chain (CD49e) with
antibodies (Ab) inhibited UV-Mph, but not LC-stimulated growth in mixed epidermal cell-
lymphocyte reactions (to 50 6 23% vs. 110 6 15% of control Ab-containing cultures). We then
explored the role of CD49e in TC activation using these Ab. Activation through CD49e and CD3
increased TC growth 180 6 17% relative to through CD3 alone. Using immunoprecipitation and
Western blotting, alterations in protein phosphotyrosine patterns are seen upon addition of anti-
CD49e to anti-CD3 stimulation including increased FAK and jun and reduced src. Although
augmented by stimulation through CD49e and CD3, FAK phosphorylation was markedly reduced
and Pyk2 was elevated by the addition of CD28 stimulating Ab. Flow cytometry showed CD3
stimulation for 24 h caused 17 6 9% of TC to become CD25+ 0. Addition of anti-CD28 Ab
increased this to 29 6 11%. In contrast, only 9 6 3% of CD3/CD49e-stimulated TC up-regulated
CD25. Interestingly, simultaneous stimulation through CD3, CD28 and CD49e up-regulated
CD25 on only 13 6 7% TC. These results demonstrate that a5 integrin (CD49e): (1) is used during
TC activation by UV-Mph, but not by LC (2) provides true costimulation rather than merely
adhesion, and (3) induces CD25-de®cient TC activation as do UV-Mph. Also, these results suggest
that depending on context, a5 integrin signaling may have a greater role in adhesion (via FAK
signaling) or TC activation (via src or Pyk2 signaling). We conclude that differences in immune
outcome mediated by UV-Mph (tolerance) and LC (sensitization) are brought about in part by
differences in costimulatory signals provided to TC and that a5 integrin signaling is important to
TC activation by UV-Mph but not LC.
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gdT Cells Regulate the Development of Hapten Speci®c Effector T Cells in Contact
Hypersensitivity Responses
H. Guan, C. Elmets, and H. Xu
Dermatology, University of Alabama at Birmingham, Birmingham, Alabama
gdT cells are widely located in the peripheral tissues and secondary lymphoid organs. It has been
reported that gdT cells are required for transfer of contact hypersensitivity (CHS) responses by
hapten primed T cells. However, the mechanism by which they do so remains to be elucidated.
Initial experiments employed Td gene knockout mice that are de®cient in gdT cells but are normal
in the development of abT cells. When mice were contact sensitized to DNFB, CHS responses
were signi®cantly greater in gdT cell de®cient mice than in wild type mice. Similar results were
obtained when wild type mice were depleted of gdT cells with antibody treatment before hapten
sensitization. Depletion of CD4+ T cells did not affect the increased CHS response in gdT cell
de®cient mice, suggesting that the effect of gdT cells is on CD8+ T cells and does not require
CD4+ T cells. Transfer of primed lymph node cells from hapten primed gdT cell de®cient mice
elicited a similar level of CHS in naõÈve wild type and the de®cient recipient mice, indicating that
gdT cells have little effects on the elicitation of primed T cells and CHS responses. Further
experiments demonstrated that primed CD8+ T cells from the de®cient mice exhibited
signi®cantly higher CTL activity than those from the wild type mice. The cytokine pro®le of
CD4+ T cells was not signi®cantly altered. We conclude that gdT cells down-regulate CHS
responses to hapten sensitization by limiting the development of hapten speci®c CD8 + effector T
cells during sensitization and that this effect is independent of CD4+ T cells.
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Expression of b-Defensins in Human Keratinocyte Cell Lines
S. Seo, S. Ahn, and C. Hong
Dermatology, College of Medicine, Chung-Ang University Hospital, Seoul, South Korea
Defensins, a major family of antimicrobial peptides, are small cationic, cysteine-rich peptides with a
wide range of antimicrobial activity. In human, b-defensin-1 was isolated from urine and cervical
mucous suggesting that this peptide plays an antimicrobial role in the genitourinary tract. b-
defensin-2 was identi®ed in psoriatic scale produced by keratinocytes suggesting that this peptide
contribute to defense the expansive surface of the integuments. This work was done to investigate
the expression and modulation of b-defensin mrna in human keratinocyte cell lines. Cultured
human keratinocytes were stimulated with ultraviolet B irradiation or tumor necrosis factor-a or
lipopolysaccharide to determine whether defensin mrna production occurred. Reverse transcrip-
tion polymerase chain reaction was performed to amplify defesin cDNA from stimulated
keratinocytes, and Southern blots were used to verify the speci®city of Reverse transcription
polymerase chain reaction amplication products. Expression of human b-defensins was up-
regulated with ultraviolet B irradiation, tumor necrosis factor-a and lipopolysaccharide in Hacat
cells and in comparison to the control, signi®cantly higher at 6 h post stimulation with ultraviolet B
100 mJ/§2 and peak at 12 through 18 h post stimulation with ultraviolet B 30 mJ/§2, tumor
necrosis factor-a and lipopolysaccharide. A431 cells did not show expression of human b-defensins
in unstimulated state, even after stimulation with ultraviolet B irradiation or tumor necrosis factor-
a or lipopolysaccharide. This report demonstrates the presence of defensin in the human
keratinocyte and th capacity of human keratinocytes to produce defensin mRNA in response to
ultraviolet B irradiation, tumor necrosis factor-a and lipopolysaccharide. Release of defensins by
keratinocytes in response to cytokines elaborated in in¯ammation may contribute to the host
defense response.
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Cathelicidin Antimicrobial Peptides Affect Adaptive Immunity by Regulation of
Cytokine Production
D. Lee, R. Dorschner,* and R. Gallo
Medicine/Pediatrics/Dermatology, U of California San Diego, San Diego, California; *Dermatology, VA
San Diego, San Diego, California
Cathelicidins are a-helical cationic peptides expressed by keratinocytes and granulocytes that are
thought to be important mediators of innate immunity due to their direct antimicrobial action. To
determine if their expression may in¯uence adaptive immunity, cytokine responsiveness was
measured in murine T cells, the Langerhans cell line XS52, and the human keratinocyte line HaCat
after exposure to cathelicidins. Splenocytes or CD4-puri®ed cells were stimulated with anti-CD3
and anti-CD28. At physiologic concentrations the murine cathelicidin CRAMP inhibited release
of IL4 by 78% (1096 6 249 vs. 241 6 16 pg per ml), IL13 by 88% (2884 6 874 vs. 357 6 31 pg
per ml), and IFNg by 67% (7571 6 1539 vs. 2464 6 823 pg per ml). CRAMP did not affect IL6
production (368 6 19 vs. 325 6 26 pg per ml). Similarly, CRAMP inhibited IL1 b production
from LPS stimulated XS52 cells (368 pg per ml 6 113 vs. 234 6 15), though in the absence of LPS
it stimulated IL1b release from undetectable baseline to 47.83 6 6 pg per ml. The human
cathelicidin LL-37 stimulated HaCat cells to produce IL1a (17 pg per ml 6 3 vs. 1.44 6 0.79 at 5
h) and IL6 (524 pg per ml 6 14 vs. 308 6 11 at 24 h). To determine if the decrease in cytokines was
due to direct cytotoxic effects, viability and apoptosis was determined by propidium iodide (PI)
staining and FACS analysis. CRAMP increased cell death in splenocytes (at 3 h, 19.5 6 1.7 sd. vs.
35.4 6 5.4%), and cellular debris with sub G0 DNA content (at 24 h, 12.6 6 0.5 vs. 17.4 6 1.7%).
These results show that depending on the state of cell activation cathelicidins can inhibit or induce
cytokines from T-cells, antigen presenting cells and keratinocytes. This suggests innate
antimicrobial peptides may in¯uence subsequent events in the adaptive immune response. Such
an interation is a previously unknown event in cutaneous immunity that may play a role in several
skin diseases.
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Analysis of the Regulation of Cathelicidin Antimicrobial Peptides in the Keratinocyte
Line HaCaT
V. Pestonjamasp, V. Morhenn, and R. Gallo
Dermatology, U of California San Diego, San Diego, California
Cathelicidins are a gene family of peptides that can directly kill bacteria while also inducing
eukaryotic cell effects such as leukocyte chemo-attraction and synthesis of extracellular matrix
components. Human cathelicidin (LL-37), is not detected in normal epidermis but is expressed in
skin disorders such as psoriasis, contact dermatitis and wound healing. Similarly, murine
cathelicidin (CRAMP) is induced in skin only when the normal skin is injured. Therefore,
cathelicidin expression may provide antimicrobial resistance to the skin and be bene®cial to wound
repair. To investigate the mechanisms that lead to cathelicidin expression, we have stimulated
HaCaT cells with known mediators of in¯ammation. Using quantitative RT-PCR by light-cycler,
we ®nd that the tumor promoter, phorbol myristate acetate (PMA), regulates the LL-37 expression
in a time- and concentration-dependent manner. Human recombinant interferon-g (IFN-g) also
modulates cathelicidin expression in a time-dependent fashion. In addition, we have detected LL-
37 protein synthesis in response to IFN-? by dot blot analysis. Our preliminary data also implicate
bacterial lipopolysaccharide (LPS) as a positive signal for induction of LL-37 expression in HaCat.
To further study the regulation of cathelicidin expression, truncations of the 5¢ ¯anking region of
the murine cathelicidin CRAMP gene have been carried out. These constructs were cloned into a
luciferase reporter system and the luciferase activity determined in a variety of cell types.
Preliminary data indicate evolutionarily conserved regions of the CRAMP promoter that regulate
gene expression. In conclusion, we show that cathelicidin expression can be modulated in response
to in¯ammatory mediators. Since cathelicidins are versatile molecules with multiple functions in
protecting the skin, these results offer a system that has potential applications for the therapy of
human skin disorders.
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Altered Cutaneous Immune Parameters in Transgenic Mice Over-Expressing Viral IL-
10 in the Epidermis
W. Ding, S. Beissert,* L. Deng, C. Cassetty, K. Seiffert, Z. Yan,² J. Wagner,² J. Bluestone,² and
R. Granstein²
Dermatology, Weill Medical College of Cornell University, New York, New York; *Dermatology,
University of Muenster, Muenster, Germany; ²Medicine, University of Calif.ornia, San Francisco, San
Francisco, California
IL-10 is a pleiotropic cytokine that inhibits several immune parameters including Th1 cell-
mediated immune responses and cytokine production, antigen presentation, and antigen-speci®c T
cell proliferation. In some systems, IL-10 augments Th2-type responses. Recent data implicate IL-
10 as a mediator in the suppression of cell-mediated immunity induced by exposure to midrange
ultraviolet radiation (UVB, 280±320 nm). Viral IL-10 (vIL-10) is ~80% identical with human IL-
10 and also exhibits considerable sequence homology with mouse IL-10. To investigate the effects
of IL-10 on the cutaneous immune system, we developed transgenic mice over-expressing vIL-10
in the epidermis. Epidermal cells from vIL-10 transgenic mice produced vIL-10 in culture and vIL-
10 could be detected in serum. I-A-positive epidermal cells and dermal dendritic cells were
reduced in number although the density of epidermal ATPase-positive cells appeared to be normal
in epidermal sheets. After hapten painting of the skin, the number of I-A-positive, hapten-bearing
cells detected in regional lymph nodes was reduced in vIL-10 transgenic mice compared to
controls. CD80 and CD86 expression by I-A-positive epidermal cells was reduced in vIL-10
transgenic mice. After immunization with allogeneic cells, these mice demonstrated a signi®cantly
smaller delayed-type hypersensitivity (DTH) response to allogeneic cells upon challenge, but had
normal contact hypersensitivity to an epicutaneously applied hapten. Fresh EC from vIL-10
transgenic mice showed a decreased ability to stimulate allogeneic T cell proliferation. Our data
demonstrate the ability of vIL-10 to alter LC physiology and inhibit DTH. These ®ndings support
the concept that IL-10 is an important regulator of cutaneous immune function.
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Comparison of g-Interferon Signal Transduction in Monolayer and Scaffold-Based
Three-Dimensional Fibroblast Culture
J. Mansbridge, K. Liu, and A. Kern
Research, Advanced Tissue Sciences, La Jolla, California
When ®broblasts in monolayer culture are treated with g-interferon (IFN-g), HLA-DR is induced
and CD-40 is stimulated. By contrast, ®broblasts grown in three-dimensional culture on a scaffold
show a major nonresponsive cell population. We have found that other IFN-g-induced genes,
including HLA class I and ICAM-1, show monotonic induction by all the cells in three-
dimensional culture. We have investigated this system by immunoblot and by Taqman real time
PCR to determine to what extent the IFN-g-related signal transduction systems of the cells are
affected by three-dimensional scaffold-based culture. Examination of STAT-1 phosphorylation by
immunoblot has shown that this activity is essentially indistinguishable between monolayer and
three-dimensional culture, indicating that the early stages of the IFN-g signal transduction pathway
are intact. We have examined the induction of the transcriptional regulator CIITA, which controls
the expression of the HLA-DR region through interaction with DNA-binding proteins.
Quantitative estimation of mRNA for CIITA has demonstrated it is induced in three-dimensional
culture but only reaches a cellular concentration of a quarter that in monolayer. This may be
accounted for by the minority of cells that shows induction. Thus, inhibition of transactivator
expression is able to account for the lack of HLA-DR induction. In an examination of MAP
kinases, we have found that p38 is not activated in three-dimensional culture as it is in monolayer.
We conclude that the IFN-g signal transduction systems is intact as far as STAT-1 phosphorylation,
but inhibition of HLA-DR and CD40 induction is caused by lack of expression of CIITA. This
effect may, in part, explain the lack of rejection of allogeneic ®broblasts cultured in this way.
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